<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Non‐invasive positive pressure ventilation for central sleep apnoea in adults - Pinto, ACPereira Nunes - 2022 | Cochrane Library</title> <meta content="Non‐invasive positive pressure ventilation for central sleep apnoea in adults - Pinto, ACPereira Nunes - 2022 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012889.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Non‐invasive positive pressure ventilation for central sleep apnoea in adults - Pinto, ACPereira Nunes - 2022 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012889.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012889.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Non‐invasive positive pressure ventilation for central sleep apnoea in adults" name="citation_title"/> <meta content="Ana Carolina Pereira Nunes Pinto" name="citation_author"/> <meta content="anacarolinapnp@hotmail.com" name="citation_author_email"/> <meta content="Aline Rocha" name="citation_author"/> <meta content="Núcleo de Avaliação de Tecnologias em Saúde" name="citation_author_institution"/> <meta content="Luciano F Drager" name="citation_author"/> <meta content="Geraldo Lorenzi-Filho" name="citation_author"/> <meta content="Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo" name="citation_author_institution"/> <meta content="Daniela V Pachito" name="citation_author"/> <meta content="Prossono" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="10" name="citation_issue"/> <meta content="10.1002/14651858.CD012889.pub2" name="citation_doi"/> <meta content="2022" name="citation_date"/> <meta content="2022/10/24" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012889.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012889.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012889.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Continuous Positive Airway Pressure; *Disorders of Excessive Somnolence; *Heart Failure; *Sleep Apnea, Central [therapy]; *Sleep Apnea, Obstructive [therapy]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012889.pub2&amp;doi=10.1002/14651858.CD012889.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012889.pub2&amp;doi=10.1002/14651858.CD012889.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012889.pub2&amp;doi=10.1002/14651858.CD012889.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012889.pub2&amp;doi=10.1002/14651858.CD012889.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012889.pub2&amp;doi=10.1002/14651858.CD012889.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012889.pub2&amp;doi=10.1002/14651858.CD012889.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012889.pub2&amp;doi=10.1002/14651858.CD012889.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012889.pub2&amp;doi=10.1002/14651858.CD012889.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012889.pub2&amp;doi=10.1002/14651858.CD012889.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012889.pub2&amp;doi=10.1002/14651858.CD012889.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012889.pub2&amp;doi=10.1002/14651858.CD012889.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012889.pub2&amp;doi=10.1002/14651858.CD012889.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012889.pub2&amp;doi=10.1002/14651858.CD012889.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012889.pub2&amp;doi=10.1002/14651858.CD012889.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012889.pub2&amp;doi=10.1002/14651858.CD012889.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012889.pub2&amp;doi=10.1002/14651858.CD012889.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012889.pub2&amp;doi=10.1002/14651858.CD012889.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012889.pub2&amp;doi=10.1002/14651858.CD012889.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012889.pub2&amp;doi=10.1002/14651858.CD012889.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012889.pub2&amp;doi=10.1002/14651858.CD012889.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012889.pub2&amp;doi=10.1002/14651858.CD012889.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012889.pub2&amp;doi=10.1002/14651858.CD012889.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012889.pub2&amp;doi=10.1002/14651858.CD012889.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="kKvAiZoF";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012889\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012889\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012889\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012889\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANS","zh_HANT","pt","ko","th","ms","ja","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012889.pub2",title:"Non\\u2010invasive positive pressure ventilation for central sleep apnoea in adults",firstPublishedDate:"Oct 24, 2022 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Airways Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=kKvAiZoF&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012889.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012889.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012889.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012889.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012889.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012889.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012889.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012889.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012889.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012889.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3280 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012889.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012889.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012889.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012889.pub2/full#CD012889-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012889.pub2/full#CD012889-sec-0156"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012889.pub2/full#CD012889-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012889.pub2/full#CD012889-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012889.pub2/full#CD012889-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012889.pub2/full#CD012889-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012889.pub2/full#CD012889-sec-0040"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012889.pub2/full#CD012889-sec-0150"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012889.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012889.pub2/appendices#CD012889-sec-0161"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012889.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012889.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/supinfo/CD012889StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/supinfo/CD012889StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012889.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012889.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012889.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012889.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012889.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012889.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2022 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Non‐invasive positive pressure ventilation for central sleep apnoea in adults</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012889.pub2/information#CD012889-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Ana Carolina Pereira Nunes Pinto</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012889.pub2/information#CD012889-cr-0005">Aline Rocha</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012889.pub2/information#CD012889-cr-0006">Luciano F Drager</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012889.pub2/information#CD012889-cr-0007">Geraldo Lorenzi-Filho</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012889.pub2/information#CD012889-cr-0008">Daniela V Pachito</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/information/en#CD012889-sec-0167">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 24 October 2022 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012889.pub2">https://doi.org/10.1002/14651858.CD012889.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012889-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012889-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012889-abs-0019">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012889-abs-0015">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012889-abs-0017">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD012889-abs-0009">한국어</a> </li> <li class="section-language"> <a class="" href="full/pt#CD012889-abs-0007">Português</a> </li> <li class="section-language"> <a class="" href="full/th#CD012889-abs-0011">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012889-abs-0004">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012889-abs-0001" lang="en"> <section id="CD012889-sec-0001"> <h3 class="title" id="CD012889-sec-0001">Background</h3> <p>Central sleep apnoea (CSA) is characterised by abnormal patterns of ventilation during sleep due to a dysfunctional drive to breathe. Consequently, people with CSA may present poor sleep quality, sleep fragmentation, inattention, fatigue, daytime sleepiness, and reduced quality of life. </p> </section> <section id="CD012889-sec-0002"> <h3 class="title" id="CD012889-sec-0002">Objectives</h3> <p>To assess the effectiveness and safety of non‐invasive positive pressure ventilation (NIPV) for the treatment of adults with CSA. </p> </section> <section id="CD012889-sec-0003"> <h3 class="title" id="CD012889-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, and Scopus on 6 September 2021. We applied no restrictions on language of publication. We also searched clinical trials registries for ongoing and unpublished studies, and scanned the reference lists of included studies to identify additional studies. </p> </section> <section id="CD012889-sec-0004"> <h3 class="title" id="CD012889-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) reported in full text, those published as abstract only, and unpublished data. </p> </section> <section id="CD012889-sec-0005"> <h3 class="title" id="CD012889-sec-0005">Data collection and analysis</h3> <p>Two review authors independently selected studies for inclusion, extracted data, and assessed risk of bias of the included studies using the Cochrane risk of bias tool version 1.0, and the certainty of the evidence using the GRADE approach. In the case of disagreement, a third review author was consulted. </p> </section> <section id="CD012889-sec-0006"> <h3 class="title" id="CD012889-sec-0006">Main results</h3> <p>We included 15 RCTs with a total of 1936 participants, ranging from 10 to 1325 participants. All studies had important methodological limitations. We assessed most studies (11 studies) as at high risk of bias for at least one domain, and all studies as at unclear risk of bias for at least two domains. The trials included participants aged &gt; 18 years old, of which 70% to 100% were men, who were followed from one week to 60 months. The included studies assessed the effects of different modes of NIPV and CSA. Most participants had CSA associated with chronic heart failure. Because CSA encompasses a variety of causes and underlying clinical conditions, data were carefully analysed, and different conditions and populations were not pooled. The findings for the primary outcomes for the seven evaluated comparisons are presented below.  </p> <p><b>Continuous positive airway pressure (CPAP) plus best supportive care versus best supportive care in CSA associated with chronic heart failure</b> </p> <p>In the short term, CPAP plus best supportive care may reduce central apnoea hypopnoea index (AHI) (mean difference (MD) −14.60, 95% confidence interval (CI) −20.11 to −9.09; 1 study; 205 participants). However, CPAP plus best supportive care may result in little to no difference in cardiovascular mortality compared to best supportive care alone. The evidence for the effect of CPAP plus best supportive care on all‐cause mortality is very uncertain. No adverse effects were observed with CPAP, and the results for adverse events in the best supportive care group were not reported. </p> <p><b>Adaptive servo ventilation (ASV) versus CPAP in CSA associated with chronic heart failure</b> </p> <p>The evidence is very uncertain about the effect of ASV versus CPAP on quality of life evaluated in both the short and medium term. Data on adverse events were not reported, and it is not clear whether data were sought but not found. </p> <p><b>ASV versus bilevel ventilation in CSA associated with chronic heart failure</b> </p> <p>In the short term, ASV may result in little to no difference in central AHI. No adverse events were detected with ASV, and the results for adverse events in the bilevel ventilation group were not reported. </p> <p><b>ASV plus best supportive care versus best supportive care in CSA associated with chronic heart failure</b> </p> <p>In the medium term, ASV plus best supportive care may reduce AHI compared to best supportive care alone (MD −20.30, 95% CI −28.75 to −11.85; 1 study; 30 participants). In the long term, ASV plus best supportive care likely increases cardiovascular mortality compared to best supportive care (risk ratio (RR) 1.25, 95% CI 1.04, 1.49; 1 study; 1325 participants). The evidence suggests that ASV plus best supportive care may result in little to no difference in quality of life in the short, medium, and long term, and in all‐cause mortality in the medium and long term. Data on adverse events were evaluated but not reported. </p> <p><b>ASV plus best supportive care versus best supportive care in CSA with acute heart failure with preserved ejection fraction</b> </p> <p>Only adverse events were reported for this comparison, and no adverse events were recorded in either group. </p> <p><b>ASV versus CPAP maintenance in CPAP‐induced CSA</b> </p> <p>In the short term, ASV may slightly reduce central AHI (MD −4.10, 95% CI −6.67 to −1.53; 1 study; 60 participants), but may result in little to no difference in quality of life. Data on adverse events were not reported, and it is not clear whether data were sought but not found. </p> <p><b>ASV versus bilevel ventilation in CPAP‐induced CSA</b> </p> <p>In the short term, ASV may slightly reduce central AHI (MD −8.70, 95% CI −11.42 to −5.98; 1 study; 30 participants) compared to bilevel ventilation. Data on adverse events were not reported, and it is not clear whether data were sought but not found. </p> </section> <section id="CD012889-sec-0007"> <h3 class="title" id="CD012889-sec-0007">Authors' conclusions</h3> <p>CPAP plus best supportive care may reduce central AHI in people with CSA associated with chronic heart failure compared to best supportive care alone. Although ASV plus best supportive care may reduce AHI in people with CSA associated with chronic heart failure, it likely increases cardiovascular mortality in these individuals. In people with CPAP‐induced CSA, ASV may slightly reduce central AHI compared to bilevel ventilation and to CPAP. </p> <p>In the absence of data showing a favourable impact on meaningful patient‐centred outcomes and defining clinically important differences in outcomes in CSA patients, these findings need to be interpreted with caution. Considering the level of certainty of the available evidence and the heterogeneity of participants with CSA, we could draw no definitive conclusions, and further high‐quality trials focusing on patient‐centred outcomes, such as quality of life, quality of sleep, and longer‐term survival, are needed to determine whether one mode of NIPV is better than another or than best supportive care for any particular CSA patient group. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012889-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012889-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD012889-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD012889-abs-0020">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012889-abs-0016">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012889-abs-0018">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD012889-abs-0014">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD012889-abs-0010">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD012889-abs-0013">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD012889-abs-0008">Português</a> </li> <li class="section-language"> <a class="" href="full/th#CD012889-abs-0012">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012889-abs-0005">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD012889-abs-0006">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012889-abs-0002" lang="en"> <h3>Non‐invasive ventilation for people with central sleep apnoea</h3> <p><b>What was studied in this review?</b> </p> <p>This review looked at the effect of non‐invasive ventilation (NIV) compared to other treatments or a different types of NIV in people with central sleep apnoea (CSA), a disorder where the person regularly stops breathing during sleep because their brain fails to tell their muscles to take in air. CSA more commonly affects men and people with chronic heart disease. People with CSA may wake up often during the night, feel very sleepy during the day, and not be able to exercise as much as usual. Sleep apnoea may also increase a person's risk of other conditions, such as heart attack and stroke, and death. </p> <p>In NIV a machine is used to help the person breath. During NIV therapy, the person uses a face mask or nasal mask through which air is forced into their lungs to lessen the need of respiratory effort. Several types of NIV therapies are available, using different ways of delivering the breathing support; some examples are below. </p> <p>• Continuous positive airway pressure (CPAP): air is forced into the lungs continuously (during inspiration and expiration).<br/>• Bilevel positive airway pressure (BiPAP): air is forced into the lungs more during inspiration than during expiration.<br/>• Adaptive servo ventilation (ASV): air is forced into the lungs mainly when the person stops breathing. </p> <p>Non‐invasive ventilation may help the air get into the lungs. However, we do not know if NIV also helps the person live longer and better, or if it can cause any harm. </p> <p><b>What was the aim of this review?</b> </p> <p>The aim of this review was to find out whether any type of NIV can be more helpful than harmful to people with CSA than other therapies or another type of NIV. We collected and analysed all currently available relevant studies to answer this question. </p> <p><b>What were the main results of this review?</b> </p> <p>We included 15 studies dating from 1995 to 2019, involving a total of 1936 adult participants. Most studies included men who had chronic heart disease and CSA at the same time. The included studies looked at different comparisons, such as CPAP versus best supportive care, ASV versus best supportive care, ASV versus CPAP, and ASV versus BiPAP. In these studies, participants were assigned to receive the types of NIV or other therapies by chance (randomised controlled trials). </p> <p>As we found studies that compared several modes of NIV, with mostly small numbers of participants to include in each comparison, the effects of these studies, even when study results were combined, were not precise.  Also, the methods used to assign participants to one of two or more study treatments were described incompletely, thus it is unclear whether these methods were adequate. Furthermore, in several studies, the participants were evaluated by researchers who knew which treatments participants had received, which may have influenced their assessments and led to results that are biased. We are therefore not confident in the results of the currently available studies, and can draw no strong conclusions from them. </p> <p>In people with CSA associated with chronic heart failure, using NIV (CPAP or ASV) seems to result in a lower frequency of episodes of apnoea (when the person stops breathing) than best supportive care alone in the short term (up to three months). However, it is not clear whether there are benefits in the long term (more than one year). In contrast, in the long‐term, ASV probably results in increased death related to heart conditions in people with CSA and chronic heart failure. Very few data were available regarding people with CSA that do not have chronic heart failure.  </p> <p><b>Key messages</b> </p> <p>Taken together, the results of the studies evaluated in this review do not allow us to be sure if one kind of NIV leads to more side effects than another, or whether one kind of NIV leads to more harm than benefit compared to best supportive care in people with CSA. </p> <p><b>How up‐to‐date is this review?</b> </p> <p>This review is current to 6 September 2021.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012889-sec-0156" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012889-sec-0156"></div> <h3 class="title" id="CD012889-sec-0157">Implications for practice</h3> <section id="CD012889-sec-0157"> <p>We found low‐certainty evidence suggesting that continuous positive airway pressure (CPAP) plus best supportive care may reduce central apnoea hypopnoea index (AHI) in people with central sleep apnoea (CSA) associated with chronic heart failure compared to best supportive care alone. Low‐certainty evidence suggests that ASV plus best supportive care may also reduce AHI in these individuals compared to best supportive care alone. Despite this, the results on the effects of adaptive servo ventilation (ASV) in cardiovascular mortality in people with CSA associated with chronic heart failure are controversial and indicate that ASV plus best supportive care likely increases cardiovascular mortality in these patients. In people with CPAP‐induced CSA, low‐certainty evidence suggests that ASV may slightly reduce central AHI and AHI compared to bilevel ventilation and to CPAP. In light of the existing evidence and the heterogeneity of participants with CSA, we cannot draw any conclusions as to whether any single ventilatory strategy is advantageous over other interventions for any particular CSA patient group. Non‐invasive positive pressure ventilation (NIPV) treatment approaches need to be individualised with appropriate follow‐up arrangements and evaluation of clinical response and potential adverse effects. Further high‐quality trials with long‐term follow‐up are needed to determine whether one mode of NIPV is safer or more effective than another or than best supportive care for the treatment of people with CSA. </p> </section> <h3 class="title" id="CD012889-sec-0158">Implications for research</h3> <section id="CD012889-sec-0158"> <p>As most trials included in this review used different modes of NIPV, in people with different causes of CSA, we were not able to perform a comprehensive meta‐analysis. More high‐quality randomised controlled trials are needed, using similar NIPV sets and modes, for treating participants with predominantly CSA. Additionally, studies with large samples or approximately 200 more events in the experimental intervention group and the comparator intervention group are required. These trials should not include people with obstructive sleep apnoea (OSA) or, if people with OSA are included, data from participants with CSA should be provided separately from those with OSA. Additionally, trials should preferably not mix the results of people with and without chronic heart failure. Furthermore, there is a special need for future studies to focus on patient‐centred outcomes, such as quality of life, quality of sleep, and longer‐term survival. Finally, a thorough, systematic evaluation of adverse effects in the short, medium, and long term is needed. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD012889-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD012889-sec-0008"></div> <div class="table" id="CD012889-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Continuous positive airway pressure (CPAP) plus best supportive care versus best supportive care for central sleep apnoea associated with chronic heart failure</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>CPAP plus best supportive care versus best supportive care for CSA associated with chronic heart failure</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Participants:</b> people with CSA associated with chronic heart failure </p> <p><b>Setting:</b> outpatient </p> <p><b>Intervention:</b> CPAP plus best supportive care </p> <p><b>Comparison:</b> best supportive care </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>What happens</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With best supportive care</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With CPAP plus best supportive care</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Difference</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Central AHI ‐ after 3 months</p> <p>Number of participants: 205<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean central AHI with best supportive care was 30.70.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean central AHI with CPAP was 16.10 (12.81 to 19.39).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 14.60 lower</p> <p>(20.11 lower to 9.09 lower)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝</p> <p>Low<sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CPAP plus best supportive care may reduce central AHI in the short term.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cardiovascular mortality ‐ after 24 months</p> <p>Number of participants: 258<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>RR 1.17<br/>(0.68 to 2.02) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean death rate from cardiovascular events with best supportive care was 15.40%.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean death rate from cardiovascular events with CPAP was 18.0%<br/>(10.50 to 31.10). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.60% more deaths from cardiovascular events in the treatment group<br/>(4.90 fewer to 15.70 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CPAP plus best supportive care may result in little to no difference in cardiovascular mortality in the long term. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of sleep</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>AHI ‐ after up to 3 months</p> <p>Number of participants: 264<br/>(4 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean AHI with best supportive care ranged across control groups from 19.00 to 37.60. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean AHI with CPAP ranged across intervention groups from 14.7 to 18.5.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 15.27 lower<br/>(22.44 lower to 8.11 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CPAP plus best supportive care may reduce AHI in the short term.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All‐cause mortality ‐ after 24 months</p> <p>Number of participants: 287<br/>(2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>RR 1.14<br/>(0.83 to 1.56) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean death rate with best supportive care was 26.20%.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean death rate with CPAP was 29.90%<br/>(21.80 to 40.90). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.70% more deaths in the treatment group <br/>(4.50 fewer to 14.70 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low <sup>5 6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of CPAP plus best supportive care on all‐cause mortality in the long term. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to life‐saving cardiovascular intervention (assessed with: transplant‐free survival rate) ‐ after 18 months </p> <p>Number of participants: 258<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>1 study reported an HR for transplantation‐free survival of 0.66; P = 0.06 (<a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a>). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CPAP plus best supportive care may slightly increase time to life‐saving intervention in the long term. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>AHI:</b> apnoea hypopnoea index;<b>CI:</b> confidence interval; <b>CPAP:</b> continuous positive airway pressure; <b>CSA:</b> central sleep apnoea; <b>HR:</b> hazard ratio; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>We downgraded one level due to methodological limitations (one study with high risk of bias for blinding of participants and personnel, incomplete outcome data, and selective reporting).<br/><sup>2</sup>We downgraded one level due to small sample size.<br/><sup>3</sup>We downgraded one level due to methodological limitations (one study with high risk of bias for incomplete outcome data and selective reporting).<br/><sup>4</sup>We downgraded one level due to the presence of few events.<br/><sup>5</sup>We downgraded one level due to methodological limitations (one study with high risk bias for incomplete outcome data and selective reporting and one study with unclear risk of bias for random sequence generation, allocation concealment, and selective reporting).<br/><sup>6</sup>We downgraded two levels due to the presence of few events and large CI (CI includes both important benefit and important harm). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012889-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Adaptive servo ventilation (ASV) versus continuous positive airway pressure (CPAP) for central sleep apnoea associated with chronic heart failure</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>ASV versus CPAP for CSA associated with chronic heart failure</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Participants:</b> people with CSA associated with chronic heart failure </p> <p><b>Setting:</b> outpatient </p> <p><b>Intervention:</b> ASV </p> <p><b>Comparison:</b> CPAP </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>What happens</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With CPAP</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With ASV</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Difference</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Central AHI</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cardiovascular mortality</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of sleep</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life measured with MLHFQ ‐ after 6 months</p> <p>Number of participants: 17<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean difference in quality of life with CPAP was −12.52.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean difference in quality of life with ASV was −21.16 (−33.14 to −9.18).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 8.64 lower<br/>(25.56 lower to 8.28 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of ASV on quality of life in the medium term. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>AHI ‐ after 6 months</p> <p>Number of participants: 17<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean difference in AHI with CPAP was −17.80.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean difference in AHI with ASV was −46.47 (−60.91 to −32.03).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 28.67 lower<br/>(48.28 lower to 9.06 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV may reduce AHI in the medium term.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All‐cause mortality</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to life‐saving cardiovascular intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>AHI:</b> apnoea hypopnoea index;<b>ASV:</b> adaptive servo ventilation;<b>CI:</b> confidence interval; <b>CPAP:</b> continuous positive airway pressure; <b>CSA:</b> central sleep apnoea; <b>MD:</b> mean difference; <b>MLHFQ:</b> Minnesota Living with Heart Failure Questionnaire; <b>RCT:</b> randomised controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>We downgraded one level due to important methodological limitations (one study with high risk of bias for blinding of participants and personnel, blinding of outcome assessors, and incomplete outcome data and unclear risk of bias for random sequence generation, allocation concealment, and selective reporting).<br/><sup>2</sup>We downgraded two levels due to small sample size and large CI (CI includes both important benefit and important harm).<br/><sup>3</sup>We downgraded one level due to important methodological limitations (one study with high risk of bias for blinding of participants and personnel and incomplete outcome data and unclear risk of bias for random sequence generation, allocation concealment, and selective reporting).<br/><sup>4</sup>We downgraded one level due to small sample size. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012889-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Adaptive servo ventilation (ASV) versus bilevel ventilation for central sleep apnoea associated with chronic heart failure</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>ASV versus bilevel ventilation for CSA associated with chronic heart failure</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Participants:</b> people with CSA associated with chronic heart failure </p> <p><b>Setting:</b> outpatient </p> <p><b>Intervention:</b> ASV </p> <p><b>Comparison:</b> bilevel ventilation </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>What happens</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With bilevel ventilation</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With ASV</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Difference</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Central AHI ‐ after 6 weeks</p> <p>Number of participants: 30<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean central AHI with bilevel ventilation was 1.60.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean central AHI with ASV was 2.50 (0.06 to 4.94).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.90 higher <br/>(2.40 lower to 4.20 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝</p> <p>Low<sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV may result in little to no difference in central AHI in the short term.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cardiovascular mortality</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of sleep</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>AHI ‐ after 6 weeks</p> <p>Number of participants: 30<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean AHI with bilevel ventilation was 16.40.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean AHI with ASV was 11.20 (5.99 to 16.41).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 5.20 lower<br/>(14.63 lower to 4.23 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of ASV on AHI in the short term.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All‐cause mortality</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to life‐saving cardiovascular intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>AHI:</b> apnoea hypopnoea index;<b>ASV:</b> adaptive servo ventilation;<b>CI:</b> confidence interval; <b>CSA:</b> central sleep apnoea; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>We downgraded one level due to methodological limitations (all domains at unclear risk of bias except other potential sources of bias).<br/><sup>2</sup>We downgraded one level due to small sample size.<br/><sup>3</sup>We downgraded two levels due to small sample size and large CI (CI includes both important benefit and important harm). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012889-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Adaptive servo ventilation (ASV) versus continuous positive airway pressure (CPAP) for CPAP‐induced central sleep apnoea</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>ASV versus CPAP for CPAP‐induced CSA</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Participants:</b> people with CPAP‐induced CSA </p> <p><b>Setting:</b> outpatient </p> <p><b>Intervention:</b> ASV </p> <p><b>Comparison:</b> CPAP </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>What happens</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With CPAP</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With ASV</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Difference</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Central AHI ‐ after 3 months</p> <p>Number of participants: 60<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean central AHI with CPAP was 4.80.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean central AHI with ASV was 0.70 (−0.59 to 1.99)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 4.10 lower<br/>(6.67 lower to 1.53 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝</p> <p>Low<sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV may slightly reduce central AHI in the short term.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cardiovascular mortality</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of sleep</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life ‐ after 3 months</p> <p>Number of participants: 61<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean difference in quality of life with CPAP was 0.10.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean difference in quality of life with ASV was 0.10 (−0.27 to 0.47).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.00<br/>(0.46 lower to 0.46 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV may result in little to no difference in quality of life in the short term.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>AHI ‐ after 3 months</p> <p>Number of participants: 60<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean AHI with CPAP was 9.90.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean AHI with ASV was 4.40 (0.75 to 8.05).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 5.50 lower <br/>(10.74 lower to 0.26 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV may slightly reduce AHI in the short term.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All‐cause mortality</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to life‐saving cardiovascular intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>AHI:</b> apnoea hypopnoea index; <b>ASV:</b> adaptive servo ventilation;<b>CI:</b> confidence interval; <b>CPAP:</b> continuous positive airway pressure; <b>CSA:</b> central sleep apnoea; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>We downgraded one level due to important methodological limitations (one study with high risk of bias for blinding of participants and personnel and incomplete outcome data and unclear risk of bias for random sequence generation, allocation concealment, and blinding of outcome assessors).<br/><sup>2</sup>We downgraded one level due to small sample size.<br/><sup>3</sup>We downgraded one level due to important methodological limitations (one study with high risk of bias for blinding of participants and personnel, blinding of outcome assessors, and incomplete outcome data and unclear risk of bias for random sequence generation and allocation concealment). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012889-tbl-0005"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Adaptive servo ventilation (ASV) versus bilevel ventilation for CPAP‐induced central sleep apnoea</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>ASV versus bilevel ventilation for CPAP‐induced CSA</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Participants:</b> people with CPAP‐induced CSA </p> <p><b>Setting:</b> outpatient </p> <p><b>Intervention:</b> ASV </p> <p><b>Comparison:</b> bilevel ventilation </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>What happens</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With bilevel ventilation</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With ASV</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Difference</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Central AHI ‐ after 6 weeks</p> <p>Number of participants: 30<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean central AHI with bilevel ventilation was 10.20.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean central AHI with ASV was 1.50 (0.56 to 2.44).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 8.70 lower<br/>(11.42 lower to 5.98 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV may slightly reduce central AHI in the short term.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cardiovascular mortality</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of sleep</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>AHI ‐ after 6 weeks</p> <p>Number of participants: 30<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean AHI with bilevel ventilation was 16.50.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean AHI with bilevel ventilation was 7.40 (5.07 to 9.73).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 9.10 lower<br/>(13.67 lower to 4.53 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV may slightly reduce AHI in the short term.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All‐cause mortality</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to life‐saving cardiovascular intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>AHI:</b> apnoea hypopnoea index;<b>ASV:</b> adaptive servo ventilation;<b>CI:</b> confidence interval; <b>CPAP:</b> continuous positive airway pressure; <b>CSA:</b> central sleep apnoea; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>We downgraded one level due to methodological limitations (one study with high risk of bias due to lack of blinding of outcome assessment and incomplete outcome data and unclear risk of bias for random sequence generation and allocation concealment).<br/><sup>2</sup>We downgraded one level due to small sample size. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012889-tbl-0006"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Adaptive servo ventilation (ASV) plus best supportive care versus best supportive care alone or inactive control for central sleep apnoea associated with chronic heart failure</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>ASV plus best supportive care versus best supportive care alone or inactive control for CSA associated with chronic heart failure</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Participants:</b> people with CSA associated with chronic heart failure </p> <p><b>Setting:</b> outpatient </p> <p><b>Intervention:</b> ASV plus best supportive care </p> <p><b>Comparison:</b> best supportive care alone or inactive control </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>What happens</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With best supportive care</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With ASV plus best supportive care</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Difference</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Central AHI</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cardiovascular mortality ‐ up to 80 months</p> <p>Number of participants: 1325<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>RR 1.25<br/>(1.04 to 1.49) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24.00%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30.00%<br/>(24.90 to 35.70) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.00% more<br/>(1.00 more to 11.70 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV plus best supportive care likely increases cardiovascular mortality in the long term. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of sleep</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life ‐ after 48 months</p> <p>Number of participants: 1325<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life with best supportive care was 32.03.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life with ASV plus best supportive care was 32.86 (30.99 to 34.73).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.83 higher<br/>(1.81 lower to 3.47 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV plus best supportive care may result in little to no difference in quality of life in the long term. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>AHI ‐ after 6 months</p> <p>Number of participants: 30<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean difference in AHI with best supportive care was −0.50.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean difference in AHI with ASV plus best supportive care was 20.80 (−28.80 to −12.71). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 20.30 lower<br/>(28.75 lower to 11.85 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV plus best supportive care may reduce AHI in the medium term.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All‐cause mortality ‐ up to 80 months</p> <p>Number of participants: 1355<br/>(2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>RR 0.56<br/>(0.06 to 4.93) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>29.20%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.40%<br/>(1.80 to 100.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.90% fewer<br/>(27.50 fewer to 114.90 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>3 6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV plus best supportive care may result in little to no difference in all‐cause mortality in the long term. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to life‐saving cardiovascular intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>AHI:</b> apnoea hypopnoea index;<b>ASV:</b> adaptive servo ventilation;<b>CI:</b> confidence interval; <b>CSA:</b> central sleep apnoea; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>We downgraded one level due to important methodological limitations (one study with high risk of bias for incomplete outcome data and unclear risk of bias for allocation concealment).<br/><sup>2</sup>We downgraded one level due to important methodological limitations (one study with high risk of bias for blinding of participants and personnel, blinding of outcome assessors, and incomplete outcome data and unclear risk of bias for allocation concealment).<br/><sup>3</sup>We downgraded one level due to large CI (CI includes both important benefit and important harm).<br/><sup>4</sup>We downgraded one level due to important methodological limitations (one study with unclear risk of bias for random sequence generation, allocation concealment, blinding of outcome assessors, and selective reporting).<br/><sup>5</sup>We downgraded one level due to small sample size.<br/><sup>6</sup>We downgraded one level due to important methodological limitations (one study with high risk of bias for incomplete outcome data and unclear risk of bias for allocation concealment, and one study with high risk of bias for incomplete outcome data and selective reporting and unclear risk of bias for random sequence generation). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012889-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD012889-sec-0009"></div> <section id="CD012889-sec-0010"> <h3 class="title" id="CD012889-sec-0010">Description of the condition</h3> <p>Central sleep apnoea (CSA) is characterised by abnormal patterns of breathing during sleep due to a dysfunctional drive to breathe. These abnormal patterns of ventilation are compounded by hypoventilation (reduction of the air flow whilst breathing) and recurrent apnoeas (cessation of breathing) or hypopnoeas (overly shallow breathing or an abnormally low respiratory rate). Hypoventilation may lead to compromised gas exchange, hypercapnia (elevation in the arterial carbon dioxide levels), and sleep fragmentation (<a href="./references#CD012889-bbs2-0066" title="EckertDJ , JordanAS , MerchiaP , MalhotraA . Central sleep apnea: pathophysiology and treatment. Chest2007;131(2):595-607. [DOI: 10.1378/chest.06.2287]">Eckert 2007</a>). As a consequence, people with CSA may present with a variety of symptoms, such as poor sleep quality, inattention, fatigue, daytime sleepiness, and reduced quality of life. </p> <p>Overall prevalence is not as established for CSA as it is for obstructive sleep apnoea (OSA), but in one recent population‐based study of adults over 40 years old undergoing polysomnography, the observed prevalence of CSA was 0.9% (<a href="./references#CD012889-bbs2-0065" title="DonovanLM , KapurVK . Prevalence and characteristics of central compared to obstructive sleep apnea: analyses from the Sleep Heart Health Study cohort. Sleep2016;39(7):1353-9. [DOI: 10.5665/sleep.5962]">Donovan 2016</a>). Prevalence appears to be increased amongst men compared with women (<a href="./references#CD012889-bbs2-0060" title="BixlerEO , VgontzasAN , LinH , Ten HaveT , ReinJ , Vela-BuenoA , et al. Prevalence of sleep-disordered breathing in women: effects of gender. American Journal of Respiratory and Critical Care Medicine2001;163:608-13. [DOI: 10.1164/ajrccm.163.3.9911064]">Bixler 2001</a>; <a href="./references#CD012889-bbs2-0065" title="DonovanLM , KapurVK . Prevalence and characteristics of central compared to obstructive sleep apnea: analyses from the Sleep Heart Health Study cohort. Sleep2016;39(7):1353-9. [DOI: 10.5665/sleep.5962]">Donovan 2016</a>), as well as in older age, particularly in those over 65 years old (<a href="./references#CD012889-bbs2-0060" title="BixlerEO , VgontzasAN , LinH , Ten HaveT , ReinJ , Vela-BuenoA , et al. Prevalence of sleep-disordered breathing in women: effects of gender. American Journal of Respiratory and Critical Care Medicine2001;163:608-13. [DOI: 10.1164/ajrccm.163.3.9911064]">Bixler 2001</a>; <a href="./references#CD012889-bbs2-0065" title="DonovanLM , KapurVK . Prevalence and characteristics of central compared to obstructive sleep apnea: analyses from the Sleep Heart Health Study cohort. Sleep2016;39(7):1353-9. [DOI: 10.5665/sleep.5962]">Donovan 2016</a>). CSA is particularly common in a few high‐risk groups including individuals with heart failure (<a href="./references#CD012889-bbs2-0065" title="DonovanLM , KapurVK . Prevalence and characteristics of central compared to obstructive sleep apnea: analyses from the Sleep Heart Health Study cohort. Sleep2016;39(7):1353-9. [DOI: 10.5665/sleep.5962]">Donovan 2016</a>), stroke (<a href="./references#CD012889-bbs2-0076" title="JohnsonKG , JohnsonDC . Frequency of sleep apnea in stroke and TIA patients: a meta-analysis. Journal of Clinical Sleep Medicine2010;6(2):131-7. [DOI: 10.5664/jcsm.27760]">Johnson 2010</a>), renal failure (<a href="./references#CD012889-bbs2-0071" title="HanlyPJ , PierratosA . Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. New England Journal of Medicine2001;344(2):102-7.">Hanly 2001</a>), and atrial fibrillation (<a href="./references#CD012889-bbs2-0089" title="SinDD , FitzgeraldF , ParkerJD , NewtonG , FlorasJS , BradleyTD . Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. American Journal of Respiratory and Critical Care Medicine1999;160(4):1101-6. [DOI: 10.1164/ajrccm.160.4.9903020]">Sin 1999</a>; <a href="./references#CD012889-bbs2-0090" title="StevensonIH , TeichtahlH , CunningtonD , CiavarellaS , GordonI , KalmanJM . Prevalence of sleep disordered breathing in paroxysmal and persistent atrial fibrillation patients with normal left ventricular function. European Heart Journal2008;29(13):1662-9. [DOI: 10.1093/eurheartj/ehn214]">Stevenson 2008</a>), and people receiving long‐term opioid therapy (<a href="./references#CD012889-bbs2-0063" title="CorreaD , FarneyRJ , ChungF , PrasadA , LamD , WongJ . Chronic opioid use and central sleep apnea. Anesthesia and Analgesia2015;120(6):1273-85. [DOI: 10.1213/ANE.0000000000000672]">Correa 2015</a>; <a href="./references#CD012889-bbs2-0091" title="WangD , TeichtahlH , DrummerO , GoodmanC , CherryG , CunningtonD , et al. Central sleep apnea in stable methadone maintenance treatment patients. Chest2005;128(3):1348-56. [DOI: 10.1378/chest.128.3.1348]">Wang 2005</a>). </p> <p>The International Classification of Sleep Disorders (ICSD), 3rd edition, presents several types of central sleep apnoea syndromes (CSAS) in adults, defined by the pattern of abnormal breathing, existence of comorbidity, or other features from a person's history, such as substance abuse or exposure to high altitude (<a href="./references#CD012889-bbs2-0057" title="American Academy of Sleep Medicine. International Classification of Sleep Disorders. Darien: American Academy of Sleep Medicine, 2014.">American Academy of Sleep Medicine 2014</a>). The categories of CSAS described in the ICSD 3rd edition thus include CSA with Cheyne‐Stokes breathing; CSA due to a medical disorder without Cheyne‐Stokes breathing; CSA due to high‐altitude periodic breathing; CSA due to a medication or substance; primary CSA; and treatment‐emergent CSA. Clinicians can diagnose CSAS on the basis of polysomnographic findings and diagnostic criteria conjointly. </p> <p>CSA with Cheyne‐Stokes breathing occurs in 40% to 50% of people with chronic heart failure (<a href="./references#CD012889-bbs2-0087" title="PeerA , LorberA , SuraiyaS , MalhotraA , PillarG . The occurrence of Cheyne-Stokes respiration in congestive heart failure: the effect of age. Frontiers in Psychiatry2010;1:1-6. [DOI: 10.3389/fpsyt.2010.00133]">Peer 2010</a>), and is considered to be a marker of chronic heart failure severity (<a href="./references#CD012889-bbs2-0087" title="PeerA , LorberA , SuraiyaS , MalhotraA , PillarG . The occurrence of Cheyne-Stokes respiration in congestive heart failure: the effect of age. Frontiers in Psychiatry2010;1:1-6. [DOI: 10.3389/fpsyt.2010.00133]">Peer 2010</a>); however, this combined disorder may also be responsible for aggravated heart failure (<a href="./references#CD012889-bbs2-0070" title="HanlyPJ , Zuberi-KhokharNS . Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure. American Journal of Respiratory and Critical Care Medicine1996;153(1):272-6. [DOI: 10.1164/ajrccm.153.1.8542128]">Hanly 1996</a>). This dysfunctional breathing pattern is not exclusive of chronic heart failure and may be found in other conditions, such as stroke and renal failure. Cheyne‐Stokes breathing is characterised by a cyclical breathing pattern compounded by periods of 20 to 30 seconds of hyperventilation alternating with central apnoeas typically lasting from 10 to 40 seconds, in a crescendo‐decrescendo pattern (<a href="./references#CD012889-bbs2-0085" title="NaughtonMT . Cheyne's Stokes respiration: friend or foe?Thorax2012;67(4):357-60. [DOI: 10.1136/thoraxjnl-2011-200927]">Naughton 2012</a>). Periodic breathing is also observed in CSA due to high altitude, which may occur after ascent to altitudes as high as 4000 metres. </p> <p>People with neurological disease or other medical conditions may manifest central apnoeas comprising other patterns of ventilatory dysfunction typically distinct from Cheyne‐Stokes breathing. Congenital central hypoventilation syndrome, also known as Ondine's curse, is an example. The ventilatory dysfunction in congenital central hypoventilation syndrome is characterised by reduced tidal volume, with a relatively preserved breathing frequency, manifested mainly in non‐rapid eye movement sleep (<a href="./references#CD012889-bbs2-0083" title="MuzumdarH , ArensR . Central alveolar hypoventilation syndromes. Sleep Medicine Clinics2008;3(4):601-15. [DOI: 10.1016/j.jsmc.2008.08.006]">Muzumdar 2008</a>). </p> <p>CSA may also arise after the start of treatment of OSA with positive pressure ventilation or, rarely, after resolution of obstructive apnoea by other modalities of treatment, such as the use of oral appliances (<a href="./references#CD012889-bbs2-0079" title="KuźniarTJ , Kovacevic-RistanovicR , FreedomT . Complex sleep apnea unmasked by the use of a mandibular advancement device. Sleep and Breathing2011;15(2):249-52. [DOI: 10.1007/s11325-010-0459-8]">Kuźniar 2011</a>). Lastly, the co‐existence of CSA and OSA in the same individual is frequently found. Common mechanistic traits may explain such overlap (<a href="./references#CD012889-bbs2-0066" title="EckertDJ , JordanAS , MerchiaP , MalhotraA . Central sleep apnea: pathophysiology and treatment. Chest2007;131(2):595-607. [DOI: 10.1378/chest.06.2287]">Eckert 2007</a>). </p> </section> <section id="CD012889-sec-0011"> <h3 class="title" id="CD012889-sec-0011">Description of the intervention</h3> <p>Non‐invasive positive pressure ventilation (NIPV) encompasses several non‐invasive ventilatory therapies that employ different ways of delivering positive airway pressure through nasal or facial masks. </p> <p>Continuous positive airway pressure (CPAP) therapy consists of the deliverance of continuous levels of positive pressure during both inspiration and expiration, aimed at maintenance of airway patency. CPAP is considered the gold‐standard treatment for people with moderate to severe OSA (<a href="./references#CD012889-bbs2-0068" title="EpsteinLJ , KristoD , StrolloPJ , FriedmanN , MalhotraA , PatilSP , et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. Journal of Clinical Sleep Medicine2009;5(3):263-76.">Epstein 2009</a>), but its role in the management of central apnoeas is controversial, as trials have reported limited benefits of CPAP for some people with CSA‐Cheyne‐Stokes breathing (<a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a>). </p> <p>Other types of non‐invasive positive pressure employ more sophisticated technology with the intention of delivering positive pressure more effectively. Bilevel positive airway pressure (BiPAP) supplies positive pressure at two distinct levels, according to inspiratory and expiratory phases of the breathing cycle. In addition to promoting airway patency, BiPAP aims to mitigate hypoventilation by delivering higher positive pressure during inspiration and by providing a ventilatory backup rate. Adaptive servo ventilation (ASV) is a modality of non‐invasive ventilation in which pressure is preset and volume or flow is cycled. ASV provides dynamic adjustment of inspiratory pressure support to normalise breathing patterns according to a prespecified target. ASV aims to mitigate hyperventilation and consequent hypocapnia by delivering preset minute ventilation (<a href="./references#CD012889-bbs2-0058" title="AuroraRN , ChowdhuriS , RamarK , BistaSR , CaseyKR , LammCI , et al. The treatment of central sleep apnea syndromes in adults: practice parameters with an evidence-based literature review and meta-analyses. Sleep2012;35(1):17-40. [DOI: 10.5665/sleep.1580]">Aurora 2012</a>). </p> </section> <section id="CD012889-sec-0012"> <h3 class="title" id="CD012889-sec-0012">How the intervention might work</h3> <p>The underlying mechanism for CSA falls into one of two main categories: hyperventilation or hypoventilation. Hyperventilation‐related CSA is characterised by periods of hyperpnoea during sleep that induce hypocapnia, which in turn causes central apnoea. This is due in part to a drop in partial pressure of carbon dioxide (PaCO<sub>2</sub>) level to below the central chemoreceptor threshold for ventilatory drive. Onset of central apnoea subsequently leads to increased PaCO<sub>2</sub>, which may restore normal ventilation or lead to another phase of hyperventilation, reinitiating the cycle. CSA due to hypoventilation is associated with impaired ventilation due to central nervous system disease, central nervous system‐depressing drugs, neuromuscular disorder, or abnormality in chest wall mechanics (such as kyphoscoliosis). In this patient group, sleep leads to a general decline in ventilatory drive with profound hypoventilation or prolonged apnoea. These periods are terminated by phases of arousal from deep sleep but recommence once deeper sleep is re‐established. </p> <p>NIPV may improve ventilation by reducing oscillations of PaCO<sub>2</sub> and by compensating central apnoeas. CPAP and BiPAP provide a pneumatic splint effect in the airways. BiPAP may further improve ventilation via backup ventilation frequency (spontaneous timed (ST) mode) (<a href="./references#CD012889-bbs2-0078" title="KuźniarTJ , MorgenthalerTI . Treatment of complex sleep apnea syndrome. Current Treatment Options in Neurology2008;10(5):336-41. [DOI: 10.1007/s11940-008-0036-7]">Kuźniar 2008b</a>). ASV automatically calculates the ventilatory support needed during inspiration through continuous analysis of the breathing pattern in an attempt to compensate for hypoventilation periods (<a href="./references#CD012889-bbs2-0059" title="BitterT , WesterheideN , FaberL , HeringD , PrinzC , LangerC , et al. Adaptive servoventilation in diastolic heart failure and Cheyne-Stokes respiration. European Respiratory Journal2010;36(2):385-92. [DOI: 10.1183/09031936.00045609]">Bitter 2010</a>). </p> <p>The co‐existence of central and obstructive apnoeas in the same patient is not rare, as both conditions are relatively common in people with chronic heart failure. Also, abnormal ventilatory control may induce airway obstruction in people with vulnerable pharyngeal anatomy, and the inverse is also observed (<a href="./references#CD012889-bbs2-0066" title="EckertDJ , JordanAS , MerchiaP , MalhotraA . Central sleep apnea: pathophysiology and treatment. Chest2007;131(2):595-607. [DOI: 10.1378/chest.06.2287]">Eckert 2007</a>). Given that NIPV is highly effective in treating individuals with OSA, it is logical to assume that by counteracting airway obstruction, NIPV may positively influence ventilatory control. </p> </section> <section id="CD012889-sec-0013"> <h3 class="title" id="CD012889-sec-0013">Why it is important to do this review</h3> <p>Treatment of people with CSAS may rely on treating or eliminating the underlying mechanism (e.g. withdrawal of opioids). However, treatment of the underlying condition is not always possible or effective. Clinical management of chronic heart failure via β‐blockers and angiotensin‐converting enzyme inhibitors does not reduce the prevalence of Cheyne‐Stokes breathing (<a href="./references#CD012889-bbs2-0080" title="MacDonaldM , FangJ , PittmanSD , WhiteDP , MalhotraA . The current prevalence of sleep disordered breathing in congestive heart failure patients treated with beta-blockers. Journal of Clinical Sleep Medicine2008;4(1):38-42. [DOI: 10.5664/jcsm.27076]">MacDonald 2008</a>). Specific treatment strategies to mitigate CSAS are therefore needed. </p> <p>Different types of non‐invasive positive pressure treatment have been developed for the treatment of CSAS, such as ASV, which aims to compensate the pattern of hyperventilation and hypoventilation found in Cheyne‐Stokes breathing. However, there are safety issues related to ASV treatment of people with Cheyne‐Stokes breathing. The Treatment of Sleep‐Disordered Breathing with Predominant Central Sleep Apnea by Adaptive Servo Ventilation in Patients with Heart Failure (SERVE‐HF) trial came to the unexpected result that all‐cause and cardiovascular mortality are increased in people with very low ejection fraction treated with ASV (<a href="./references#CD012889-bbs2-0013" title="CowieM , WoehrleH , WegscheiderK , AngermannC , D'OrthoMP , ErdmannE , et al. Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results. European Respiratory Journal2015;46:OA3475. [DOI: 10.1183/13993003.congress-2015.OA3475]CowieMR , WoehrleH , WegscheiderK , AngermannC , D'Ortho M-P, ErdmannE , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. New England Journal of Medicine2015;373(12):1095-105. [DOI: 10.1056/NEJMoa1506459]CowieMR , WoehrleH , WegscheiderK , VettorazziE , LeziusS , KoenigW , et al. Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF. European Journal of Heart Failure2018;20:536-44. [DOI: 10.1002/ejhf.1048]EulenburgC , WegscheiderK , WoehrleH , AngermannC , D'Ortho M-P, ErdmannE , et al. Understanding SERVE-HF: a multistate analysis to explain mechanisms underlying increased mortality risk in patients randomised to adaptive servo-ventilation (ASV). European Respiratory Journal2016;48:OA1985. [DOI: 10.1183/13993003.congress-2016.OA1985]TamisierR , PepinJL , CowieM , WegscheiderK , VettorazziE , SulingA , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure: PSG data from the SERVE-HF major substudy. American Journal of Respiratory and Critical Care Medicine2017;195:A4513. [DOI: 10.1164/ajrccm-conference.2017.B80-G]TamisierR , Pepin J-L, SalvatM , WoehrleH , Barone-RochetteG , RoccaC , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure does not improve muscle sympathetic nerve activity: a SERVE-HF substudy. European Respiratory Journal2016;48:PA2083. [DOI: 10.1183/13993003.congress-2016.PA2083]">SERVE HF 2015</a>). It is not entirely clear whether these results can be extrapolated to all people with chronic heart failure with a low ejection fraction. The same level of uncertainty applies to other non‐invasive positive pressure devices and to CSAS of different causes, given the significant heterogeneity noted amongst patient groups and their response to different treatment modalities. Synthesis of evidence identifying the best treatment options for different types of CSAS has the potential to aid clinicians, patients, and policymakers. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012889-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012889-sec-0014"></div> <p>To assess the effectiveness and safety of non‐invasive positive pressure ventilation for treatment of adults with central sleep apnoea syndromes. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012889-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012889-sec-0015"></div> <section id="CD012889-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012889-sec-0017"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials (RCTs) with a parallel design that employed individual allocation. We considered studies reported in full text, those published as abstract only, and unpublished data for inclusion in the review. </p> </section> <section id="CD012889-sec-0018"> <h4 class="title">Types of participants</h4> <p>We included participants older than 18 years of age for whom one of the following CSAS had been diagnosed, as defined by the ICSD, 3rd edition (<a href="./references#CD012889-bbs2-0057" title="American Academy of Sleep Medicine. International Classification of Sleep Disorders. Darien: American Academy of Sleep Medicine, 2014.">American Academy of Sleep Medicine 2014</a>). </p> <p> <ul id="CD012889-list-0001"> <li> <p>CSA with Cheyne‐Stokes breathing.</p> </li> <li> <p>CSA due to a medical disorder without Cheyne‐Stokes breathing.</p> </li> <li> <p>CSA due to a medication or substance.</p> </li> <li> <p>Primary CSA.</p> </li> <li> <p>Treatment‐emergent CSA.</p> </li> </ul> </p> </section> <section id="CD012889-sec-0019"> <h4 class="title">Types of interventions</h4> <p>We included studies comparing any type of non‐invasive positive pressure versus prespecified comparators, as listed below. </p> <p>Types of non‐invasive positive pressure ventilation included the following.</p> <p> <ul id="CD012889-list-0002"> <li> <p>Continuous positive airway pressure (CPAP).</p> </li> <li> <p>Auto‐set positive airway pressure.</p> </li> <li> <p>Bilevel positive airway pressure (BiPAP).</p> </li> <li> <p>Adaptive servo ventilation (ASV).</p> </li> </ul> </p> <p>Types of comparators included the following.</p> <p> <ul id="CD012889-list-0003"> <li> <p>Sham therapy (subtherapeutic positive pressure).</p> </li> <li> <p>Another type of non‐invasive positive pressure.</p> </li> <li> <p>No treatment.</p> </li> <li> <p>Usual care defined as treatment for underlying disease.</p> </li> </ul> </p> <p>We planned to make comparisons involving different types of interventions versus active controls or inactive controls, as follows: </p> <p> <ul id="CD012889-list-0004"> <li> <p>CPAP versus another type of non‐invasive positive pressure</p> </li> <li> <p>CPAP versus inactive control (subtherapeutic positive pressure, no treatment, or usual care). </p> </li> <li> <p>Auto‐set positive airway pressure versus another type of non‐invasive positive pressure.</p> </li> <li> <p>Auto‐set positive airway pressure versus inactive control (subtherapeutic positive pressure, no treatment, or usual care). </p> </li> <li> <p>BiPAP versus another type of non‐invasive positive pressure.</p> </li> <li> <p>BiPAP versus inactive control (subtherapeutic positive pressure, no treatment, or usual care). </p> </li> <li> <p>ASV versus another type of non‐invasive positive pressure.</p> </li> <li> <p>ASV versus inactive control (subtherapeutic positive pressure, no treatment, or usual care). </p> </li> </ul> </p> <p>For each comparison, we performed distinct meta‐analyses for each type of population, according to the type of health condition associated with CSA. </p> </section> <section id="CD012889-sec-0020"> <h4 class="title">Types of outcome measures</h4> <section id="CD012889-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD012889-list-0005"> <li> <p>Central apnoea hypopnoea index (cAHI)</p> </li> </ul> </p> <p>We defined cAHI as the number of central apnoea hypopnoeas per hour of sleep, measured objectively by polysomnography or assessed by analysis of data from non‐invasive positive pressure devices, registered in smart cards, or transmitted by modem, or via Web‐based methods. </p> <p> <ul id="CD012889-list-0006"> <li> <p>Cardiovascular mortality</p> </li> </ul> </p> <p>We defined cardiovascular mortality as the number of deaths attributable to myocardial ischaemia and infarction, heart failure, cardiac arrest because of other or unknown cause, or cerebrovascular accident (<a href="./references#CD012889-bbs2-0062" title="CarreroJJ , De JagerDJ , VerduijnM , RavaniP , De MeesterJ , HeafJG , et al. Cardiovascular and noncardiovascular mortality among men and women starting dialysis. Clinical Journal of the American Society of Nephrology2011;6(7):1722-30. [DOI: 10.2215/CJN.11331210]">Carrero 2011</a>). </p> <p> <ul id="CD012889-list-0007"> <li> <p>Serious adverse events</p> </li> </ul> </p> <p>We defined serious adverse events as life‐threatening events and those leading to death, hospitalisation, disability or permanent damage, congenital anomaly, or that required intervention to prevent permanent impairment or damage. </p> </section> <section id="CD012889-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD012889-list-0008"> <li> <p>Quality of sleep</p> </li> </ul> </p> <p>We planned to include studies that assessed quality of sleep using validated scales or questionnaires, such as the Pittsburgh Sleep Quality Index (<a href="./references#CD012889-bbs2-0061" title="BuysseDJ , ReynoldsCF , MonkTH , BermanSR , KupferDJ . The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Research1989;28(2):193-213. [DOI: 10.1016/0165-1781(89)90047-4]">Buysse 1989</a>). </p> <p> <ul id="CD012889-list-0009"> <li> <p>Quality of life</p> </li> </ul> </p> <p>We included studies that assessed quality of life using validated scales or questionnaires, such as the 36‐item Short Form Health Survey (SF‐36) (<a href="./references#CD012889-bbs2-0075" title="JenkinsonC , LayteR , WrightL , CoulterA . Manual and Interpretation Guide for the UK SF-36. Oxford: Health Services Research Unit, 1996.">Jenkinson 1996</a>). </p> <p> <ul id="CD012889-list-0010"> <li> <p>Apnoea hypopnoea index (AHI)</p> </li> </ul> </p> <p>We included studies evaluating total AHI, defined as the number of events of obstructive, mixed, or central apnoea/hypopnoea per hour of sleep, measured objectively by polysomnography or assessed by analysis of data from non‐invasive positive pressure devices, registered in smart cards, or transmitted by modem, or via Web‐based methods. </p> <p> <ul id="CD012889-list-0011"> <li> <p>All‐cause mortality, defined as number of deaths irrespective of cause.</p> </li> <li> <p>Time to life‐saving cardiovascular intervention (cardiac transplantation, implantation of cardioverter‐defibrillator). </p> </li> <li> <p>Adverse events/side effects, such as nasal congestion, upper airway dryness, mask‐induced pressure ulcer. </p> </li> </ul> </p> <p>We assessed outcomes at all time points reported in primary studies and planned to pool short‐, medium‐, and long‐term data, defined as follows. </p> <p> <ul id="CD012889-list-0012"> <li> <p>Short‐term: up to three months.</p> </li> <li> <p>Medium‐term: three months to one year.</p> </li> <li> <p>Long‐term: longer than one year.</p> </li> </ul> </p> </section> </section> </section> <section id="CD012889-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD012889-sec-0024"> <h4 class="title">Electronic searches</h4> <p>We identified studies from the following sources:</p> <p> <ul id="CD012889-list-0013"> <li> <p>Cochrane Airways Trials Register, through the Cochrane Register of Studies (<a href="./references#CD012889-bbs2-0064" title="CRS (Cochrane Register of Studies). community.cochrane.org/help/tools-and-software/crs-cochrane-register-studies (accessed 4 February 2022).">CRS 2022</a>), from inception to 6 September 2021; </p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL), through the Cochrane Register of Studies (<a href="./references#CD012889-bbs2-0064" title="CRS (Cochrane Register of Studies). community.cochrane.org/help/tools-and-software/crs-cochrane-register-studies (accessed 4 February 2022).">CRS 2022</a>), on 6 September 2021 (2021, Issue 9); </p> </li> <li> <p>MEDLINE (Ovid SP) ALL from 1946 to 6 September 2021;</p> </li> <li> <p>Embase (Ovid SP) from 1974 to 6 September 2021;</p> </li> <li> <p>Scopus from inception to 6 September 2021.</p> </li> </ul> </p> <p>Search strategies are listed in Appendix 1. We designed the initial search strategy in MEDLINE and adapted this for use in the other databases. We searched all databases from their inception to 6 September 2021, and applied no restrictions on language of publication. We handsearched conference abstracts and grey literature through the CENTRAL database. </p> <p>In addition, we searched the following trials registries on 6 September 2021.</p> <p> <ul id="CD012889-list-0014"> <li> <p>US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (<a href="https://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov/</a>). </p> </li> <li> <p>World Health Organization International Clinical Trials Registry Platform (<a href="https://trialsearch.who.int/" target="_blank">trialsearch.who.int/</a>). </p> </li> </ul> </p> </section> <section id="CD012889-sec-0025"> <h4 class="title">Searching other resources</h4> <p>We checked the reference lists of all primary studies and review articles for additional references. We searched relevant manufacturers' websites for study information. </p> <p>We searched for errata or retractions from the included studies published in full text on PubMed (<a href="http://www.ncbi.nlm.nih.gov/pubmed" target="_blank">www.ncbi.nlm.nih.gov/pubmed</a>), and planned to report within the review the date this was done. </p> </section> </section> <section id="CD012889-sec-0026"> <h3 class="title" id="CD012889-sec-0026">Data collection and analysis</h3> <section id="CD012889-sec-0027"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently (ACPNP, AR, or DVP) screened the titles and abstracts of studies identified by the search, coding studies as 'retrieve' (eligible or potentially eligible/unclear) or 'do not retrieve'. We retrieved the full‐text study reports of all potentially eligible studies, and two review authors (ACPNP, AR, or DVP) independently screened these for inclusion and recorded the reasons for exclusion of ineligible studies. Any disagreements were resolved through discussion or by consulting a third person/review author (ACPNP, AR, or DVP) when required. We identified and excluded duplicates and collated multiple reports of the same study so that each study, rather than each report, was the unit of interest in the review. We recorded the selection process in sufficient detail to complete a PRISMA flow diagram and 'Characteristics of excluded studies' tables (<a href="./references#CD012889-bbs2-0081" title="MoherD , LiberatiA , TetzlaffJ , AltmanD . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Medicine2009;6(7):e1000097. [DOI: 10.1136/bmj.b2535]">Moher 2009</a>). </p> </section> <section id="CD012889-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>We used a data collection form that had been piloted on at least one study in the review to record study characteristics and outcomes, adapted from <a href="./references#CD012889-bbs2-0067" title="EPOC. Data collection form. EPOC Resources for Review Authors. epoc.cochrane.org/epoc-specific-resources review-authors (accessed prior to 24 July 2017).">EPOC 2013</a>. </p> <p>One review author (ACPNP or DVP) extracted the following study characteristics from the included studies. </p> <p> <ul id="CD012889-list-0015"> <li> <p>Methods: study design, total duration of study, details of any 'run‐in' period, number of study centres and locations, study setting, withdrawals, and dates of study. </p> </li> <li> <p>Participants: N, mean age, age range, gender, severity of condition, diagnostic criteria, baseline lung function, smoking history, inclusion criteria, and exclusion criteria. </p> </li> <li> <p>Interventions: intervention, comparison, concomitant medications, and excluded medications.</p> </li> <li> <p>Outcomes: primary and secondary outcomes specified and collected, and time points reported. </p> </li> <li> <p>Notes: funding for studies and notable conflicts of interest of trial authors.</p> </li> </ul> </p> <p>Two review authors (ACPNP, AR, or DVP) independently extracted outcome data from the included studies. We noted in the 'Characteristics of included studies' tables if outcome data were not reported in an useable way. Any disagreements were resolved through consensus or by involving a third person/review author (AR or DVP). One review author (DVP) transferred data into the Review Manager 5 file (<a href="./references#CD012889-bbs2-0088" title="Review Manager 5 (RevMan 5). Version 5.4. Copenhagen: The Cochrane Collaboration, 2020.">Review Manager 2020</a>). We double‐checked that data had been entered correctly by comparing the data presented in the systematic review with information provided in the study reports. A second review author (ACPNP) spot‐checked the study characteristics for accuracy against the study report. </p> </section> <section id="CD012889-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (ACPNP, AR) independently assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012889-bbs2-0072" title="HigginsJPT , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>). Any disagreements were resolved by discussion or through consultation with another review author (DVP). We assessed risk of bias according to the following domains. </p> <p> <ul id="CD012889-list-0016"> <li> <p>Random sequence generation.</p> </li> <li> <p>Allocation concealment.</p> </li> <li> <p>Blinding of participants and personnel.</p> </li> <li> <p>Blinding of outcome assessment.</p> </li> <li> <p>Incomplete outcome data.</p> </li> <li> <p>Selective outcome reporting.</p> </li> <li> <p>Other bias.</p> </li> </ul> </p> <p>We judged each risk of bias domain as low, high, or unclear risk of bias, and provided a quote from the study report together with a justification for our judgement in the risk of bias table. We summarised risk of bias judgements across different studies for each of the domains listed. </p> <p>We considered the domains 'blinding of participants and personnel' and 'blinding of outcome assessment' differently according to the type of outcome. For subjective outcomes, such as quality of life and quality of sleep, we judged any deviation from blinding procedures as introducing a high risk of bias. For objective outcomes, such as mortality, we did not judge absence or inadequacy of blinding as imposing risk of bias. For other outcomes, including laboratory outcomes such as AHI, we required at least blinding of outcome assessors to permit a judgement of low risk of bias for this domain. </p> <p>Where required, we attempted to contact study authors to check information on risk of bias. When considering treatment effects, we took into account the risk of bias for the studies that contributed to that outcome. </p> <section id="CD012889-sec-0030"> <h5 class="title">Assessment of bias in conducting the systematic review</h5> <p>We conducted the review according to the published protocol (<a href="./references#CD012889-bbs2-0092" title="PachitoDV , MartimbiancoALC , LatorracaCOC , PachecoRL , DragerLF , Lorenzi‐FilhoG , et al. Non‐invasive positive pressure ventilation for central sleep apnoea in adults. Cochrane Database of Systematic Reviews2017, Issue 11. Art. No: CD012889. [DOI: 10.1002/14651858.CD012889]">Pachito 2017</a>). </p> </section> </section> <section id="CD012889-sec-0031"> <h4 class="title">Measures of treatment effect</h4> <p>We analysed dichotomous data as risks ratios (RRs) and continuous data as mean differences (MDs) or standardised mean differences (SMDs). If we combined data from rating scales in a meta‐analysis, we ensured that the data were entered with a consistent direction of effect (e.g. lower scores always indicate improvement). </p> <p>We undertook meta‐analyses only when this was meaningful, that is if treatments, participants, and the underlying clinical question were similar enough for pooling to make sense. We planned to describe skewed data narratively (e.g. as medians and interquartile ranges for each group). </p> <p>When multiple trial arms were reported in a single study, we included only the relevant arms. If two comparisons (e.g. intervention A versus placebo and intervention B versus placebo) were combined in the same meta‐analysis, we would combine the active arms, or halve the control group to avoid double‐counting. </p> <p>If adjusted analyses were available (analysis of variance (ANOVA) or analysis of covariance (ANCOVA)), we used these as items of preference in our meta‐analyses. If both change‐from‐baseline and endpoint scores were available for continuous data, we used change from baseline. If a study reported outcomes at multiple time points, we used all time points. We used intention‐to‐treat (ITT) or 'full analysis set' analyses when these were reported (i.e. analyses in which data have been imputed for participants who were randomly assigned but did not complete the study) instead of completer or per‐protocol analyses. </p> </section> <section id="CD012889-sec-0032"> <h4 class="title">Unit of analysis issues</h4> <p>For dichotomous outcomes, we used participants, rather than events, as the unit of analysis (i.e. number of participants admitted to hospital, rather than number of admissions per participant). However, if rate ratios were reported in a study, we planned to analyse them on this basis. </p> </section> <section id="CD012889-sec-0033"> <h4 class="title">Dealing with missing data</h4> <p>We contacted investigators or study sponsors to verify key study characteristics and to obtain missing numerical outcome data when possible. When this was not possible, and missing data were thought to introduce serious bias, we took this into consideration in the GRADE rating for the affected outcomes, and planned to explore the impact of including such studies in the overall assessment of results by sensitivity analysis. We planned that if outcome data such as standard deviations or correlation coefficients were not available and could not be obtained from the trial authors, we would calculate these values from other available statistics such as P values, according to the methods described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012889-bbs2-0073" title="HigginsJPT , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from training.cochrane.org/handbook.">Higgins 2022</a>)<i>.</i> </p> </section> <section id="CD012889-sec-0034"> <h4 class="title">Assessment of heterogeneity</h4> <p>We used the I<sup>2</sup> statistic to measure heterogeneity in each analysis. If we identified substantial heterogeneity, we would report this and explore possible causes by performing prespecified subgroup analyses. We considered heterogeneity as substantial for values of I<sup>2</sup> equal to or above 50% (<a href="./references#CD012889-bbs2-0072" title="HigginsJPT , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>), although we recognise that uncertainty surrounds the I<sup>2</sup> measurement when a meta‐analysis includes few studies. We used a significance level of P &lt; 0.1 to indicate whether we observed a problem with heterogeneity. </p> </section> <section id="CD012889-sec-0035"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned that if we were able to pool more than 10 studies, we would create and examine a funnel plot to explore possible small‐study and publication biases. </p> </section> <section id="CD012889-sec-0036"> <h4 class="title">Data synthesis</h4> <p>We used a random‐effects model to summarise pooled data.</p> </section> <section id="CD012889-sec-0037"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If we found substantial heterogeneity and there were sufficient data, we would investigate possible causes for the heterogeneity by exploring the impact of the condition of participants using subgroup analyses. We planned to carry out the following subgroup analyses. </p> <p> <ul id="CD012889-list-0017"> <li> <p>Severity of CSA based on cAHI, with two prespecified subgroups, namely mild CSA, defined as fewer than 15 central apnoeas per hour of sleep, and moderate to severe CSA, defined as equal or more than 15 central apnoeas per hour of sleep. </p> </li> </ul> </p> <p>The rationale for this subgroup analysis was based on the assumption that treatment for CSA may have variable impact according to the severity of CSA. </p> <p> <ul id="CD012889-list-0018"> <li> <p>Severity of chronic heart failure based on the functional classification of the New York Heart Association (Class IV versus others) (<a href="./references#CD012889-bbs2-0086" title="New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. 9th revised edition. Boston: Lippincott Williams and Wilkins, 1994.">NYHA 1994</a>), or based on the ejection fraction (&lt; 30% versus other levels). </p> </li> </ul> </p> <p>The rationale for scrutinising intervention effects regarding severity of chronic heart failure was based on findings of higher mortality rates amongst people with severe chronic heart failure treated with servo ventilation (<a href="./references#CD012889-bbs2-0013" title="CowieM , WoehrleH , WegscheiderK , AngermannC , D'OrthoMP , ErdmannE , et al. Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results. European Respiratory Journal2015;46:OA3475. [DOI: 10.1183/13993003.congress-2015.OA3475]CowieMR , WoehrleH , WegscheiderK , AngermannC , D'Ortho M-P, ErdmannE , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. New England Journal of Medicine2015;373(12):1095-105. [DOI: 10.1056/NEJMoa1506459]CowieMR , WoehrleH , WegscheiderK , VettorazziE , LeziusS , KoenigW , et al. Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF. European Journal of Heart Failure2018;20:536-44. [DOI: 10.1002/ejhf.1048]EulenburgC , WegscheiderK , WoehrleH , AngermannC , D'Ortho M-P, ErdmannE , et al. Understanding SERVE-HF: a multistate analysis to explain mechanisms underlying increased mortality risk in patients randomised to adaptive servo-ventilation (ASV). European Respiratory Journal2016;48:OA1985. [DOI: 10.1183/13993003.congress-2016.OA1985]TamisierR , PepinJL , CowieM , WegscheiderK , VettorazziE , SulingA , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure: PSG data from the SERVE-HF major substudy. American Journal of Respiratory and Critical Care Medicine2017;195:A4513. [DOI: 10.1164/ajrccm-conference.2017.B80-G]TamisierR , Pepin J-L, SalvatM , WoehrleH , Barone-RochetteG , RoccaC , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure does not improve muscle sympathetic nerve activity: a SERVE-HF substudy. European Respiratory Journal2016;48:PA2083. [DOI: 10.1183/13993003.congress-2016.PA2083]">SERVE HF 2015</a>). </p> <p> <ul id="CD012889-list-0019"> <li> <p>Cause of central sleep apnoea as defined by the ICSD, 3rd edition (<a href="./references#CD012889-bbs2-0057" title="American Academy of Sleep Medicine. International Classification of Sleep Disorders. Darien: American Academy of Sleep Medicine, 2014.">American Academy of Sleep Medicine 2014</a>), for comparisons involving heterogeneous populations. </p> </li> </ul> </p> <p>We planned to use the following outcomes in subgroup analyses.</p> <p> <ul id="CD012889-list-0020"> <li> <p>AHI.</p> </li> <li> <p>Cardiovascular mortality.</p> </li> </ul> </p> <p>We planned to use the formal test for subgroup interactions provided in Review Manager 5 (<a href="./references#CD012889-bbs2-0088" title="Review Manager 5 (RevMan 5). Version 5.4. Copenhagen: The Cochrane Collaboration, 2020.">Review Manager 2020</a>). However, we included few studies regarding these outcomes in meta‐analyses, with insufficient data to be explored, therefore these subgroup analyses could not be performed. </p> </section> <section id="CD012889-sec-0038"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to carry out the following sensitivity analyses whilst removing the following from analyses of primary outcomes. </p> <p> <ul id="CD012889-list-0021"> <li> <p>For assessment of risk of bias (excluding studies with high risk of bias), we planned to consider studies as having a high risk of bias if they fulfilled criteria for high or unclear risk of bias in at least two risk of bias domains. However, these analyses were not possible because no studies included in the meta‐analyses were at low risk of bias. </p> </li> <li> <p>For comparisons involving any type of NIPV versus inactive control (sham therapy, no treatment, or usual care), we planned to perform sensitivity analysis by including only studies that used sham therapy as the comparator, in order to account for the placebo effect. However, these analyses were not possible because none of the studies included in the meta‐analyses used sham therapy. </p> </li> <li> <p>We assessed the role of industry sponsorship in identified studies.</p> </li> <li> <p>We compared the results derived from a fixed‐effect model versus those obtained from a random‐effects model. </p> </li> </ul> </p> </section> <section id="CD012889-sec-0039"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We created summary of findings tables using the following outcomes.</p> <p> <ul id="CD012889-list-0022"> <li> <p>AHI</p> </li> <li> <p>Cardiovascular mortality</p> </li> <li> <p>Quality of sleep</p> </li> <li> <p>Quality of life</p> </li> <li> <p>All‐cause mortality</p> </li> <li> <p>Time to life‐saving cardiovascular intervention</p> </li> <li> <p>Serious adverse events</p> </li> </ul> </p> <p>We planned to include quality of sleep and serious adverse events; however, no studies evaluated these outcomes. When outcomes were reported at more than one time point, we presented the longer time point in the summary of findings table. </p> <p>We used the five GRADE considerations (risk of bias, consistency of effect, imprecision, indirectness, and publication bias) to assess the quality of a body of evidence as it relates to studies that contribute data for the prespecified outcomes. We used the methods and recommendations described in Section 8.5 and Chapter 12 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012889-bbs2-0072" title="HigginsJPT , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>), employing GRADEpro GDT software (<a href="./references#CD012889-bbs2-0069" title="GRADEpro GDT. Version accessed 24 July 2017. Hamilton (ON): McMaster University (developed by Evidence Prime). Available from gradepro.org.">GRADEpro GDT</a>). We justified all decisions to downgrade the certainty of the evidence using footnotes, and made comments to aid the reader's understanding of the review when necessary. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012889-sec-0040" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012889-sec-0040"></div> <section id="CD012889-sec-0041"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD012889-sec-0173" title="">Characteristics of included studies</a> and <a href="./references#CD012889-sec-0174" title="">Characteristics of excluded studies</a>. </p> <section id="CD012889-sec-0042"> <h4 class="title">Results of the search</h4> <p>Our search conducted on 6 September 6 2021 yielded 2541 records. After excluding duplicate publications and irrelevant records, we identified 15 studies (29 reports) for inclusion in the review. A study flow diagram is presented in <a href="#CD012889-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD012889-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD012889-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/image_n/nCD012889-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD012889-sec-0043"> <h4 class="title">Included studies</h4> <p>This review is based on a published protocol (<a href="./references#CD012889-bbs2-0092" title="PachitoDV , MartimbiancoALC , LatorracaCOC , PachecoRL , DragerLF , Lorenzi‐FilhoG , et al. Non‐invasive positive pressure ventilation for central sleep apnoea in adults. Cochrane Database of Systematic Reviews2017, Issue 11. Art. No: CD012889. [DOI: 10.1002/14651858.CD012889]">Pachito 2017</a>). An overview of the characteristics of the included studies is provided in <a href="#CD012889-tbl-0007">Table 1</a>. We identified three ongoing studies (see <a href="./references#CD012889-sec-0176" title="">Characteristics of ongoing studies</a>). </p> <div class="table" id="CD012889-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Study characteristics</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="center" class="headercell" colspan="7" rowspan="1" scope="col" valign="bottom"> <p><b>Participants</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comparator</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>N, condition</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>CSA or CSR criteria</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Age, mean (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>AHI, mean (SD) per hour/cAHI, mean % (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>BMI, mean (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>LVEF, mean % (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Men n (%)</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>258 participants with CSA associated with chronic heart failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 or more episodes of apnoea and hypopnoea per hour of sleep, more than 50% of which were determined to be central </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 (16)/89<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29.05<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24.50 (7.70)<br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>248 (96.12)</p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CPAP plus best supportive care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Best supportive care</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012889-bbs2-0005" title="GrantonJT , NaughtonMT , BenardDC , LiuPP , GoldsteinRS , BradleyTD . CPAP improves inspiratory muscle strength in patients with heart failure and central sleep apnea. American Journal of Respiratory and Critical Care Medicine1996;153(1):277-82. [DOI: 10.1164/ajrccm.153.1.8542129]">Granton 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17 participants with CSA associated with chronic heart failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CSR‐CSA with a cAHI of at least 10/h of sleep, alternating with a crescendo‐decrescendo pattern of hyperpnoea; at least 85% of apnoeas and hypopnoeas had to be central </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58.15<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42<sup>a</sup>/NR </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27.15<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.30<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17 (100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CPAP plus best supportive care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Best supportive care</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012889-bbs2-0009" title="NaughtonMT , LiuPP , BernardDC , GoldsteinRS , BradleyTD . Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. American Journal of Respiratory and Critical Care Medicine1995;151(1):92-7. [DOI: 10.1164/ajrccm.151.1.7812579]NaughtonMT , LuiPP , BenardDC , GoldsteinRS , BradleyTD . A randomized controlled clinical trial of CPAP in patients with heart failure and Cheyne-Stokes respiration. American Review of Respiratory Disease1993;147(7):A687. ">Naughton 1995a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29 participants with CSA associated with chronic heart failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CSR‐CSA, with a crescendo‐decrescendo pattern of hyperpnoea alternating with central apnoeas or hypopnoeas at a rate of &gt; 10/h of sleep </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58.80<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38.15<sup>a</sup>/NR<br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.55<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20.45<sup>a</sup><br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29 (100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CPAP plus best supportive care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Best supportive care</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012889-bbs2-0010" title="NaughtonMT , BenardDC , LiuPP , RutherfordR , RankinF , BradleyTD . Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. American Journal of Respiratory and Critical Care Medicine1995;152(2):473-9. [DOI: 10.1164/ajrccm.152.2.7633695]">Naughton 1995b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18 participants with CSA associated with chronic heart failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CSR‐CSA, with a crescendo‐decrescendo pattern of hyperpnoea alternating with central apnoeas or hypopnoeas at a rate of &gt; 10/h of sleep </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60.50 (1.40)<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42.70 (4.60)<sup>b</sup>/NR </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.80 (1.00)<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18.30 (2.00)<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18 (100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CPAP plus best supportive care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Best supportive care</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012889-bbs2-0014" title="SinDD , LoganAG , FitzgeraldFS , LiuPP , BradleyTD . Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation2000;102 C(1):61-6. [DOI: 10.1161/01.cir.102.1.61]">Sin 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29 participants with CSA associated with chronic heart failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CSR‐CSA, with a crescendo‐decrescendo pattern of hyperpnoea, alternating with central apnoeas or hypopnoeas at a rate ≥ 15 per hour of sleep of which &gt; 75% of events were central </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>57.90 (9.70)<br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39.20 (21.90)/NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20.20 (10.00)<br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29 (100)<br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CPAP plus best supportive care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Best supportive care</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012889-bbs2-0007" title="KasaiT , KasagiS , Maeno K-I, DohiT , KawanaF , KatoM , et al. Adaptive servo-ventilation in cardiac function and neurohormonal status in patients with heart failure and central sleep apnea nonresponsive to continuous positive airway pressure. JACC: Heart Failure2013;1(1):58-63. [DOI: 10.1016/j.jchf.2012.11.002]">Kasai 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23 participants with CSA associated with chronic heart failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>AHI 15 events per hour, of which ≥ 50% were central</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65.05<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47.85<sup>a</sup>/81.60<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.60<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32.45<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23 (100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CPAP</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012889-bbs2-0012" title="PhilippeC , Stoica-HermanM , DrouotX , RaffestinB , EscourrouP , HittingerL , et al. Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart2006;92(3):337-42. [DOI: 10.1136/hrt.2005.060038]">Philippe 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 participants with CSA associated with chronic heart failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CSR, with a crescendo–decrescendo periodic ventilation and CSA with an AHI of 15/h of which more than 80% were central </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62.25<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43.75<sup>a</sup>/NR </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29.50<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 (100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CPAP</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012889-bbs2-0004" title="FietzeI , BlauA , GlosM , TheresH , BaumannG , PenzelT . Bi-level positive pressure ventilation and adaptive servo ventilation in patients with heart failure and Cheyne-Stokes respiration. Sleep Medicine2008;9:652-9. [DOI: 10.1016/j.sleep.2007.09.008]">Fietze 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 participants with CSA associated with chronic heart failure</p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CSR with an RDI &gt; 15/h, with less than 20% obstructive respiratory events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58.90 (10.40)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33.30<sup>a,c</sup>/ 32.20<sup>a,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28 (3.90)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.05<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34 (91.89)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bilevel ventilation</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012889-bbs2-0008" title="MorgenthalerTI , KuzniarTJ , WolfeLF , WillesL , McLainWC , GoldbergR . The Complex Sleep Apnea Resolution Study: a prospective randomized controlled trial of continuous positive airway pressure versus adaptive servoventilation therapy. Sleep2014;37(5):927-34. [DOI: 10.5665/sleep.3662]">Morgenthaler 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>66 participants with CPAP‐induced CSA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CPAP titration eliminating events defining OSA, but had a residual CAI ≥ 10 events/hour or residual CSR pattern that was predominant and disruptive during PSG </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>59.20 (12.90)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34.45<sup>a</sup>/ 23.70<sup>a,e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35.00 (8.00)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56 (84.84)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CPAP</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012889-bbs2-0003" title="DellwegD , KerlJ , HoehnE , WenzelM , KoehlerD . Randomized controlled trial of noninvasive positive pressure ventilation (NPPV) versus servoventilation in patients with CPAP-induced central sleep apnea (complex sleep apnea). Sleep2013;36(8):1163-71. [DOI: 10.5665/sleep.2878]">Dellweg 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 participants with CPAP‐induced CSA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>AHI ≥ 15 during the initial PSG with a predominance of obstructive events according to AASM criteria and AHI ≥ 15 on CPAP therapy after 6 weeks of CPAP treatment during a follow‐up PSG with a predominance of central events according to AASM criteria </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62.50<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28.15<sup>a</sup>/ 17.45<sup>a,e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21 (70)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bilevel ventilation</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012889-bbs2-0013" title="CowieM , WoehrleH , WegscheiderK , AngermannC , D'OrthoMP , ErdmannE , et al. Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results. European Respiratory Journal2015;46:OA3475. [DOI: 10.1183/13993003.congress-2015.OA3475]CowieMR , WoehrleH , WegscheiderK , AngermannC , D'Ortho M-P, ErdmannE , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. New England Journal of Medicine2015;373(12):1095-105. [DOI: 10.1056/NEJMoa1506459]CowieMR , WoehrleH , WegscheiderK , VettorazziE , LeziusS , KoenigW , et al. Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF. European Journal of Heart Failure2018;20:536-44. [DOI: 10.1002/ejhf.1048]EulenburgC , WegscheiderK , WoehrleH , AngermannC , D'Ortho M-P, ErdmannE , et al. Understanding SERVE-HF: a multistate analysis to explain mechanisms underlying increased mortality risk in patients randomised to adaptive servo-ventilation (ASV). European Respiratory Journal2016;48:OA1985. [DOI: 10.1183/13993003.congress-2016.OA1985]TamisierR , PepinJL , CowieM , WegscheiderK , VettorazziE , SulingA , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure: PSG data from the SERVE-HF major substudy. American Journal of Respiratory and Critical Care Medicine2017;195:A4513. [DOI: 10.1164/ajrccm-conference.2017.B80-G]TamisierR , Pepin J-L, SalvatM , WoehrleH , Barone-RochetteG , RoccaC , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure does not improve muscle sympathetic nerve activity: a SERVE-HF substudy. European Respiratory Journal2016;48:PA2083. [DOI: 10.1183/13993003.congress-2016.PA2083]">SERVE HF 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1325 participants with CSA associated with chronic heart failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>cAHI of ≥ 10 events/hour and AHI of ≥ 15 events/hour, of which &gt; 50% were central</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69.45<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31.45<sup>a</sup>/ 81.30<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28.50<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32.35<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1198 (90.42)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV plus best supportive care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Best supportive care</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012889-bbs2-0006" title="HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three months treatment with adaptive servo-ventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration in a prospective randomized controlled trial. Circulation2011;124(21 Suppl):A11007. [DOI: 10.1161/circ.124.suppl_21.A11007]HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three-month treatment with adaptive servoventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration: a prospective randomized controlled trial. Cardiology2013;126(C(2)):81-90. [DOI: 10.1159/000350826]OlsengMW , OlsenBF , HetlandA , FagermoenS , JacobsenM . Quality of life improves in patients with chronic heart failure and Cheyne-Stokes respiration treated with adaptive servo-ventilation in a nurse-led heart failure clinic. Journal of Clinical Nursing2017;26(9-10):1226-33. [DOI: 10.1111/jocn.13416]">Hetland 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51 participants with CSA associated with chronic heart failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CSR of &gt; 25%; CSB with a minimum of 3 consecutive cycles of a crescendo‐decrescendo pattern in the breathing signal with periods of hyperventilation separated by central apnoeas or hypopnoeas </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70.50<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29.65<sup>a</sup>/65.50<sup>a,f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27.15<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31.80<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47 (92.16)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV plus best supportive care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Best supportive care</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012889-bbs2-0011" title="PepperellJCT , MaskellNA , JonesDR , Langford-WileyBA , CrosthwaiteN , StradlingJR , et al. A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. American Journal of Respiratory and Critical Care Medicine2003;168(9):1109-14. [DOI: 10.1164/rccm.200212-1476OC]">Pepperell 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 participants with CSA associated with chronic heart failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 50% of apnoeas or hypopnoea events were central</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>71.15<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24<sup>a</sup>/NR </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.20<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34.75<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29 (96.67)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV plus best supportive care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Best supportive care</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012889-bbs2-0015" title="ToyamaT , HoshizakiH , KasamaS , MiyaishiY , KanH , YamashitaE , et al. Adaptive servo-ventilation therapy improves cardiac sympathetic nerve activity, cardiac function, exercise capacity, and symptom in patients with chronic heart failure and Cheyne-Stokes respiration. Journal of Nuclear Cardiology2016;24(6):1-12. [DOI: 10.1007/s12350-016-0529-9]">Toyama 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31 participants with CSA associated with chronic heart failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CSR‐CSA, with at least 3 consecutive cycles of a cyclic crescendo‐decrescendo change in breathing and an AHI ≥ 5/h, or persistence of a cyclic crescendo‐decrescendo breathing pattern for at least 10 consecutive minutes </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68 (9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.25<sup>a</sup>/37.85<sup>a,g</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24.10<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.50<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28 (93.33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV plus best supportive care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Best supportive care</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012889-bbs2-0002" title="D'eliaE , FerreroP , VittoriC , BaioP , DuinoV , GrosuA , et al. Enhanced adaptive servo-ventilation improves echocardiographic parameters of diastolic and right ventricle function in patients with sleep apnea and heart failure with preserved ejection fraction. European Journal of Heart Failure2016;18:474. D’EliaE , FerreroP , VittoriC , IacovoniA , GrosuA , GoriM , et al. Beneficial effects of adaptive servo-ventilation on natriuretic peptides and diastolic function in acute heart failure patients with preserved ejection fraction and sleep-disordered breathing. Sleep and Breathing2019;23:287-91. [DOI: 10.1007/s11325-018-1681-z]">D'Elia 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 participants with CSA associated with acute heart failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>AHI &gt; 15/h, of which &gt; 50% were central</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69.90<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36.90<sup>a</sup>/28<sup>a,e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.65<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50.80<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 (100)<br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV plus best supportive care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Best supportive care</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations: AASM: American Academy of Sleep Medicine; AHI: apnoea hypopnoea index; ASV: adaptive servo ventilation; BMI: body mass index; cAHI: central apnoea hypopnoea index; CAI: central apnoea index; CPAP: continuous positive airway pressure; CSA: central sleep apnoea; CSB: Cheyne‐Stokes breathing; CSR: Cheyne‐Stokes respiration; LVEF: left ventricular ejection fraction; NR: not reported; OSA: obstructive sleep apnoea; PSG: polysomnography; RDI: respiratory disturbance index; SD: standard deviation </p> <p><sup>a</sup>As the study did not provide total measures, we calculated an average between means of experimental and control groups.<br/><sup>b</sup>Data expressed in standard error.<br/><sup>c</sup>Respiratory disturbance index per hour calculated by the sum of Cheyne‐Stokes respiration index, obstructive apnoea index, and mixed apnoea index.<br/><sup>d</sup>Cheyne‐Stokes respiration index per hour.<br/><sup>e</sup>Central sleep apnoea index, events per hour.<br/><sup>f</sup>Cheyne‐Stokes respiration %.<br/><sup>g</sup>CSA %. </p> </div> </div> <p>We assessed 17 studies as awaiting classification (see <a href="./references#CD012889-sec-0175" title="">Characteristics of studies awaiting classification</a>). Six of these studies evaluated the effects of NIPV in people with sleep apnoea (<a href="./references#CD012889-bbs2-0038" title="ArtzM , SeriesF , LewisK , EscourrouP , ObermeierR , KehIV , et al. Effects of auto-servo ventilation on cardiovascular function in patients with congestive heart failure and sleep-disordered breathing - a multicenter randomised controlled trial. European Respiratory Journal2011;38:1743. ArztM , SchrollS , SeriesF , LewisK , BenjaminA , EscourrouP , et al. Auto-servoventilation in heart failure with sleep apnoea: a randomised controlled trial. European Respiratory Journal2013;42:1244-54. [DOI: 10.1183/09031936.00083312]ArztM , SeriesF , LewisK , BenjaminA , EscourrouP , LuigartR , et al. Treatment of central and obstructive sleep apnea in stable heart failure patients with auto-servo ventilation reduces sleep fragmentation - a randomized controlled trial. European Respiratory Journal2012;40(C Suppl 56):588s [3289]. BirnerC , SeriesF , LewisK , BenjaminA , EscourrouP , LuigartR , et al. Treatment with auto-servo ventilation of patients with sleep-disordered breathing, stable systolic heart failure and concomitant diastolic dysfunction - a randomized controlled pilot study. European Respiratory Journal2012;40:3467. BirnerC , SeriesF , LewisK , BenjaminA , WunderlichS , EscourrouP , et al. Effects of auto-servo ventilation on patients with sleep-disordered breathing, stable systolic heart failure and concomitant diastolic dysfunction: subanalysis of a randomized controlled trial. Respiration2014;87(1):54-62. [DOI: 10.1159/000351797]HetzeneckerA , EscourrouP , KunaST , SeriesF , LewisK , BirnerC , et al. Treatment of sleep apnea in chronic heart failure patients with auto-servo ventilation improves sleep fragmentation: a randomized controlled trial. Sleep Medicine2016;17:25-31. [DOI: 10.1016/j.sleep.2015.08.020]">Arzt 2013</a>; <a href="./references#CD012889-bbs2-0039" title="DaubertMA , WhellanDJ , WoehrleH , TasissaG , AnstromKJ , LindenfeldJ , et al. Treatment of sleep-disordered breathing in heart failure impacts cardiac remodeling: insights from the CATHF Trial. American Heart Journal2018;201:40-8. [DOI: 10.1016/j.ahj.2018.03.026]FiuzatM , OldenbergO , WhellanDJ , WoehrleH , PunjabiNM , AnstromKJ , et al. Lessons learned from a clinical trial: design, rationale, and insights from The Cardiovascular Improvements with Minute Ventilation-targeted Adaptive Sero-Ventilation (ASV) Therapy in Heart Failure (CAT-HF) Study. Contemporary Clinical Trials2016;47:158-64. [DOI: 10.1016/j.cct.2016.01.001]O'connorC , WhellanD , FiuzatM , BenjafieldA , WoehrleH , PunjabiN , et al. Adaptive servo-ventilation in heart failure: results of a randomized, controlled clinical trial. European Journal of Heart Failure2016;18:318. [DOI: 10.1002/ejhf.539]O'ConnorCM , WhellanDJ , FiuzatM , PunjabiNM , TasissaG , AnstromKJ , et al. Cardiovascular outcomes with minute ventilation-targeted adaptive servo-ventilation therapy in heart failure: the CAT-HF trial. Journal of the American College of Cardiology2017;69(12):1577-87. [DOI: 10.1016/j.jacc.2017.01.041]PicciniJP , PokorneySD , AnstromKJ , OldenburgO , PunjabiNM , FiuzatM , et al. Adaptive servo-ventilation reduces atrial fibrillation burden in patients with heart failure and sleep apnea. Heart Rhythm2019;16:91-7. [DOI: 10.1016/j.hrthm.2018.07.027]">CAT‐HF 2016</a>; <a href="./references#CD012889-bbs2-0041" title="EgeaC , AizpuruF , PintoJ , AyuelaJ , BallesterE , ZamarronC , et al. Cardiac function after CPAP therapy in chronic heart failure and sleep apnea. A multicenter study. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. [A296]EgeaC , PintoJ , AyuelaJ , BallesterE , ZamarronC , SojoA , et al. Eficacy of the treatment with CPAP in patients with chronic heart failure and sleep apnoea. European Respiratory Journal2004;24 C(Suppl 48):564s. EgeaCJ , AizpuruF , PintoJA , AyuelaJM , BallesterE , ZamarronC , et al. Cardiac function after CPAP therapy in patients with chronic heart failure and sleep apnea: a multicenter study. Sleep Medicine2008;9 C(6):660-6. [DOI: 10.1016/j.sleep.2007.06.018]">Egea 2004</a>; <a href="./references#CD012889-bbs2-0049" title="UshijimaR , JohoS , AkabaneT , OdaY , InoueH . Differing effects of adaptive servoventilation and continuous positive airway pressure on muscle sympathetic nerve activity in patients with heart failure. Circulation Journal2014;78(6):1387-95. [DOI: 10.1253/circj.cj-13-1468]">Ushijima 2014</a>; <a href="./references#CD012889-bbs2-0052" title="YoshihisaA , SuzukiS , TakeishiY . Impact of adaptive servo ventilation on cardiovascular function and prognosis in patients with HFpEF and sleep-disordered breathing. Journal of Cardiac Failure2014;20(10):S140. YoshihisaA , SuzukiS , YamakiT , SugimotoK , KuniiH , NakazatoK , et al. Impact of adaptive servo-ventilation on cardiovascular function and prognosis in heart failure patients with preserved leC ventricular ejection fraction and sleep disordered breathing. European Journal of Heart Failure2013;15:543-50. [DOI: 10.1093/eurjhf/hfs197]">Yoshihisa 2013</a>; <a href="./references#CD012889-bbs2-0053" title="ZhaoZ , LiuZ , LuoQ . The effect of positive pressure ventilation in patients with heart failure and sleep apnea. In: American Thoracic Society International Conference; 2008 May 16-21; Toronto. 2008:A480. ZhaoZH , LiuZH , LuoQ , XiongCM , NiXH , ZhangJ , et al. Positive pressure ventilation treatment reduces plasma levels of amino terminal-pro brain natriuretic peptide in congestive heart failure patients with sleep apnea. Circulation Journal2006;70(5):572-4. [DOI: 10.1253/circj.70.572]ZhaoZH , LiuZH , LuoQ , ZhangJ , XiongCM , NiXH , et al. The effects of noninvasive positive pressure ventilation treatment on plasma concentration of amino terminal-pro brain natriuretic peptide in congestive heart failure in patients with sleep apnea. Zhonghua nei ke za zhi [Chinese Journal of Internal Medicine]2006;45(5):386-8. ">Zhao 2006</a>), and we contacted the authors to check the availability of separate data for CSA. Seven studies evaluated the effects of NIPV in people with CSA, but did not present results for the outcomes of interest in this review; we contacted the authors of these studies to check whether they assessed and could provide results for the outcomes of interest in this review (<a href="./references#CD012889-bbs2-0037" title="AlterP , WagnerJ , ApeltS , RuppH , HeitmannJ . Influences of continuous positive airway pressure (CPAP) ventilation on cardiac function and left ventricular wall stress in dilative heart failure as assessed by cardiac magnetic resonance imaging. Somnologie2013;17:75. ">Alter 2013</a>; <a href="./references#CD012889-bbs2-0042" title="GoldbergLR , HorstkotteD , ShakarSF , LowesBD , WalkerJM , ClowardTV , et al. Long term results of a randomized multicenter trial comparing adaptive servo ventilation positive airway pressure to nasal oxygen in heart failure patients with central sleep apnea. Journal of the American College of Cardiology2007;49(9):94A-5A. ">Goldberg 2007</a>; <a href="./references#CD012889-bbs2-0043" title="MiyataM , YoshihisaA , SuzukiS , SugimotoK , YamakiT , KuniiH , et al. Adaptive servo ventilation improves cardiac function and reduces re-hospitalization in chronic heart failure patients with Cheyne-Stokes respiration after cardiac resynchronization therapy. European Heart Journal2012;33:332. [DOI: 10.1016/j.jjcc.2012.01.021]MiyataM , YoshihisaA , SuzukiS , YamadaS , KamiokaM , KamiyamaY , et al. Adaptive servo ventilation improves cardiac function and prognosis in chronic heart failure patients with Cheyne-Stokes respiration after cardiac resynchronization therapy. In: American Heart Association (AHA) Scientific Sessions; 2011 Nov 12-16; Orlando. 2011. ">Miyata 2012</a>; <a href="./references#CD012889-bbs2-0045" title="NodaA , IzawaH , AsanoH , NakataS , HirashikiA , MuraseY , et al. Beneficial effect of bilevel positive airway pressure on left ventricular function in ambulatory patients with idiopathic dilated cardiomyopathy and central sleep apnea-hypopnea: a preliminary study. Chest2007;131(C(6)):1694-701. [DOI: 10.1378/chest.06-2271]">Noda 2007</a>; <a href="./references#CD012889-bbs2-0047" title="TkacovaR , LiuPP , NaughtonMT , BradleyTD . Effect of continuous positive airway pressure on mitral regurgitant fraction and atrial natriuretic peptide in patients with heart failure. Journal of the American College of Cardiology1997;30(3):739-45. ">Tkacova 1997</a>; <a href="./references#CD012889-bbs2-0048" title="ToepferV , El-SebaiMA , SchulzR , WessendorfTE , TeschlerH . Six weeks adaptive servo-ventilation increases exercise capacity and reduces sympathetic activity in central sleep apnea due to heart failure [Abstract]. In: American Thoracic Society 99th International Conference; 2003 May 16-21; Seattle. 2003. ">Toepfer 2003</a>; <a href="./references#CD012889-bbs2-0051" title="YoshihisaA , SatoT , SuzukiH , SaitoS , IshibashiT , TakeishiY . Adaptive servo ventilation restores cardiac dysfunction in heart failure patients with Cheyne-Stokes respiration. European Journal of Heart Failure2009;8:ii75. ">Yoshihisa 2009</a>). There was insufficient information to judge whether the remaining four studies fulfilled the eligibility criteria of this review. We contacted the authors to check whether these studies were eligible (<a href="./references#CD012889-bbs2-0040" title="De MichelisC , PrestG , PerrettaE , RivaL , ZoccaliP . Congestive heart failure and Cheyne-Stokes periodic respiration breathing: new modalities of positive airways pressure ventilation alternative to CPAP. Rassegna di Patologia dell'Apparato Respiratorio2008;23(1):17-25. ">De Michelis 2008</a>; <a href="./references#CD012889-bbs2-0044" title="MuraseK , OnoK , AkaoM , MikiS , NoharaR , MishimaM , et al. The clinical effects of adaptive servo ventilation versus nocturnal oxygen therapy for sleep disordered breathing in heart failure patients: a randomized trial. American Journal of Respiratory and Critical Care Medicine2015;191:A6109. MuraseK , OnoK , YonedaT , IguchiM , YokomatsuT , MizoguchiT , et al. Adaptive servoventilation versus oxygen therapy for sleep disordered breathing in patients with heart failure: a randomised trial. Open Heart2016;3(1):e000366. [DOI: 10.1136/openhrt-2015-000366]">Murase 2016</a>; <a href="./references#CD012889-bbs2-0046" title="TeschlerH , DohringJ , WessendorfTE , WangYM , ThilmannA , Berthon JonesM . Effect of autoset CS servo-ventilation on central sleep apnea in brainstem stroke. American Journal of Respiratory and Critical Care Medicine2000;161 C(3 Suppl):A361. ">Teschler 2000</a>; <a href="./references#CD012889-bbs2-0050" title="Vogt LadnerG , SchacherC , DitterichW , VogtM , TeschlerH , WorthH . Nocturnal oxygen therapy (NOY) versus adaptive servo-ventilation (ASV) in patients with severe chronic heart failure (CHF) and Cheyne Stokes respiration (CSR). American Journal of Respiratory and Critical Care Medicine2002;165(C Suppl 8):A247. ">Vogt‐Ladner 2002</a>), but did not receive any responses. </p> <section id="CD012889-sec-0044"> <h5 class="title">Methods</h5> <p>We included 15 randomised, parallel‐group, two‐arm studies. The studies were performed from 1995 to 2019. We found protocols for only five of the 15 RCTs (<a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a>; <a href="./references#CD012889-bbs2-0003" title="DellwegD , KerlJ , HoehnE , WenzelM , KoehlerD . Randomized controlled trial of noninvasive positive pressure ventilation (NPPV) versus servoventilation in patients with CPAP-induced central sleep apnea (complex sleep apnea). Sleep2013;36(8):1163-71. [DOI: 10.5665/sleep.2878]">Dellweg 2013</a>; <a href="./references#CD012889-bbs2-0006" title="HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three months treatment with adaptive servo-ventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration in a prospective randomized controlled trial. Circulation2011;124(21 Suppl):A11007. [DOI: 10.1161/circ.124.suppl_21.A11007]HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three-month treatment with adaptive servoventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration: a prospective randomized controlled trial. Cardiology2013;126(C(2)):81-90. [DOI: 10.1159/000350826]OlsengMW , OlsenBF , HetlandA , FagermoenS , JacobsenM . Quality of life improves in patients with chronic heart failure and Cheyne-Stokes respiration treated with adaptive servo-ventilation in a nurse-led heart failure clinic. Journal of Clinical Nursing2017;26(9-10):1226-33. [DOI: 10.1111/jocn.13416]">Hetland 2013</a>; <a href="./references#CD012889-bbs2-0008" title="MorgenthalerTI , KuzniarTJ , WolfeLF , WillesL , McLainWC , GoldbergR . The Complex Sleep Apnea Resolution Study: a prospective randomized controlled trial of continuous positive airway pressure versus adaptive servoventilation therapy. Sleep2014;37(5):927-34. [DOI: 10.5665/sleep.3662]">Morgenthaler 2014</a>; <a href="./references#CD012889-bbs2-0013" title="CowieM , WoehrleH , WegscheiderK , AngermannC , D'OrthoMP , ErdmannE , et al. Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results. European Respiratory Journal2015;46:OA3475. [DOI: 10.1183/13993003.congress-2015.OA3475]CowieMR , WoehrleH , WegscheiderK , AngermannC , D'Ortho M-P, ErdmannE , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. New England Journal of Medicine2015;373(12):1095-105. [DOI: 10.1056/NEJMoa1506459]CowieMR , WoehrleH , WegscheiderK , VettorazziE , LeziusS , KoenigW , et al. Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF. European Journal of Heart Failure2018;20:536-44. [DOI: 10.1002/ejhf.1048]EulenburgC , WegscheiderK , WoehrleH , AngermannC , D'Ortho M-P, ErdmannE , et al. Understanding SERVE-HF: a multistate analysis to explain mechanisms underlying increased mortality risk in patients randomised to adaptive servo-ventilation (ASV). European Respiratory Journal2016;48:OA1985. [DOI: 10.1183/13993003.congress-2016.OA1985]TamisierR , PepinJL , CowieM , WegscheiderK , VettorazziE , SulingA , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure: PSG data from the SERVE-HF major substudy. American Journal of Respiratory and Critical Care Medicine2017;195:A4513. [DOI: 10.1164/ajrccm-conference.2017.B80-G]TamisierR , Pepin J-L, SalvatM , WoehrleH , Barone-RochetteG , RoccaC , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure does not improve muscle sympathetic nerve activity: a SERVE-HF substudy. European Respiratory Journal2016;48:PA2083. [DOI: 10.1183/13993003.congress-2016.PA2083]">SERVE HF 2015</a>), therefore for the majority of studies it was difficult to determine whether data were sought but not reported. Only four studies performed sample size calculations (<a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a>; <a href="./references#CD012889-bbs2-0003" title="DellwegD , KerlJ , HoehnE , WenzelM , KoehlerD . Randomized controlled trial of noninvasive positive pressure ventilation (NPPV) versus servoventilation in patients with CPAP-induced central sleep apnea (complex sleep apnea). Sleep2013;36(8):1163-71. [DOI: 10.5665/sleep.2878]">Dellweg 2013</a>; <a href="./references#CD012889-bbs2-0008" title="MorgenthalerTI , KuzniarTJ , WolfeLF , WillesL , McLainWC , GoldbergR . The Complex Sleep Apnea Resolution Study: a prospective randomized controlled trial of continuous positive airway pressure versus adaptive servoventilation therapy. Sleep2014;37(5):927-34. [DOI: 10.5665/sleep.3662]">Morgenthaler 2014</a>; <a href="./references#CD012889-bbs2-0013" title="CowieM , WoehrleH , WegscheiderK , AngermannC , D'OrthoMP , ErdmannE , et al. Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results. European Respiratory Journal2015;46:OA3475. [DOI: 10.1183/13993003.congress-2015.OA3475]CowieMR , WoehrleH , WegscheiderK , AngermannC , D'Ortho M-P, ErdmannE , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. New England Journal of Medicine2015;373(12):1095-105. [DOI: 10.1056/NEJMoa1506459]CowieMR , WoehrleH , WegscheiderK , VettorazziE , LeziusS , KoenigW , et al. Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF. European Journal of Heart Failure2018;20:536-44. [DOI: 10.1002/ejhf.1048]EulenburgC , WegscheiderK , WoehrleH , AngermannC , D'Ortho M-P, ErdmannE , et al. Understanding SERVE-HF: a multistate analysis to explain mechanisms underlying increased mortality risk in patients randomised to adaptive servo-ventilation (ASV). European Respiratory Journal2016;48:OA1985. [DOI: 10.1183/13993003.congress-2016.OA1985]TamisierR , PepinJL , CowieM , WegscheiderK , VettorazziE , SulingA , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure: PSG data from the SERVE-HF major substudy. American Journal of Respiratory and Critical Care Medicine2017;195:A4513. [DOI: 10.1164/ajrccm-conference.2017.B80-G]TamisierR , Pepin J-L, SalvatM , WoehrleH , Barone-RochetteG , RoccaC , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure does not improve muscle sympathetic nerve activity: a SERVE-HF substudy. European Respiratory Journal2016;48:PA2083. [DOI: 10.1183/13993003.congress-2016.PA2083]">SERVE HF 2015</a>). In five trials (<a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a>; <a href="./references#CD012889-bbs2-0003" title="DellwegD , KerlJ , HoehnE , WenzelM , KoehlerD . Randomized controlled trial of noninvasive positive pressure ventilation (NPPV) versus servoventilation in patients with CPAP-induced central sleep apnea (complex sleep apnea). Sleep2013;36(8):1163-71. [DOI: 10.5665/sleep.2878]">Dellweg 2013</a>; <a href="./references#CD012889-bbs2-0006" title="HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three months treatment with adaptive servo-ventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration in a prospective randomized controlled trial. Circulation2011;124(21 Suppl):A11007. [DOI: 10.1161/circ.124.suppl_21.A11007]HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three-month treatment with adaptive servoventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration: a prospective randomized controlled trial. Cardiology2013;126(C(2)):81-90. [DOI: 10.1159/000350826]OlsengMW , OlsenBF , HetlandA , FagermoenS , JacobsenM . Quality of life improves in patients with chronic heart failure and Cheyne-Stokes respiration treated with adaptive servo-ventilation in a nurse-led heart failure clinic. Journal of Clinical Nursing2017;26(9-10):1226-33. [DOI: 10.1111/jocn.13416]">Hetland 2013</a>; <a href="./references#CD012889-bbs2-0009" title="NaughtonMT , LiuPP , BernardDC , GoldsteinRS , BradleyTD . Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. American Journal of Respiratory and Critical Care Medicine1995;151(1):92-7. [DOI: 10.1164/ajrccm.151.1.7812579]NaughtonMT , LuiPP , BenardDC , GoldsteinRS , BradleyTD . A randomized controlled clinical trial of CPAP in patients with heart failure and Cheyne-Stokes respiration. American Review of Respiratory Disease1993;147(7):A687. ">Naughton 1995a</a>; <a href="./references#CD012889-bbs2-0012" title="PhilippeC , Stoica-HermanM , DrouotX , RaffestinB , EscourrouP , HittingerL , et al. Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart2006;92(3):337-42. [DOI: 10.1136/hrt.2005.060038]">Philippe 2006</a>), there were important losses of participants during follow‐up, with the following dropout: <a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a> (40/258), <a href="./references#CD012889-bbs2-0003" title="DellwegD , KerlJ , HoehnE , WenzelM , KoehlerD . Randomized controlled trial of noninvasive positive pressure ventilation (NPPV) versus servoventilation in patients with CPAP-induced central sleep apnea (complex sleep apnea). Sleep2013;36(8):1163-71. [DOI: 10.5665/sleep.2878]">Dellweg 2013</a> (7/37), <a href="./references#CD012889-bbs2-0006" title="HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three months treatment with adaptive servo-ventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration in a prospective randomized controlled trial. Circulation2011;124(21 Suppl):A11007. [DOI: 10.1161/circ.124.suppl_21.A11007]HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three-month treatment with adaptive servoventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration: a prospective randomized controlled trial. Cardiology2013;126(C(2)):81-90. [DOI: 10.1159/000350826]OlsengMW , OlsenBF , HetlandA , FagermoenS , JacobsenM . Quality of life improves in patients with chronic heart failure and Cheyne-Stokes respiration treated with adaptive servo-ventilation in a nurse-led heart failure clinic. Journal of Clinical Nursing2017;26(9-10):1226-33. [DOI: 10.1111/jocn.13416]">Hetland 2013</a> (21/51), <a href="./references#CD012889-bbs2-0009" title="NaughtonMT , LiuPP , BernardDC , GoldsteinRS , BradleyTD . Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. American Journal of Respiratory and Critical Care Medicine1995;151(1):92-7. [DOI: 10.1164/ajrccm.151.1.7812579]NaughtonMT , LuiPP , BenardDC , GoldsteinRS , BradleyTD . A randomized controlled clinical trial of CPAP in patients with heart failure and Cheyne-Stokes respiration. American Review of Respiratory Disease1993;147(7):A687. ">Naughton 1995a</a> (5/29), and <a href="./references#CD012889-bbs2-0012" title="PhilippeC , Stoica-HermanM , DrouotX , RaffestinB , EscourrouP , HittingerL , et al. Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart2006;92(3):337-42. [DOI: 10.1136/hrt.2005.060038]">Philippe 2006</a> (8/25). Only two of these studies performed an ITT analysis (<a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a>; <a href="./references#CD012889-bbs2-0008" title="MorgenthalerTI , KuzniarTJ , WolfeLF , WillesL , McLainWC , GoldbergR . The Complex Sleep Apnea Resolution Study: a prospective randomized controlled trial of continuous positive airway pressure versus adaptive servoventilation therapy. Sleep2014;37(5):927-34. [DOI: 10.5665/sleep.3662]">Morgenthaler 2014</a>). </p> </section> <section id="CD012889-sec-0045"> <h5 class="title">Setting</h5> <p>The trials included outpatient participants aged &gt; 18 years old who were followed from one week to 60 months. The studies were conducted in Canada (<a href="./references#CD012889-bbs2-0005" title="GrantonJT , NaughtonMT , BenardDC , LiuPP , GoldsteinRS , BradleyTD . CPAP improves inspiratory muscle strength in patients with heart failure and central sleep apnea. American Journal of Respiratory and Critical Care Medicine1996;153(1):277-82. [DOI: 10.1164/ajrccm.153.1.8542129]">Granton 1996</a>; <a href="./references#CD012889-bbs2-0009" title="NaughtonMT , LiuPP , BernardDC , GoldsteinRS , BradleyTD . Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. American Journal of Respiratory and Critical Care Medicine1995;151(1):92-7. [DOI: 10.1164/ajrccm.151.1.7812579]NaughtonMT , LuiPP , BenardDC , GoldsteinRS , BradleyTD . A randomized controlled clinical trial of CPAP in patients with heart failure and Cheyne-Stokes respiration. American Review of Respiratory Disease1993;147(7):A687. ">Naughton 1995a</a>; <a href="./references#CD012889-bbs2-0010" title="NaughtonMT , BenardDC , LiuPP , RutherfordR , RankinF , BradleyTD . Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. American Journal of Respiratory and Critical Care Medicine1995;152(2):473-9. [DOI: 10.1164/ajrccm.152.2.7633695]">Naughton 1995b</a>; <a href="./references#CD012889-bbs2-0014" title="SinDD , LoganAG , FitzgeraldFS , LiuPP , BradleyTD . Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation2000;102 C(1):61-6. [DOI: 10.1161/01.cir.102.1.61]">Sin 2000</a>), the USA (<a href="./references#CD012889-bbs2-0008" title="MorgenthalerTI , KuzniarTJ , WolfeLF , WillesL , McLainWC , GoldbergR . The Complex Sleep Apnea Resolution Study: a prospective randomized controlled trial of continuous positive airway pressure versus adaptive servoventilation therapy. Sleep2014;37(5):927-34. [DOI: 10.5665/sleep.3662]">Morgenthaler 2014</a>), Japan (<a href="./references#CD012889-bbs2-0007" title="KasaiT , KasagiS , Maeno K-I, DohiT , KawanaF , KatoM , et al. Adaptive servo-ventilation in cardiac function and neurohormonal status in patients with heart failure and central sleep apnea nonresponsive to continuous positive airway pressure. JACC: Heart Failure2013;1(1):58-63. [DOI: 10.1016/j.jchf.2012.11.002]">Kasai 2013</a>; <a href="./references#CD012889-bbs2-0015" title="ToyamaT , HoshizakiH , KasamaS , MiyaishiY , KanH , YamashitaE , et al. Adaptive servo-ventilation therapy improves cardiac sympathetic nerve activity, cardiac function, exercise capacity, and symptom in patients with chronic heart failure and Cheyne-Stokes respiration. Journal of Nuclear Cardiology2016;24(6):1-12. [DOI: 10.1007/s12350-016-0529-9]">Toyama 2016</a>), the UK (<a href="./references#CD012889-bbs2-0011" title="PepperellJCT , MaskellNA , JonesDR , Langford-WileyBA , CrosthwaiteN , StradlingJR , et al. A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. American Journal of Respiratory and Critical Care Medicine2003;168(9):1109-14. [DOI: 10.1164/rccm.200212-1476OC]">Pepperell 2003</a>), Italy (<a href="./references#CD012889-bbs2-0002" title="D'eliaE , FerreroP , VittoriC , BaioP , DuinoV , GrosuA , et al. Enhanced adaptive servo-ventilation improves echocardiographic parameters of diastolic and right ventricle function in patients with sleep apnea and heart failure with preserved ejection fraction. European Journal of Heart Failure2016;18:474. D’EliaE , FerreroP , VittoriC , IacovoniA , GrosuA , GoriM , et al. Beneficial effects of adaptive servo-ventilation on natriuretic peptides and diastolic function in acute heart failure patients with preserved ejection fraction and sleep-disordered breathing. Sleep and Breathing2019;23:287-91. [DOI: 10.1007/s11325-018-1681-z]">D'Elia 2019</a>), Germany (<a href="./references#CD012889-bbs2-0003" title="DellwegD , KerlJ , HoehnE , WenzelM , KoehlerD . Randomized controlled trial of noninvasive positive pressure ventilation (NPPV) versus servoventilation in patients with CPAP-induced central sleep apnea (complex sleep apnea). Sleep2013;36(8):1163-71. [DOI: 10.5665/sleep.2878]">Dellweg 2013</a>; <a href="./references#CD012889-bbs2-0004" title="FietzeI , BlauA , GlosM , TheresH , BaumannG , PenzelT . Bi-level positive pressure ventilation and adaptive servo ventilation in patients with heart failure and Cheyne-Stokes respiration. Sleep Medicine2008;9:652-9. [DOI: 10.1016/j.sleep.2007.09.008]">Fietze 2008</a>), France (<a href="./references#CD012889-bbs2-0012" title="PhilippeC , Stoica-HermanM , DrouotX , RaffestinB , EscourrouP , HittingerL , et al. Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart2006;92(3):337-42. [DOI: 10.1136/hrt.2005.060038]">Philippe 2006</a>), and Norway (<a href="./references#CD012889-bbs2-0006" title="HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three months treatment with adaptive servo-ventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration in a prospective randomized controlled trial. Circulation2011;124(21 Suppl):A11007. [DOI: 10.1161/circ.124.suppl_21.A11007]HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three-month treatment with adaptive servoventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration: a prospective randomized controlled trial. Cardiology2013;126(C(2)):81-90. [DOI: 10.1159/000350826]OlsengMW , OlsenBF , HetlandA , FagermoenS , JacobsenM . Quality of life improves in patients with chronic heart failure and Cheyne-Stokes respiration treated with adaptive servo-ventilation in a nurse-led heart failure clinic. Journal of Clinical Nursing2017;26(9-10):1226-33. [DOI: 10.1111/jocn.13416]">Hetland 2013</a>); one multicentric study was conducted in Canada and Germany (<a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a>), and the largest study was conducted in several countries including Australia, Switzerland, the Czech Republic, Germany, Denmark, Finland, France, the UK, the Netherlands, Norway, and Sweden (<a href="./references#CD012889-bbs2-0013" title="CowieM , WoehrleH , WegscheiderK , AngermannC , D'OrthoMP , ErdmannE , et al. Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results. European Respiratory Journal2015;46:OA3475. [DOI: 10.1183/13993003.congress-2015.OA3475]CowieMR , WoehrleH , WegscheiderK , AngermannC , D'Ortho M-P, ErdmannE , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. New England Journal of Medicine2015;373(12):1095-105. [DOI: 10.1056/NEJMoa1506459]CowieMR , WoehrleH , WegscheiderK , VettorazziE , LeziusS , KoenigW , et al. Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF. European Journal of Heart Failure2018;20:536-44. [DOI: 10.1002/ejhf.1048]EulenburgC , WegscheiderK , WoehrleH , AngermannC , D'Ortho M-P, ErdmannE , et al. Understanding SERVE-HF: a multistate analysis to explain mechanisms underlying increased mortality risk in patients randomised to adaptive servo-ventilation (ASV). European Respiratory Journal2016;48:OA1985. [DOI: 10.1183/13993003.congress-2016.OA1985]TamisierR , PepinJL , CowieM , WegscheiderK , VettorazziE , SulingA , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure: PSG data from the SERVE-HF major substudy. American Journal of Respiratory and Critical Care Medicine2017;195:A4513. [DOI: 10.1164/ajrccm-conference.2017.B80-G]TamisierR , Pepin J-L, SalvatM , WoehrleH , Barone-RochetteG , RoccaC , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure does not improve muscle sympathetic nerve activity: a SERVE-HF substudy. European Respiratory Journal2016;48:PA2083. [DOI: 10.1183/13993003.congress-2016.PA2083]">SERVE HF 2015</a>). </p> </section> <section id="CD012889-sec-0046"> <h5 class="title">Participants</h5> <p>We included 15 RCTs with a total of 1936 participants, of which 70% to 100% were men. The smallest study included 10 adult participants (<a href="./references#CD012889-bbs2-0002" title="D'eliaE , FerreroP , VittoriC , BaioP , DuinoV , GrosuA , et al. Enhanced adaptive servo-ventilation improves echocardiographic parameters of diastolic and right ventricle function in patients with sleep apnea and heart failure with preserved ejection fraction. European Journal of Heart Failure2016;18:474. D’EliaE , FerreroP , VittoriC , IacovoniA , GrosuA , GoriM , et al. Beneficial effects of adaptive servo-ventilation on natriuretic peptides and diastolic function in acute heart failure patients with preserved ejection fraction and sleep-disordered breathing. Sleep and Breathing2019;23:287-91. [DOI: 10.1007/s11325-018-1681-z]">D'Elia 2019</a>), and the largest study included 1325 adult participants (mean 129 participants) (<a href="./references#CD012889-bbs2-0013" title="CowieM , WoehrleH , WegscheiderK , AngermannC , D'OrthoMP , ErdmannE , et al. Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results. European Respiratory Journal2015;46:OA3475. [DOI: 10.1183/13993003.congress-2015.OA3475]CowieMR , WoehrleH , WegscheiderK , AngermannC , D'Ortho M-P, ErdmannE , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. New England Journal of Medicine2015;373(12):1095-105. [DOI: 10.1056/NEJMoa1506459]CowieMR , WoehrleH , WegscheiderK , VettorazziE , LeziusS , KoenigW , et al. Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF. European Journal of Heart Failure2018;20:536-44. [DOI: 10.1002/ejhf.1048]EulenburgC , WegscheiderK , WoehrleH , AngermannC , D'Ortho M-P, ErdmannE , et al. Understanding SERVE-HF: a multistate analysis to explain mechanisms underlying increased mortality risk in patients randomised to adaptive servo-ventilation (ASV). European Respiratory Journal2016;48:OA1985. [DOI: 10.1183/13993003.congress-2016.OA1985]TamisierR , PepinJL , CowieM , WegscheiderK , VettorazziE , SulingA , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure: PSG data from the SERVE-HF major substudy. American Journal of Respiratory and Critical Care Medicine2017;195:A4513. [DOI: 10.1164/ajrccm-conference.2017.B80-G]TamisierR , Pepin J-L, SalvatM , WoehrleH , Barone-RochetteG , RoccaC , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure does not improve muscle sympathetic nerve activity: a SERVE-HF substudy. European Respiratory Journal2016;48:PA2083. [DOI: 10.1183/13993003.congress-2016.PA2083]">SERVE HF 2015</a>). Most studies included people with CSA associated with chronic heart failure (<a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a>; <a href="./references#CD012889-bbs2-0004" title="FietzeI , BlauA , GlosM , TheresH , BaumannG , PenzelT . Bi-level positive pressure ventilation and adaptive servo ventilation in patients with heart failure and Cheyne-Stokes respiration. Sleep Medicine2008;9:652-9. [DOI: 10.1016/j.sleep.2007.09.008]">Fietze 2008</a>; <a href="./references#CD012889-bbs2-0005" title="GrantonJT , NaughtonMT , BenardDC , LiuPP , GoldsteinRS , BradleyTD . CPAP improves inspiratory muscle strength in patients with heart failure and central sleep apnea. American Journal of Respiratory and Critical Care Medicine1996;153(1):277-82. [DOI: 10.1164/ajrccm.153.1.8542129]">Granton 1996</a>; <a href="./references#CD012889-bbs2-0006" title="HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three months treatment with adaptive servo-ventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration in a prospective randomized controlled trial. Circulation2011;124(21 Suppl):A11007. [DOI: 10.1161/circ.124.suppl_21.A11007]HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three-month treatment with adaptive servoventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration: a prospective randomized controlled trial. Cardiology2013;126(C(2)):81-90. [DOI: 10.1159/000350826]OlsengMW , OlsenBF , HetlandA , FagermoenS , JacobsenM . Quality of life improves in patients with chronic heart failure and Cheyne-Stokes respiration treated with adaptive servo-ventilation in a nurse-led heart failure clinic. Journal of Clinical Nursing2017;26(9-10):1226-33. [DOI: 10.1111/jocn.13416]">Hetland 2013</a>; <a href="./references#CD012889-bbs2-0007" title="KasaiT , KasagiS , Maeno K-I, DohiT , KawanaF , KatoM , et al. Adaptive servo-ventilation in cardiac function and neurohormonal status in patients with heart failure and central sleep apnea nonresponsive to continuous positive airway pressure. JACC: Heart Failure2013;1(1):58-63. [DOI: 10.1016/j.jchf.2012.11.002]">Kasai 2013</a>; <a href="./references#CD012889-bbs2-0009" title="NaughtonMT , LiuPP , BernardDC , GoldsteinRS , BradleyTD . Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. American Journal of Respiratory and Critical Care Medicine1995;151(1):92-7. [DOI: 10.1164/ajrccm.151.1.7812579]NaughtonMT , LuiPP , BenardDC , GoldsteinRS , BradleyTD . A randomized controlled clinical trial of CPAP in patients with heart failure and Cheyne-Stokes respiration. American Review of Respiratory Disease1993;147(7):A687. ">Naughton 1995a</a>; <a href="./references#CD012889-bbs2-0010" title="NaughtonMT , BenardDC , LiuPP , RutherfordR , RankinF , BradleyTD . Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. American Journal of Respiratory and Critical Care Medicine1995;152(2):473-9. [DOI: 10.1164/ajrccm.152.2.7633695]">Naughton 1995b</a>; <a href="./references#CD012889-bbs2-0011" title="PepperellJCT , MaskellNA , JonesDR , Langford-WileyBA , CrosthwaiteN , StradlingJR , et al. A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. American Journal of Respiratory and Critical Care Medicine2003;168(9):1109-14. [DOI: 10.1164/rccm.200212-1476OC]">Pepperell 2003</a>; <a href="./references#CD012889-bbs2-0012" title="PhilippeC , Stoica-HermanM , DrouotX , RaffestinB , EscourrouP , HittingerL , et al. Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart2006;92(3):337-42. [DOI: 10.1136/hrt.2005.060038]">Philippe 2006</a>; <a href="./references#CD012889-bbs2-0013" title="CowieM , WoehrleH , WegscheiderK , AngermannC , D'OrthoMP , ErdmannE , et al. Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results. European Respiratory Journal2015;46:OA3475. [DOI: 10.1183/13993003.congress-2015.OA3475]CowieMR , WoehrleH , WegscheiderK , AngermannC , D'Ortho M-P, ErdmannE , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. New England Journal of Medicine2015;373(12):1095-105. [DOI: 10.1056/NEJMoa1506459]CowieMR , WoehrleH , WegscheiderK , VettorazziE , LeziusS , KoenigW , et al. Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF. European Journal of Heart Failure2018;20:536-44. [DOI: 10.1002/ejhf.1048]EulenburgC , WegscheiderK , WoehrleH , AngermannC , D'Ortho M-P, ErdmannE , et al. Understanding SERVE-HF: a multistate analysis to explain mechanisms underlying increased mortality risk in patients randomised to adaptive servo-ventilation (ASV). European Respiratory Journal2016;48:OA1985. [DOI: 10.1183/13993003.congress-2016.OA1985]TamisierR , PepinJL , CowieM , WegscheiderK , VettorazziE , SulingA , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure: PSG data from the SERVE-HF major substudy. American Journal of Respiratory and Critical Care Medicine2017;195:A4513. [DOI: 10.1164/ajrccm-conference.2017.B80-G]TamisierR , Pepin J-L, SalvatM , WoehrleH , Barone-RochetteG , RoccaC , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure does not improve muscle sympathetic nerve activity: a SERVE-HF substudy. European Respiratory Journal2016;48:PA2083. [DOI: 10.1183/13993003.congress-2016.PA2083]">SERVE HF 2015</a>; <a href="./references#CD012889-bbs2-0014" title="SinDD , LoganAG , FitzgeraldFS , LiuPP , BradleyTD . Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation2000;102 C(1):61-6. [DOI: 10.1161/01.cir.102.1.61]">Sin 2000</a>; <a href="./references#CD012889-bbs2-0015" title="ToyamaT , HoshizakiH , KasamaS , MiyaishiY , KanH , YamashitaE , et al. Adaptive servo-ventilation therapy improves cardiac sympathetic nerve activity, cardiac function, exercise capacity, and symptom in patients with chronic heart failure and Cheyne-Stokes respiration. Journal of Nuclear Cardiology2016;24(6):1-12. [DOI: 10.1007/s12350-016-0529-9]">Toyama 2016</a>); one study included people with acute heart failure and preserved ejection fraction (<a href="./references#CD012889-bbs2-0002" title="D'eliaE , FerreroP , VittoriC , BaioP , DuinoV , GrosuA , et al. Enhanced adaptive servo-ventilation improves echocardiographic parameters of diastolic and right ventricle function in patients with sleep apnea and heart failure with preserved ejection fraction. European Journal of Heart Failure2016;18:474. D’EliaE , FerreroP , VittoriC , IacovoniA , GrosuA , GoriM , et al. Beneficial effects of adaptive servo-ventilation on natriuretic peptides and diastolic function in acute heart failure patients with preserved ejection fraction and sleep-disordered breathing. Sleep and Breathing2019;23:287-91. [DOI: 10.1007/s11325-018-1681-z]">D'Elia 2019</a>); and two studies included people with CPAP‐induced CSA (<a href="./references#CD012889-bbs2-0003" title="DellwegD , KerlJ , HoehnE , WenzelM , KoehlerD . Randomized controlled trial of noninvasive positive pressure ventilation (NPPV) versus servoventilation in patients with CPAP-induced central sleep apnea (complex sleep apnea). Sleep2013;36(8):1163-71. [DOI: 10.5665/sleep.2878]">Dellweg 2013</a>; <a href="./references#CD012889-bbs2-0008" title="MorgenthalerTI , KuzniarTJ , WolfeLF , WillesL , McLainWC , GoldbergR . The Complex Sleep Apnea Resolution Study: a prospective randomized controlled trial of continuous positive airway pressure versus adaptive servoventilation therapy. Sleep2014;37(5):927-34. [DOI: 10.5665/sleep.3662]">Morgenthaler 2014</a>). </p> </section> <section id="CD012889-sec-0047"> <h5 class="title">Interventions</h5> <p>The variability of participants, intervention types, controls, and follow‐up periods made it difficult to carry out a comprehensive meta‐analysis. For summarising the available evidence, we formulated different comparisons, being careful not to pool different populations, interventions, and follow‐up periods. We therefore performed seven separate comparisons, as follows. </p> <p> <ul id="CD012889-list-0023"> <li> <p>Continuous positive airway pressure versus inactive control (subtherapeutic positive pressure, no treatment, or usual care): </p> <ul id="CD012889-list-0024"> <li> <p>CPAP plus best supportive care versus best supportive care alone (or inactive control) in CSA associated with chronic heart failure (five studies: <a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a>; <a href="./references#CD012889-bbs2-0005" title="GrantonJT , NaughtonMT , BenardDC , LiuPP , GoldsteinRS , BradleyTD . CPAP improves inspiratory muscle strength in patients with heart failure and central sleep apnea. American Journal of Respiratory and Critical Care Medicine1996;153(1):277-82. [DOI: 10.1164/ajrccm.153.1.8542129]">Granton 1996</a>; <a href="./references#CD012889-bbs2-0009" title="NaughtonMT , LiuPP , BernardDC , GoldsteinRS , BradleyTD . Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. American Journal of Respiratory and Critical Care Medicine1995;151(1):92-7. [DOI: 10.1164/ajrccm.151.1.7812579]NaughtonMT , LuiPP , BenardDC , GoldsteinRS , BradleyTD . A randomized controlled clinical trial of CPAP in patients with heart failure and Cheyne-Stokes respiration. American Review of Respiratory Disease1993;147(7):A687. ">Naughton 1995a</a>; <a href="./references#CD012889-bbs2-0010" title="NaughtonMT , BenardDC , LiuPP , RutherfordR , RankinF , BradleyTD . Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. American Journal of Respiratory and Critical Care Medicine1995;152(2):473-9. [DOI: 10.1164/ajrccm.152.2.7633695]">Naughton 1995b</a>; <a href="./references#CD012889-bbs2-0014" title="SinDD , LoganAG , FitzgeraldFS , LiuPP , BradleyTD . Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation2000;102 C(1):61-6. [DOI: 10.1161/01.cir.102.1.61]">Sin 2000</a>). </p> </li> </ul> </li> <li> <p>Adaptive servo ventilation versus another type of non‐invasive positive pressure:</p> <ul id="CD012889-list-0025"> <li> <p>ASV versus CPAP in CSA associated with chronic heart failure (two studies: <a href="./references#CD012889-bbs2-0007" title="KasaiT , KasagiS , Maeno K-I, DohiT , KawanaF , KatoM , et al. Adaptive servo-ventilation in cardiac function and neurohormonal status in patients with heart failure and central sleep apnea nonresponsive to continuous positive airway pressure. JACC: Heart Failure2013;1(1):58-63. [DOI: 10.1016/j.jchf.2012.11.002]">Kasai 2013</a>; <a href="./references#CD012889-bbs2-0012" title="PhilippeC , Stoica-HermanM , DrouotX , RaffestinB , EscourrouP , HittingerL , et al. Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart2006;92(3):337-42. [DOI: 10.1136/hrt.2005.060038]">Philippe 2006</a>); </p> </li> <li> <p>ASV versus bilevel ventilation in CSA associated with chronic heart failure (one study: <a href="./references#CD012889-bbs2-0004" title="FietzeI , BlauA , GlosM , TheresH , BaumannG , PenzelT . Bi-level positive pressure ventilation and adaptive servo ventilation in patients with heart failure and Cheyne-Stokes respiration. Sleep Medicine2008;9:652-9. [DOI: 10.1016/j.sleep.2007.09.008]">Fietze 2008</a>); </p> </li> <li> <p>ASV versus CPAP in CPAP‐induced CSA (one study: <a href="./references#CD012889-bbs2-0008" title="MorgenthalerTI , KuzniarTJ , WolfeLF , WillesL , McLainWC , GoldbergR . The Complex Sleep Apnea Resolution Study: a prospective randomized controlled trial of continuous positive airway pressure versus adaptive servoventilation therapy. Sleep2014;37(5):927-34. [DOI: 10.5665/sleep.3662]">Morgenthaler 2014</a>); </p> </li> <li> <p>ASV versus bilevel ventilation in CPAP‐induced CSA (one study: <a href="./references#CD012889-bbs2-0003" title="DellwegD , KerlJ , HoehnE , WenzelM , KoehlerD . Randomized controlled trial of noninvasive positive pressure ventilation (NPPV) versus servoventilation in patients with CPAP-induced central sleep apnea (complex sleep apnea). Sleep2013;36(8):1163-71. [DOI: 10.5665/sleep.2878]">Dellweg 2013</a>). </p> </li> </ul> </li> <li> <p>Adaptive servo ventilation versus inactive control (subtherapeutic positive pressure, no treatment, or usual care): </p> <ul id="CD012889-list-0026"> <li> <p>ASV plus best supportive care versus best supportive care alone (or inactive control) in CSA associated with chronic heart failure (four studies: <a href="./references#CD012889-bbs2-0006" title="HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three months treatment with adaptive servo-ventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration in a prospective randomized controlled trial. Circulation2011;124(21 Suppl):A11007. [DOI: 10.1161/circ.124.suppl_21.A11007]HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three-month treatment with adaptive servoventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration: a prospective randomized controlled trial. Cardiology2013;126(C(2)):81-90. [DOI: 10.1159/000350826]OlsengMW , OlsenBF , HetlandA , FagermoenS , JacobsenM . Quality of life improves in patients with chronic heart failure and Cheyne-Stokes respiration treated with adaptive servo-ventilation in a nurse-led heart failure clinic. Journal of Clinical Nursing2017;26(9-10):1226-33. [DOI: 10.1111/jocn.13416]">Hetland 2013</a>; <a href="./references#CD012889-bbs2-0011" title="PepperellJCT , MaskellNA , JonesDR , Langford-WileyBA , CrosthwaiteN , StradlingJR , et al. A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. American Journal of Respiratory and Critical Care Medicine2003;168(9):1109-14. [DOI: 10.1164/rccm.200212-1476OC]">Pepperell 2003</a>; <a href="./references#CD012889-bbs2-0013" title="CowieM , WoehrleH , WegscheiderK , AngermannC , D'OrthoMP , ErdmannE , et al. Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results. European Respiratory Journal2015;46:OA3475. [DOI: 10.1183/13993003.congress-2015.OA3475]CowieMR , WoehrleH , WegscheiderK , AngermannC , D'Ortho M-P, ErdmannE , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. New England Journal of Medicine2015;373(12):1095-105. [DOI: 10.1056/NEJMoa1506459]CowieMR , WoehrleH , WegscheiderK , VettorazziE , LeziusS , KoenigW , et al. Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF. European Journal of Heart Failure2018;20:536-44. [DOI: 10.1002/ejhf.1048]EulenburgC , WegscheiderK , WoehrleH , AngermannC , D'Ortho M-P, ErdmannE , et al. Understanding SERVE-HF: a multistate analysis to explain mechanisms underlying increased mortality risk in patients randomised to adaptive servo-ventilation (ASV). European Respiratory Journal2016;48:OA1985. [DOI: 10.1183/13993003.congress-2016.OA1985]TamisierR , PepinJL , CowieM , WegscheiderK , VettorazziE , SulingA , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure: PSG data from the SERVE-HF major substudy. American Journal of Respiratory and Critical Care Medicine2017;195:A4513. [DOI: 10.1164/ajrccm-conference.2017.B80-G]TamisierR , Pepin J-L, SalvatM , WoehrleH , Barone-RochetteG , RoccaC , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure does not improve muscle sympathetic nerve activity: a SERVE-HF substudy. European Respiratory Journal2016;48:PA2083. [DOI: 10.1183/13993003.congress-2016.PA2083]">SERVE HF 2015</a>; <a href="./references#CD012889-bbs2-0015" title="ToyamaT , HoshizakiH , KasamaS , MiyaishiY , KanH , YamashitaE , et al. Adaptive servo-ventilation therapy improves cardiac sympathetic nerve activity, cardiac function, exercise capacity, and symptom in patients with chronic heart failure and Cheyne-Stokes respiration. Journal of Nuclear Cardiology2016;24(6):1-12. [DOI: 10.1007/s12350-016-0529-9]">Toyama 2016</a>); </p> </li> <li> <p>ASV plus best supportive care versus best supportive care alone (or inactive control) in people with CSA and acute heart failure with preserved ejection fraction (one study: <a href="./references#CD012889-bbs2-0002" title="D'eliaE , FerreroP , VittoriC , BaioP , DuinoV , GrosuA , et al. Enhanced adaptive servo-ventilation improves echocardiographic parameters of diastolic and right ventricle function in patients with sleep apnea and heart failure with preserved ejection fraction. European Journal of Heart Failure2016;18:474. D’EliaE , FerreroP , VittoriC , IacovoniA , GrosuA , GoriM , et al. Beneficial effects of adaptive servo-ventilation on natriuretic peptides and diastolic function in acute heart failure patients with preserved ejection fraction and sleep-disordered breathing. Sleep and Breathing2019;23:287-91. [DOI: 10.1007/s11325-018-1681-z]">D'Elia 2019</a>). </p> </li> </ul> </li> </ul> </p> </section> <section id="CD012889-sec-0048"> <h5 class="title">Conflicts of interest and study funding</h5> <p>In <a href="./references#CD012889-bbs2-0002" title="D'eliaE , FerreroP , VittoriC , BaioP , DuinoV , GrosuA , et al. Enhanced adaptive servo-ventilation improves echocardiographic parameters of diastolic and right ventricle function in patients with sleep apnea and heart failure with preserved ejection fraction. European Journal of Heart Failure2016;18:474. D’EliaE , FerreroP , VittoriC , IacovoniA , GrosuA , GoriM , et al. Beneficial effects of adaptive servo-ventilation on natriuretic peptides and diastolic function in acute heart failure patients with preserved ejection fraction and sleep-disordered breathing. Sleep and Breathing2019;23:287-91. [DOI: 10.1007/s11325-018-1681-z]">D'Elia 2019</a>, the authors declared that they did not have any conflict of interest. In <a href="./references#CD012889-bbs2-0009" title="NaughtonMT , LiuPP , BernardDC , GoldsteinRS , BradleyTD . Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. American Journal of Respiratory and Critical Care Medicine1995;151(1):92-7. [DOI: 10.1164/ajrccm.151.1.7812579]NaughtonMT , LuiPP , BenardDC , GoldsteinRS , BradleyTD . A randomized controlled clinical trial of CPAP in patients with heart failure and Cheyne-Stokes respiration. American Review of Respiratory Disease1993;147(7):A687. ">Naughton 1995a</a> and <a href="./references#CD012889-bbs2-0010" title="NaughtonMT , BenardDC , LiuPP , RutherfordR , RankinF , BradleyTD . Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. American Journal of Respiratory and Critical Care Medicine1995;152(2):473-9. [DOI: 10.1164/ajrccm.152.2.7633695]">Naughton 1995b</a>, the authors reported they did not receive grants from industry. In <a href="./references#CD012889-bbs2-0015" title="ToyamaT , HoshizakiH , KasamaS , MiyaishiY , KanH , YamashitaE , et al. Adaptive servo-ventilation therapy improves cardiac sympathetic nerve activity, cardiac function, exercise capacity, and symptom in patients with chronic heart failure and Cheyne-Stokes respiration. Journal of Nuclear Cardiology2016;24(6):1-12. [DOI: 10.1007/s12350-016-0529-9]">Toyama 2016</a>, the authors also indicated that they had no financial conflict of interest. In nine studies (<a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a>; <a href="./references#CD012889-bbs2-0003" title="DellwegD , KerlJ , HoehnE , WenzelM , KoehlerD . Randomized controlled trial of noninvasive positive pressure ventilation (NPPV) versus servoventilation in patients with CPAP-induced central sleep apnea (complex sleep apnea). Sleep2013;36(8):1163-71. [DOI: 10.5665/sleep.2878]">Dellweg 2013</a>; <a href="./references#CD012889-bbs2-0005" title="GrantonJT , NaughtonMT , BenardDC , LiuPP , GoldsteinRS , BradleyTD . CPAP improves inspiratory muscle strength in patients with heart failure and central sleep apnea. American Journal of Respiratory and Critical Care Medicine1996;153(1):277-82. [DOI: 10.1164/ajrccm.153.1.8542129]">Granton 1996</a>; <a href="./references#CD012889-bbs2-0007" title="KasaiT , KasagiS , Maeno K-I, DohiT , KawanaF , KatoM , et al. Adaptive servo-ventilation in cardiac function and neurohormonal status in patients with heart failure and central sleep apnea nonresponsive to continuous positive airway pressure. JACC: Heart Failure2013;1(1):58-63. [DOI: 10.1016/j.jchf.2012.11.002]">Kasai 2013</a>; <a href="./references#CD012889-bbs2-0008" title="MorgenthalerTI , KuzniarTJ , WolfeLF , WillesL , McLainWC , GoldbergR . The Complex Sleep Apnea Resolution Study: a prospective randomized controlled trial of continuous positive airway pressure versus adaptive servoventilation therapy. Sleep2014;37(5):927-34. [DOI: 10.5665/sleep.3662]">Morgenthaler 2014</a>; <a href="./references#CD012889-bbs2-0011" title="PepperellJCT , MaskellNA , JonesDR , Langford-WileyBA , CrosthwaiteN , StradlingJR , et al. A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. American Journal of Respiratory and Critical Care Medicine2003;168(9):1109-14. [DOI: 10.1164/rccm.200212-1476OC]">Pepperell 2003</a>; <a href="./references#CD012889-bbs2-0012" title="PhilippeC , Stoica-HermanM , DrouotX , RaffestinB , EscourrouP , HittingerL , et al. Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart2006;92(3):337-42. [DOI: 10.1136/hrt.2005.060038]">Philippe 2006</a>; <a href="./references#CD012889-bbs2-0013" title="CowieM , WoehrleH , WegscheiderK , AngermannC , D'OrthoMP , ErdmannE , et al. Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results. European Respiratory Journal2015;46:OA3475. [DOI: 10.1183/13993003.congress-2015.OA3475]CowieMR , WoehrleH , WegscheiderK , AngermannC , D'Ortho M-P, ErdmannE , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. New England Journal of Medicine2015;373(12):1095-105. [DOI: 10.1056/NEJMoa1506459]CowieMR , WoehrleH , WegscheiderK , VettorazziE , LeziusS , KoenigW , et al. Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF. European Journal of Heart Failure2018;20:536-44. [DOI: 10.1002/ejhf.1048]EulenburgC , WegscheiderK , WoehrleH , AngermannC , D'Ortho M-P, ErdmannE , et al. Understanding SERVE-HF: a multistate analysis to explain mechanisms underlying increased mortality risk in patients randomised to adaptive servo-ventilation (ASV). European Respiratory Journal2016;48:OA1985. [DOI: 10.1183/13993003.congress-2016.OA1985]TamisierR , PepinJL , CowieM , WegscheiderK , VettorazziE , SulingA , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure: PSG data from the SERVE-HF major substudy. American Journal of Respiratory and Critical Care Medicine2017;195:A4513. [DOI: 10.1164/ajrccm-conference.2017.B80-G]TamisierR , Pepin J-L, SalvatM , WoehrleH , Barone-RochetteG , RoccaC , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure does not improve muscle sympathetic nerve activity: a SERVE-HF substudy. European Respiratory Journal2016;48:PA2083. [DOI: 10.1183/13993003.congress-2016.PA2083]">SERVE HF 2015</a>; <a href="./references#CD012889-bbs2-0014" title="SinDD , LoganAG , FitzgeraldFS , LiuPP , BradleyTD . Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation2000;102 C(1):61-6. [DOI: 10.1161/01.cir.102.1.61]">Sin 2000</a>), at least one author received grants from industry. In one manuscript (<a href="./references#CD012889-bbs2-0004" title="FietzeI , BlauA , GlosM , TheresH , BaumannG , PenzelT . Bi-level positive pressure ventilation and adaptive servo ventilation in patients with heart failure and Cheyne-Stokes respiration. Sleep Medicine2008;9:652-9. [DOI: 10.1016/j.sleep.2007.09.008]">Fietze 2008</a>), we found no report regarding possible author conflict of interest. In <a href="./references#CD012889-bbs2-0006" title="HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three months treatment with adaptive servo-ventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration in a prospective randomized controlled trial. Circulation2011;124(21 Suppl):A11007. [DOI: 10.1161/circ.124.suppl_21.A11007]HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three-month treatment with adaptive servoventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration: a prospective randomized controlled trial. Cardiology2013;126(C(2)):81-90. [DOI: 10.1159/000350826]OlsengMW , OlsenBF , HetlandA , FagermoenS , JacobsenM . Quality of life improves in patients with chronic heart failure and Cheyne-Stokes respiration treated with adaptive servo-ventilation in a nurse-led heart failure clinic. Journal of Clinical Nursing2017;26(9-10):1226-33. [DOI: 10.1111/jocn.13416]">Hetland 2013</a>, although the study received funding from industry, the authors reported that the sponsors had no role in study design, data collection and interpretation, manuscript writing, or the decision to submit for publication, and therefore they did not have any conflicts of interest. </p> <p>Regarding study funding, eight of the 15 studies received financial support from an industry sponsor (<a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a>; <a href="./references#CD012889-bbs2-0004" title="FietzeI , BlauA , GlosM , TheresH , BaumannG , PenzelT . Bi-level positive pressure ventilation and adaptive servo ventilation in patients with heart failure and Cheyne-Stokes respiration. Sleep Medicine2008;9:652-9. [DOI: 10.1016/j.sleep.2007.09.008]">Fietze 2008</a>; <a href="./references#CD012889-bbs2-0006" title="HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three months treatment with adaptive servo-ventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration in a prospective randomized controlled trial. Circulation2011;124(21 Suppl):A11007. [DOI: 10.1161/circ.124.suppl_21.A11007]HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three-month treatment with adaptive servoventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration: a prospective randomized controlled trial. Cardiology2013;126(C(2)):81-90. [DOI: 10.1159/000350826]OlsengMW , OlsenBF , HetlandA , FagermoenS , JacobsenM . Quality of life improves in patients with chronic heart failure and Cheyne-Stokes respiration treated with adaptive servo-ventilation in a nurse-led heart failure clinic. Journal of Clinical Nursing2017;26(9-10):1226-33. [DOI: 10.1111/jocn.13416]">Hetland 2013</a>; <a href="./references#CD012889-bbs2-0008" title="MorgenthalerTI , KuzniarTJ , WolfeLF , WillesL , McLainWC , GoldbergR . The Complex Sleep Apnea Resolution Study: a prospective randomized controlled trial of continuous positive airway pressure versus adaptive servoventilation therapy. Sleep2014;37(5):927-34. [DOI: 10.5665/sleep.3662]">Morgenthaler 2014</a>; <a href="./references#CD012889-bbs2-0009" title="NaughtonMT , LiuPP , BernardDC , GoldsteinRS , BradleyTD . Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. American Journal of Respiratory and Critical Care Medicine1995;151(1):92-7. [DOI: 10.1164/ajrccm.151.1.7812579]NaughtonMT , LuiPP , BenardDC , GoldsteinRS , BradleyTD . A randomized controlled clinical trial of CPAP in patients with heart failure and Cheyne-Stokes respiration. American Review of Respiratory Disease1993;147(7):A687. ">Naughton 1995a</a>; <a href="./references#CD012889-bbs2-0011" title="PepperellJCT , MaskellNA , JonesDR , Langford-WileyBA , CrosthwaiteN , StradlingJR , et al. A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. American Journal of Respiratory and Critical Care Medicine2003;168(9):1109-14. [DOI: 10.1164/rccm.200212-1476OC]">Pepperell 2003</a>; <a href="./references#CD012889-bbs2-0012" title="PhilippeC , Stoica-HermanM , DrouotX , RaffestinB , EscourrouP , HittingerL , et al. Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart2006;92(3):337-42. [DOI: 10.1136/hrt.2005.060038]">Philippe 2006</a>; <a href="./references#CD012889-bbs2-0013" title="CowieM , WoehrleH , WegscheiderK , AngermannC , D'OrthoMP , ErdmannE , et al. Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results. European Respiratory Journal2015;46:OA3475. [DOI: 10.1183/13993003.congress-2015.OA3475]CowieMR , WoehrleH , WegscheiderK , AngermannC , D'Ortho M-P, ErdmannE , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. New England Journal of Medicine2015;373(12):1095-105. [DOI: 10.1056/NEJMoa1506459]CowieMR , WoehrleH , WegscheiderK , VettorazziE , LeziusS , KoenigW , et al. Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF. European Journal of Heart Failure2018;20:536-44. [DOI: 10.1002/ejhf.1048]EulenburgC , WegscheiderK , WoehrleH , AngermannC , D'Ortho M-P, ErdmannE , et al. Understanding SERVE-HF: a multistate analysis to explain mechanisms underlying increased mortality risk in patients randomised to adaptive servo-ventilation (ASV). European Respiratory Journal2016;48:OA1985. [DOI: 10.1183/13993003.congress-2016.OA1985]TamisierR , PepinJL , CowieM , WegscheiderK , VettorazziE , SulingA , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure: PSG data from the SERVE-HF major substudy. American Journal of Respiratory and Critical Care Medicine2017;195:A4513. [DOI: 10.1164/ajrccm-conference.2017.B80-G]TamisierR , Pepin J-L, SalvatM , WoehrleH , Barone-RochetteG , RoccaC , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure does not improve muscle sympathetic nerve activity: a SERVE-HF substudy. European Respiratory Journal2016;48:PA2083. [DOI: 10.1183/13993003.congress-2016.PA2083]">SERVE HF 2015</a>). Four studies received other support: <a href="./references#CD012889-bbs2-0005" title="GrantonJT , NaughtonMT , BenardDC , LiuPP , GoldsteinRS , BradleyTD . CPAP improves inspiratory muscle strength in patients with heart failure and central sleep apnea. American Journal of Respiratory and Critical Care Medicine1996;153(1):277-82. [DOI: 10.1164/ajrccm.153.1.8542129]">Granton 1996</a> and <a href="./references#CD012889-bbs2-0010" title="NaughtonMT , BenardDC , LiuPP , RutherfordR , RankinF , BradleyTD . Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. American Journal of Respiratory and Critical Care Medicine1995;152(2):473-9. [DOI: 10.1164/ajrccm.152.2.7633695]">Naughton 1995b</a> were supported by operating grants from both the Ontario Ministry of Health and the Medical Research Council of Canada; <a href="./references#CD012889-bbs2-0014" title="SinDD , LoganAG , FitzgeraldFS , LiuPP , BradleyTD . Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation2000;102 C(1):61-6. [DOI: 10.1161/01.cir.102.1.61]">Sin 2000</a> was supported by an operating grant from the Medical Research Council of Canada only; and <a href="./references#CD012889-bbs2-0007" title="KasaiT , KasagiS , Maeno K-I, DohiT , KawanaF , KatoM , et al. Adaptive servo-ventilation in cardiac function and neurohormonal status in patients with heart failure and central sleep apnea nonresponsive to continuous positive airway pressure. JACC: Heart Failure2013;1(1):58-63. [DOI: 10.1016/j.jchf.2012.11.002]">Kasai 2013</a> was funded by grants from the Okinaka Memorial Institute for Medical Research in Tokyo, Japan. The authors of <a href="./references#CD012889-bbs2-0003" title="DellwegD , KerlJ , HoehnE , WenzelM , KoehlerD . Randomized controlled trial of noninvasive positive pressure ventilation (NPPV) versus servoventilation in patients with CPAP-induced central sleep apnea (complex sleep apnea). Sleep2013;36(8):1163-71. [DOI: 10.5665/sleep.2878]">Dellweg 2013</a> declared that their study was not funded by industry sponsors but did not report whether it had received other support. In the other two manuscripts (<a href="./references#CD012889-bbs2-0002" title="D'eliaE , FerreroP , VittoriC , BaioP , DuinoV , GrosuA , et al. Enhanced adaptive servo-ventilation improves echocardiographic parameters of diastolic and right ventricle function in patients with sleep apnea and heart failure with preserved ejection fraction. European Journal of Heart Failure2016;18:474. D’EliaE , FerreroP , VittoriC , IacovoniA , GrosuA , GoriM , et al. Beneficial effects of adaptive servo-ventilation on natriuretic peptides and diastolic function in acute heart failure patients with preserved ejection fraction and sleep-disordered breathing. Sleep and Breathing2019;23:287-91. [DOI: 10.1007/s11325-018-1681-z]">D'Elia 2019</a>; <a href="./references#CD012889-bbs2-0015" title="ToyamaT , HoshizakiH , KasamaS , MiyaishiY , KanH , YamashitaE , et al. Adaptive servo-ventilation therapy improves cardiac sympathetic nerve activity, cardiac function, exercise capacity, and symptom in patients with chronic heart failure and Cheyne-Stokes respiration. Journal of Nuclear Cardiology2016;24(6):1-12. [DOI: 10.1007/s12350-016-0529-9]">Toyama 2016</a>), we found no report regarding possible funding sources. </p> </section> <section id="CD012889-sec-0049"> <h5 class="title">Outcomes</h5> <p>Regarding our primary outcomes, only four trials evaluated central AHI (<a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a>; <a href="./references#CD012889-bbs2-0003" title="DellwegD , KerlJ , HoehnE , WenzelM , KoehlerD . Randomized controlled trial of noninvasive positive pressure ventilation (NPPV) versus servoventilation in patients with CPAP-induced central sleep apnea (complex sleep apnea). Sleep2013;36(8):1163-71. [DOI: 10.5665/sleep.2878]">Dellweg 2013</a>; <a href="./references#CD012889-bbs2-0004" title="FietzeI , BlauA , GlosM , TheresH , BaumannG , PenzelT . Bi-level positive pressure ventilation and adaptive servo ventilation in patients with heart failure and Cheyne-Stokes respiration. Sleep Medicine2008;9:652-9. [DOI: 10.1016/j.sleep.2007.09.008]">Fietze 2008</a>; <a href="./references#CD012889-bbs2-0008" title="MorgenthalerTI , KuzniarTJ , WolfeLF , WillesL , McLainWC , GoldbergR . The Complex Sleep Apnea Resolution Study: a prospective randomized controlled trial of continuous positive airway pressure versus adaptive servoventilation therapy. Sleep2014;37(5):927-34. [DOI: 10.5665/sleep.3662]">Morgenthaler 2014</a>); two trials evaluated cardiovascular mortality (<a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a>; <a href="./references#CD012889-bbs2-0013" title="CowieM , WoehrleH , WegscheiderK , AngermannC , D'OrthoMP , ErdmannE , et al. Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results. European Respiratory Journal2015;46:OA3475. [DOI: 10.1183/13993003.congress-2015.OA3475]CowieMR , WoehrleH , WegscheiderK , AngermannC , D'Ortho M-P, ErdmannE , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. New England Journal of Medicine2015;373(12):1095-105. [DOI: 10.1056/NEJMoa1506459]CowieMR , WoehrleH , WegscheiderK , VettorazziE , LeziusS , KoenigW , et al. Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF. European Journal of Heart Failure2018;20:536-44. [DOI: 10.1002/ejhf.1048]EulenburgC , WegscheiderK , WoehrleH , AngermannC , D'Ortho M-P, ErdmannE , et al. Understanding SERVE-HF: a multistate analysis to explain mechanisms underlying increased mortality risk in patients randomised to adaptive servo-ventilation (ASV). European Respiratory Journal2016;48:OA1985. [DOI: 10.1183/13993003.congress-2016.OA1985]TamisierR , PepinJL , CowieM , WegscheiderK , VettorazziE , SulingA , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure: PSG data from the SERVE-HF major substudy. American Journal of Respiratory and Critical Care Medicine2017;195:A4513. [DOI: 10.1164/ajrccm-conference.2017.B80-G]TamisierR , Pepin J-L, SalvatM , WoehrleH , Barone-RochetteG , RoccaC , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure does not improve muscle sympathetic nerve activity: a SERVE-HF substudy. European Respiratory Journal2016;48:PA2083. [DOI: 10.1183/13993003.congress-2016.PA2083]">SERVE HF 2015</a>); and only the authors of the <a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a> trial reported on serious adverse effects, finding that none occurred in participants randomised to CPAP within one month of its initiation; however, results for the best supportive care study arm were not reported. </p> <p>Regarding our secondary outcomes, most trials (11/15) evaluated AHI (<a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a>; <a href="./references#CD012889-bbs2-0003" title="DellwegD , KerlJ , HoehnE , WenzelM , KoehlerD . Randomized controlled trial of noninvasive positive pressure ventilation (NPPV) versus servoventilation in patients with CPAP-induced central sleep apnea (complex sleep apnea). Sleep2013;36(8):1163-71. [DOI: 10.5665/sleep.2878]">Dellweg 2013</a>; <a href="./references#CD012889-bbs2-0004" title="FietzeI , BlauA , GlosM , TheresH , BaumannG , PenzelT . Bi-level positive pressure ventilation and adaptive servo ventilation in patients with heart failure and Cheyne-Stokes respiration. Sleep Medicine2008;9:652-9. [DOI: 10.1016/j.sleep.2007.09.008]">Fietze 2008</a>; <a href="./references#CD012889-bbs2-0005" title="GrantonJT , NaughtonMT , BenardDC , LiuPP , GoldsteinRS , BradleyTD . CPAP improves inspiratory muscle strength in patients with heart failure and central sleep apnea. American Journal of Respiratory and Critical Care Medicine1996;153(1):277-82. [DOI: 10.1164/ajrccm.153.1.8542129]">Granton 1996</a>; <a href="./references#CD012889-bbs2-0007" title="KasaiT , KasagiS , Maeno K-I, DohiT , KawanaF , KatoM , et al. Adaptive servo-ventilation in cardiac function and neurohormonal status in patients with heart failure and central sleep apnea nonresponsive to continuous positive airway pressure. JACC: Heart Failure2013;1(1):58-63. [DOI: 10.1016/j.jchf.2012.11.002]">Kasai 2013</a>; <a href="./references#CD012889-bbs2-0008" title="MorgenthalerTI , KuzniarTJ , WolfeLF , WillesL , McLainWC , GoldbergR . The Complex Sleep Apnea Resolution Study: a prospective randomized controlled trial of continuous positive airway pressure versus adaptive servoventilation therapy. Sleep2014;37(5):927-34. [DOI: 10.5665/sleep.3662]">Morgenthaler 2014</a>; <a href="./references#CD012889-bbs2-0009" title="NaughtonMT , LiuPP , BernardDC , GoldsteinRS , BradleyTD . Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. American Journal of Respiratory and Critical Care Medicine1995;151(1):92-7. [DOI: 10.1164/ajrccm.151.1.7812579]NaughtonMT , LuiPP , BenardDC , GoldsteinRS , BradleyTD . A randomized controlled clinical trial of CPAP in patients with heart failure and Cheyne-Stokes respiration. American Review of Respiratory Disease1993;147(7):A687. ">Naughton 1995a</a>; <a href="./references#CD012889-bbs2-0010" title="NaughtonMT , BenardDC , LiuPP , RutherfordR , RankinF , BradleyTD . Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. American Journal of Respiratory and Critical Care Medicine1995;152(2):473-9. [DOI: 10.1164/ajrccm.152.2.7633695]">Naughton 1995b</a>; <a href="./references#CD012889-bbs2-0011" title="PepperellJCT , MaskellNA , JonesDR , Langford-WileyBA , CrosthwaiteN , StradlingJR , et al. A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. American Journal of Respiratory and Critical Care Medicine2003;168(9):1109-14. [DOI: 10.1164/rccm.200212-1476OC]">Pepperell 2003</a>; <a href="./references#CD012889-bbs2-0012" title="PhilippeC , Stoica-HermanM , DrouotX , RaffestinB , EscourrouP , HittingerL , et al. Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart2006;92(3):337-42. [DOI: 10.1136/hrt.2005.060038]">Philippe 2006</a>; <a href="./references#CD012889-bbs2-0015" title="ToyamaT , HoshizakiH , KasamaS , MiyaishiY , KanH , YamashitaE , et al. Adaptive servo-ventilation therapy improves cardiac sympathetic nerve activity, cardiac function, exercise capacity, and symptom in patients with chronic heart failure and Cheyne-Stokes respiration. Journal of Nuclear Cardiology2016;24(6):1-12. [DOI: 10.1007/s12350-016-0529-9]">Toyama 2016</a>). However, only three trials evaluated quality of life (<a href="./references#CD012889-bbs2-0006" title="HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three months treatment with adaptive servo-ventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration in a prospective randomized controlled trial. Circulation2011;124(21 Suppl):A11007. [DOI: 10.1161/circ.124.suppl_21.A11007]HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three-month treatment with adaptive servoventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration: a prospective randomized controlled trial. Cardiology2013;126(C(2)):81-90. [DOI: 10.1159/000350826]OlsengMW , OlsenBF , HetlandA , FagermoenS , JacobsenM . Quality of life improves in patients with chronic heart failure and Cheyne-Stokes respiration treated with adaptive servo-ventilation in a nurse-led heart failure clinic. Journal of Clinical Nursing2017;26(9-10):1226-33. [DOI: 10.1111/jocn.13416]">Hetland 2013</a>; <a href="./references#CD012889-bbs2-0008" title="MorgenthalerTI , KuzniarTJ , WolfeLF , WillesL , McLainWC , GoldbergR . The Complex Sleep Apnea Resolution Study: a prospective randomized controlled trial of continuous positive airway pressure versus adaptive servoventilation therapy. Sleep2014;37(5):927-34. [DOI: 10.5665/sleep.3662]">Morgenthaler 2014</a>; <a href="./references#CD012889-bbs2-0013" title="CowieM , WoehrleH , WegscheiderK , AngermannC , D'OrthoMP , ErdmannE , et al. Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results. European Respiratory Journal2015;46:OA3475. [DOI: 10.1183/13993003.congress-2015.OA3475]CowieMR , WoehrleH , WegscheiderK , AngermannC , D'Ortho M-P, ErdmannE , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. New England Journal of Medicine2015;373(12):1095-105. [DOI: 10.1056/NEJMoa1506459]CowieMR , WoehrleH , WegscheiderK , VettorazziE , LeziusS , KoenigW , et al. Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF. European Journal of Heart Failure2018;20:536-44. [DOI: 10.1002/ejhf.1048]EulenburgC , WegscheiderK , WoehrleH , AngermannC , D'Ortho M-P, ErdmannE , et al. Understanding SERVE-HF: a multistate analysis to explain mechanisms underlying increased mortality risk in patients randomised to adaptive servo-ventilation (ASV). European Respiratory Journal2016;48:OA1985. [DOI: 10.1183/13993003.congress-2016.OA1985]TamisierR , PepinJL , CowieM , WegscheiderK , VettorazziE , SulingA , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure: PSG data from the SERVE-HF major substudy. American Journal of Respiratory and Critical Care Medicine2017;195:A4513. [DOI: 10.1164/ajrccm-conference.2017.B80-G]TamisierR , Pepin J-L, SalvatM , WoehrleH , Barone-RochetteG , RoccaC , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure does not improve muscle sympathetic nerve activity: a SERVE-HF substudy. European Respiratory Journal2016;48:PA2083. [DOI: 10.1183/13993003.congress-2016.PA2083]">SERVE HF 2015</a>); four evaluated all‐cause mortality (<a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a>; <a href="./references#CD012889-bbs2-0006" title="HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three months treatment with adaptive servo-ventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration in a prospective randomized controlled trial. Circulation2011;124(21 Suppl):A11007. [DOI: 10.1161/circ.124.suppl_21.A11007]HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three-month treatment with adaptive servoventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration: a prospective randomized controlled trial. Cardiology2013;126(C(2)):81-90. [DOI: 10.1159/000350826]OlsengMW , OlsenBF , HetlandA , FagermoenS , JacobsenM . Quality of life improves in patients with chronic heart failure and Cheyne-Stokes respiration treated with adaptive servo-ventilation in a nurse-led heart failure clinic. Journal of Clinical Nursing2017;26(9-10):1226-33. [DOI: 10.1111/jocn.13416]">Hetland 2013</a>; <a href="./references#CD012889-bbs2-0013" title="CowieM , WoehrleH , WegscheiderK , AngermannC , D'OrthoMP , ErdmannE , et al. Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results. European Respiratory Journal2015;46:OA3475. [DOI: 10.1183/13993003.congress-2015.OA3475]CowieMR , WoehrleH , WegscheiderK , AngermannC , D'Ortho M-P, ErdmannE , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. New England Journal of Medicine2015;373(12):1095-105. [DOI: 10.1056/NEJMoa1506459]CowieMR , WoehrleH , WegscheiderK , VettorazziE , LeziusS , KoenigW , et al. Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF. European Journal of Heart Failure2018;20:536-44. [DOI: 10.1002/ejhf.1048]EulenburgC , WegscheiderK , WoehrleH , AngermannC , D'Ortho M-P, ErdmannE , et al. Understanding SERVE-HF: a multistate analysis to explain mechanisms underlying increased mortality risk in patients randomised to adaptive servo-ventilation (ASV). European Respiratory Journal2016;48:OA1985. [DOI: 10.1183/13993003.congress-2016.OA1985]TamisierR , PepinJL , CowieM , WegscheiderK , VettorazziE , SulingA , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure: PSG data from the SERVE-HF major substudy. American Journal of Respiratory and Critical Care Medicine2017;195:A4513. [DOI: 10.1164/ajrccm-conference.2017.B80-G]TamisierR , Pepin J-L, SalvatM , WoehrleH , Barone-RochetteG , RoccaC , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure does not improve muscle sympathetic nerve activity: a SERVE-HF substudy. European Respiratory Journal2016;48:PA2083. [DOI: 10.1183/13993003.congress-2016.PA2083]">SERVE HF 2015</a>; <a href="./references#CD012889-bbs2-0014" title="SinDD , LoganAG , FitzgeraldFS , LiuPP , BradleyTD . Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation2000;102 C(1):61-6. [DOI: 10.1161/01.cir.102.1.61]">Sin 2000</a>); and one evaluated time to life‐saving intervention (<a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a>). Although <a href="./references#CD012889-bbs2-0013" title="CowieM , WoehrleH , WegscheiderK , AngermannC , D'OrthoMP , ErdmannE , et al. Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results. European Respiratory Journal2015;46:OA3475. [DOI: 10.1183/13993003.congress-2015.OA3475]CowieMR , WoehrleH , WegscheiderK , AngermannC , D'Ortho M-P, ErdmannE , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. New England Journal of Medicine2015;373(12):1095-105. [DOI: 10.1056/NEJMoa1506459]CowieMR , WoehrleH , WegscheiderK , VettorazziE , LeziusS , KoenigW , et al. Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF. European Journal of Heart Failure2018;20:536-44. [DOI: 10.1002/ejhf.1048]EulenburgC , WegscheiderK , WoehrleH , AngermannC , D'Ortho M-P, ErdmannE , et al. Understanding SERVE-HF: a multistate analysis to explain mechanisms underlying increased mortality risk in patients randomised to adaptive servo-ventilation (ASV). European Respiratory Journal2016;48:OA1985. [DOI: 10.1183/13993003.congress-2016.OA1985]TamisierR , PepinJL , CowieM , WegscheiderK , VettorazziE , SulingA , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure: PSG data from the SERVE-HF major substudy. American Journal of Respiratory and Critical Care Medicine2017;195:A4513. [DOI: 10.1164/ajrccm-conference.2017.B80-G]TamisierR , Pepin J-L, SalvatM , WoehrleH , Barone-RochetteG , RoccaC , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure does not improve muscle sympathetic nerve activity: a SERVE-HF substudy. European Respiratory Journal2016;48:PA2083. [DOI: 10.1183/13993003.congress-2016.PA2083]">SERVE HF 2015</a> reported the composite endpoint of time to first event of death from any cause, life‐saving cardiovascular intervention, or unplanned hospital admission for worsening heart failure, the results of time to life‐saving cardiovascular intervention were not reported separately. Regarding non‐serious adverse events, although <a href="./references#CD012889-bbs2-0004" title="FietzeI , BlauA , GlosM , TheresH , BaumannG , PenzelT . Bi-level positive pressure ventilation and adaptive servo ventilation in patients with heart failure and Cheyne-Stokes respiration. Sleep Medicine2008;9:652-9. [DOI: 10.1016/j.sleep.2007.09.008]">Fietze 2008</a> and <a href="./references#CD012889-bbs2-0009" title="NaughtonMT , LiuPP , BernardDC , GoldsteinRS , BradleyTD . Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. American Journal of Respiratory and Critical Care Medicine1995;151(1):92-7. [DOI: 10.1164/ajrccm.151.1.7812579]NaughtonMT , LuiPP , BenardDC , GoldsteinRS , BradleyTD . A randomized controlled clinical trial of CPAP in patients with heart failure and Cheyne-Stokes respiration. American Review of Respiratory Disease1993;147(7):A687. ">Naughton 1995a</a> mention that they did not detect any adverse events of treatment, they did not provide the data for the control group. Only one study evaluated the effects of ASV plus best supportive care versus best supportive care alone in 10 consecutive acute heart failure with preserved ejection fraction (HFpEF) (left ventricle ejection fraction (LVEF) ≥ 45%) patients with CSA (<a href="./references#CD012889-bbs2-0002" title="D'eliaE , FerreroP , VittoriC , BaioP , DuinoV , GrosuA , et al. Enhanced adaptive servo-ventilation improves echocardiographic parameters of diastolic and right ventricle function in patients with sleep apnea and heart failure with preserved ejection fraction. European Journal of Heart Failure2016;18:474. D’EliaE , FerreroP , VittoriC , IacovoniA , GrosuA , GoriM , et al. Beneficial effects of adaptive servo-ventilation on natriuretic peptides and diastolic function in acute heart failure patients with preserved ejection fraction and sleep-disordered breathing. Sleep and Breathing2019;23:287-91. [DOI: 10.1007/s11325-018-1681-z]">D'Elia 2019</a>). The authors reported that no adverse events were recorded in either group. No studies evaluated quality of sleep. </p> </section> </section> <section id="CD012889-sec-0050"> <h4 class="title">Excluded studies</h4> <p>We excluded 21 full‐text articles; the reasons for their exclusion are described in the <a href="./references#CD012889-sec-0174" title="">Characteristics of excluded studies</a> table. Six studies did not have an RCT design (<a href="./references#CD012889-bbs2-0016" title="ArztM , SchulzM , WenselR , MontalvanS , BlumbergFC , RieggerGA , et al. Nocturnal continuous positive airway pressure improves ventilatory efficiency during exercise in patients with chronic heart failure. Chest2005;127(3):794-802. [DOI: 10.1378/chest.127.3.794]">Arzt 2005</a>; <a href="./references#CD012889-bbs2-0020" title="HetlandA , HaugaaK , VistnesM , LilandKH , OlsengM , JacobsenMB , et al. Adaptive servo-ventilation decreased mortality and admission rates in heart failure patients with Cheyne-Stokes respiration in a 18 months prospective study. Journal of the American College of Cardiology2014;63(12 Suppl 1):A757. HetlandA , HaugaaKH , VistnesM , LilandKH , OlsengM , JacobsenMB , et al. A retrospective analysis of cardiovascular outcomes in patients treated with ASV. Scandinavian Cardiovascular Journal2017;51(2):106-13. [DOI: 10.1080/14017431.2016.1262546]">Hetland 2014</a>; <a href="./references#CD012889-bbs2-0021" title="HetlandA , LerumTV , HaugaaKH , EdvardsenT . Patients with Cheyne Stokes respiration and heart failure: patient tolerance after three-month discontinuation of treatment with adaptive servo-ventilation. Heart and Vessels2017;32(8):909-15. [DOI: 10.1007/s00380-017-0951-1]">Hetland 2017</a>; <a href="./references#CD012889-bbs2-0022" title="HetzeneckerA , RothT , BirnerC , MaierLS , PfeiferM , ArztM . Adaptive servo-ventilation therapy of central sleep apnoea and its effect on sleep quality. Clinical Research in Cardiology2016;105(3):189-95. [DOI: 10.1007/s00392-015-0904-6]">Hetzenecker 2016</a>; <a href="./references#CD012889-bbs2-0028" title="KrachmanSL , CrocettiJ , BergerTJ , ChatilaW , EisenHJ , D'AlonzoGE . Effects of nasal continuous positive airway pressure on oxygen body stores in patients with Cheyne-Stokes respiration and congestive heart failure. Chest2003;123(1):59-66. [DOI: 10.1378/chest.123.1.59]">Krachman 2003</a>; <a href="./references#CD012889-bbs2-0032" title="PriefertHJ , HetzeneckerA , EscourrouP , LuigartR , SeriesF , LewisK , et al. Effects of adaptive servo-ventilation on ventricular arrhythmias in patients with stable chronic heart failure and sleep-disordered breathing: subanalysis of a randomized controlled trial. Somnologie2016;20(2):96-105. [DOI: 10.1007/s11818-016-0072-6]Priefert H-J, HetzeneckerA , EscourrouP , LuigartR , SeriesF , LewisK , et al. Effects of adaptive servoventilation on ventricular arrhythmias in patients with stable congestive heart failure and sleep-disordered breathing: subanalysis of a randomized controlled trial. Somnologie2017;Suppl 1(21):S19–27. [DOI: 10.1007/s11818-016-0072-6]">Priefert 2017</a>); two studies included people with co‐existing OSA and CSA/Cheyne‐Stokes respiration and did not separate data for predominantly CSA patients (<a href="./references#CD012889-bbs2-0025" title="KasaiT , UsuiY , YoshiokaT , YanagisawaN , TakataY , NaruiK , et al. Effect of flow-triggered adaptive servo-ventilation compared with continuous positive airway pressure in patients with chronic heart failure with coexisting obstructive sleep apnea and Cheyne-Stokes respiration. Circulation: Heart Failure2010;3(1):140-8. [DOI: 10.1161/CIRCHEARTFAILURE.109.868786]">Kasai 2010</a>; <a href="./references#CD012889-bbs2-0033" title="RanderathW , GaletkeW , StiegliitzS , PriegnitzC , SchaferT . Adaptive servoventilation in coexisting obstructive sleep apnoea/hypopnoea and Cheyne-Stokes respiration [Abstract]. In: European Respiratory Society 18th Annual Congress; 2008 Oct 3-7; Berlin. 2008. RanderathW , NothoferG , AnduleitN , TremiM , SchaferT , GaletkeW . Longterm efficacy of adaptive servo-ventilation (ASV) in patients with co-existing obstructive sleep apnea (OSAS) and Cheyne-stokes respiration (CSR). A randomized CPAP-controlled trial [Abstract]. In: European Respiratory Society 19th Annual Congress; 2009 Sep 12-15; Vienna. 2009:[359]. RanderathW , NothoferG , AnduleitN , TremlM , PriegnitzC , GaletkeW . Effect of auto servo-ventilation (ASV) and continuous positive airway pressure (CPAP) on B-type natriuretic peptide (NT-proBNP) in patients with co-existing obstructive (OSA) and central sleep apnea (CSA) in heart failure (HF). In: European Respiratory Society Annual Congress; 2011 Sep 24-28; Amsterdam. 2011 . [299s [P1744]]RanderathW , NothoferG , AnduleitN , TremlM , PriegnitzC , GaletkeW . Efficacy of auto servo-ventilation (ASV) in patients with co-existing obstructive sleep apnea (OSAS) and Cheyne-Stokes respiration (CSR). A randomized CPAP-controlled trial [Abstract]. In: European Respiratory Society 20th Annual Congress; 2010 Sep 18-22; Barcelona. 2010:[P924]. RanderathWJ , GaletkeW , DomanskiU , GillissenA , RuhleKH . Efficacy of adaptive servo-ventilation versus constant positive airways pressure therapy in patients with heart failure and Cheyne-Stokes respiration [Abstract]. In: American Thoracic Society 100th International Conference; 2004 May 21-26; Orlando. 2004:B87. RanderathWJ , NothoferG , PriegnitzC , AnduleitN , TremlM , KehlV , et al. Long-term auto-servoventilation or constant positive pressure in heart failure and coexisting central with obstructive sleep apnea. Chest2012;142(2):440-7. [DOI: 10.1378/chest.11-2089]">Randerath 2012</a>); and 13 studies were cross‐over studies (<a href="./references#CD012889-bbs2-0017" title="CampbellA , FerrierK , NeillA . Oxygen versus adaptive pressure support servoventilation (Autoset CS) in patients with central sleep apnoea-Cheyne Stokes respiration (CSA-CSR) and congestive heart failure (CHF). Internal Medicine Journal2005;35:A43. CampbellAJ , FerrierK , NeillAM . Effect of oxygen versus adaptive pressure support servo-ventilation in patients with central sleep apnoea-Cheyne Stokes respiration and congestive heart failure. Internal Medicine Journal2012;42(10):1130-6. [DOI: 10.1111/j.1445-5994.2011.02623.x]">Campbell 2012</a>; <a href="./references#CD012889-bbs2-0018" title="CaoM , KushidaC , CardellC , WillesL , MendozaJ , BenjaieldA . A novel adaptive servo ventilation (ASVAuto) for the treatment of central sleep apnea associated with chronic use of opioids. Sleep2014;37:A143. [DOI: 10.5664/jcsm.3954]">Cao 2014</a>; <a href="./references#CD012889-bbs2-0019" title="GaletkeW , AnduleitN , FunkeN , KuhnelJ , RichterK , StieglitzS . Continuous positive airway pressure versus adaptive servoventilation in patients with combined obstructive sleep apnea and Cheyne-Stokes respiration. American Thoracic Society International Conference2009;179:A5339. GaletkeW , GhassemiBM , PriegnitzC , StieglitzS , AnduleitN , RichterK , et al. Anticyclic modulated ventilation versus continuous positive airway pressure in patients with coexisting obstructive sleep apnea and Cheyne-Stokes respiration: a randomized crossover trial. Sleep Medicine2014;15(8):874-9. [DOI: 10.1016/j.sleep.2014.02.012]GaletkeW , KietzmannI , RichterK , RanderathW . Continuous positive airway pressure versus adaptive servoventilation in patients with obstructive sleep apnea and Cheyne-stokes respiration - a randomized cross-over trial. In: European Respiratory Society 19th Annual Congress; 2009 Sep 12-15; Vienna. 2009:[362]. ">Galetke 2014</a>; <a href="./references#CD012889-bbs2-0023" title="HuK , YangJ , ChenXQ , YuCP , ZhaoJL . Comparison of oxygen therapy with nasal continuous positive airway pressure on Cheyne-Stokes respiration in patients with chronic congestive heart failure. Chinese Journal of Internal Medicine2005;44(10):759-63. ">Hu 2005</a>; <a href="./references#CD012889-bbs2-0024" title="JavaheriS , GoettingMG , GoodwinJL , WylieP , KhayatR . Auto servo ventilation successfully treats complex central sleep apnea (CompCSA) and Hunter-Cheyne-Stokes breathing (HCSB). Sleep2010;33(Suppl):A146-7. JavaheriS , GoettingMG , KhayatR , WyliePE , GoodwinJL , ParthasarathyS . The performance of two automatic servo-ventilation devices in the treatment of central sleep apnea. Sleep2011;34(12):1693-8. [DOI: 10.5665/sleep.1438]JavaheriS , KhayatR , GoodwinJ , WylieP , GoettingM . Complex central sleep apnea (compcsa) treatment with auto servo ventilation. Chest2009;136(4):43S-f. [DOI: 10.1378/chest.136.4_MeetingAbstracts.43S-f]">Javaheri 2011</a>; <a href="./references#CD012889-bbs2-0026" title="KohnleinT , WelteT , TanLB , ElliottMW . Assisted ventilation for heart failure patients with Cheyne-Stokes respiration. European Respiratory Journal2002;20 C(4):934-41. [DOI: 10.1183/09031936.00.02622001]KohnleinT , WelteT , TanLB , ElliottMW . Treatment of central sleep apnea in patients with chronic heart failure with CPAP or bilevel ventilation. American Journal of Respiratory and Critical Care Medicine2002;165 C(Suppl 8):A247. ">Kohnlein 2002</a>; <a href="./references#CD012889-bbs2-0027" title="KrachmanSL , D'AlonzoGE , BergerTJ , EisenHJ . Comparison of oxygen therapy with nasal continuous positive airway pressure on Cheyne-Stokes respiration during sleep in congestive heart failure. Chest1999;116 C(6):1550-7. [DOI: 10.1378/chest.116.6.1550]">Krachman 1999</a>; <a href="./references#CD012889-bbs2-0029" title="LiuJ , LuZ , ZhuX , ZhangD , SunM , ZhangX , et al. Beneficial effect of bilevel positive airway pressure on Cheyne-Stokes respiration in patients with congestive heart failure. Sleep Medicine2015;16:S190. ">Liu 2015</a>; <a href="./references#CD012889-bbs2-0030" title="GayPC , MorgenthalerTI , BrownLK , FedorovichCL . A multi-center randomized trial of adaptive servo-ventilation (ASV) vs bilevel nasal positive pressure ventilation (NPPV) treatment for central apnea/Cheyne-Stokes respiration (CSA/CSR) and complex sleep apnea syndromes (CompSAS) [Abstract]. In: American Thoracic Society International Conference; 2006 May 19-21; San Diego. 2006. MorgenthalerTI , GayPC , GordonN , BrownLK . Adaptive servoventilation versus noninvasive positive pressure ventilation for central, mixed, and complex sleep apnea syndromes. Sleep2007;30(4):468-75. [DOI: 10.1093/sleep/30.4.468]">Morgenthaler 2007</a>; <a href="./references#CD012889-bbs2-0031" title="OldenburgO , BitterT , PribN , LohseM , KoerberB , FischbachT , et al. Performance of adaptive servoventilation and enhanced adaptive servoventilation in heart failure patients with central sleep apnea. Sleep2012;35 C:A176. OldenburgO , SpiesshoferJ , FoxH , PribN , HorstkotteD . Performance of conventional and enhanced adaptive servoventilation (ASV) in heart failure patients with central sleep apnea who have adapted to conventional ASV. Sleep and Breathing2015;19(3):795-800. [DOI: 10.1007/s11325-014-1083-9]">Oldenburg 2015</a>; <a href="./references#CD012889-bbs2-0034" title="PegramV , WyliePE , RosenbergR , HolleR , ShapiroCM , ChungSA , et al. Servo ventilation versus CPAP therapy in chronic pain patients with sleep disordered breathing. Sleep2013;36 C:A150. ShapiroCM , ChungSA , WyliePE , HossainNK , HolleRH , RosenbergRP , et al. Home-use servo-ventilation therapy in chronic pain patients with central sleep apnea: initial and 3-month follow-up. Schlaf und Atmung [Sleep and Breathing]2015;19 C(4):1285-92. [DOI: 10.1007/s11325-015-1161-7]WyliePE , PegramV , RosenbergR , HolleR , ShapiroCM , HossainNK , et al. Home-use servo ventilation therapy in chronic pain patients with sleep disordered breathing. Sleep2013;36 C:A149. ">Shapiro 2015</a>; <a href="./references#CD012889-bbs2-0035" title="SzollosiI , O'DriscollDM , DayerMJ , CoatsAJ , MorrellMJ , SimondsAK . Adaptive servo-ventilation and deadspace: effects on central sleep apnoea. Journal of Sleep Research2006;15(2):199-205. [DOI: 10.1111/j.1365-2869.2006.00515.x]">Szollosi 2006</a>; <a href="./references#CD012889-bbs2-0036" title="TeschlerH , DohringJ , WangYM , Berthon-JonesM . Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. American Journal of Respiratory and Critical Care Medicine2001;164 C(4):614-9. [DOI: 10.1164/ajrccm.164.4.9908114]">Teschler 2001</a>). </p> </section> </section> <section id="CD012889-sec-0051"> <h3 class="title">Risk of bias in included studies</h3> <p>Our risk of bias evaluations for each included study are presented in the risk of bias tables in <a href="./references#CD012889-sec-0173" title="">Characteristics of included studies</a>. Review authors' judgements on each risk of bias domain of the included studies are presented in <a href="#CD012889-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD012889-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012889-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/image_n/nCD012889-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD012889-sec-0052"> <h4 class="title">Allocation</h4> <p>Only two studies described their randomisation sequence generation methods (<a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a>; <a href="./references#CD012889-bbs2-0013" title="CowieM , WoehrleH , WegscheiderK , AngermannC , D'OrthoMP , ErdmannE , et al. Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results. European Respiratory Journal2015;46:OA3475. [DOI: 10.1183/13993003.congress-2015.OA3475]CowieMR , WoehrleH , WegscheiderK , AngermannC , D'Ortho M-P, ErdmannE , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. New England Journal of Medicine2015;373(12):1095-105. [DOI: 10.1056/NEJMoa1506459]CowieMR , WoehrleH , WegscheiderK , VettorazziE , LeziusS , KoenigW , et al. Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF. European Journal of Heart Failure2018;20:536-44. [DOI: 10.1002/ejhf.1048]EulenburgC , WegscheiderK , WoehrleH , AngermannC , D'Ortho M-P, ErdmannE , et al. Understanding SERVE-HF: a multistate analysis to explain mechanisms underlying increased mortality risk in patients randomised to adaptive servo-ventilation (ASV). European Respiratory Journal2016;48:OA1985. [DOI: 10.1183/13993003.congress-2016.OA1985]TamisierR , PepinJL , CowieM , WegscheiderK , VettorazziE , SulingA , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure: PSG data from the SERVE-HF major substudy. American Journal of Respiratory and Critical Care Medicine2017;195:A4513. [DOI: 10.1164/ajrccm-conference.2017.B80-G]TamisierR , Pepin J-L, SalvatM , WoehrleH , Barone-RochetteG , RoccaC , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure does not improve muscle sympathetic nerve activity: a SERVE-HF substudy. European Respiratory Journal2016;48:PA2083. [DOI: 10.1183/13993003.congress-2016.PA2083]">SERVE HF 2015</a>); we assessed the remaining studies as at unclear risk of bias for this domain. Only two studies clearly described their methods of concealing the allocation (<a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a>; <a href="./references#CD012889-bbs2-0011" title="PepperellJCT , MaskellNA , JonesDR , Langford-WileyBA , CrosthwaiteN , StradlingJR , et al. A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. American Journal of Respiratory and Critical Care Medicine2003;168(9):1109-14. [DOI: 10.1164/rccm.200212-1476OC]">Pepperell 2003</a>); we assessed the remaining studies as at unclear risk of bias for allocation concealment. </p> </section> <section id="CD012889-sec-0053"> <h4 class="title">Blinding</h4> <p>In nine studies, participants and treating physicians were not blinded (<a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a>; <a href="./references#CD012889-bbs2-0002" title="D'eliaE , FerreroP , VittoriC , BaioP , DuinoV , GrosuA , et al. Enhanced adaptive servo-ventilation improves echocardiographic parameters of diastolic and right ventricle function in patients with sleep apnea and heart failure with preserved ejection fraction. European Journal of Heart Failure2016;18:474. D’EliaE , FerreroP , VittoriC , IacovoniA , GrosuA , GoriM , et al. Beneficial effects of adaptive servo-ventilation on natriuretic peptides and diastolic function in acute heart failure patients with preserved ejection fraction and sleep-disordered breathing. Sleep and Breathing2019;23:287-91. [DOI: 10.1007/s11325-018-1681-z]">D'Elia 2019</a>; <a href="./references#CD012889-bbs2-0006" title="HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three months treatment with adaptive servo-ventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration in a prospective randomized controlled trial. Circulation2011;124(21 Suppl):A11007. [DOI: 10.1161/circ.124.suppl_21.A11007]HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three-month treatment with adaptive servoventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration: a prospective randomized controlled trial. Cardiology2013;126(C(2)):81-90. [DOI: 10.1159/000350826]OlsengMW , OlsenBF , HetlandA , FagermoenS , JacobsenM . Quality of life improves in patients with chronic heart failure and Cheyne-Stokes respiration treated with adaptive servo-ventilation in a nurse-led heart failure clinic. Journal of Clinical Nursing2017;26(9-10):1226-33. [DOI: 10.1111/jocn.13416]">Hetland 2013</a>; <a href="./references#CD012889-bbs2-0007" title="KasaiT , KasagiS , Maeno K-I, DohiT , KawanaF , KatoM , et al. Adaptive servo-ventilation in cardiac function and neurohormonal status in patients with heart failure and central sleep apnea nonresponsive to continuous positive airway pressure. JACC: Heart Failure2013;1(1):58-63. [DOI: 10.1016/j.jchf.2012.11.002]">Kasai 2013</a>; <a href="./references#CD012889-bbs2-0008" title="MorgenthalerTI , KuzniarTJ , WolfeLF , WillesL , McLainWC , GoldbergR . The Complex Sleep Apnea Resolution Study: a prospective randomized controlled trial of continuous positive airway pressure versus adaptive servoventilation therapy. Sleep2014;37(5):927-34. [DOI: 10.5665/sleep.3662]">Morgenthaler 2014</a>; <a href="./references#CD012889-bbs2-0009" title="NaughtonMT , LiuPP , BernardDC , GoldsteinRS , BradleyTD . Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. American Journal of Respiratory and Critical Care Medicine1995;151(1):92-7. [DOI: 10.1164/ajrccm.151.1.7812579]NaughtonMT , LuiPP , BenardDC , GoldsteinRS , BradleyTD . A randomized controlled clinical trial of CPAP in patients with heart failure and Cheyne-Stokes respiration. American Review of Respiratory Disease1993;147(7):A687. ">Naughton 1995a</a>; <a href="./references#CD012889-bbs2-0010" title="NaughtonMT , BenardDC , LiuPP , RutherfordR , RankinF , BradleyTD . Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. American Journal of Respiratory and Critical Care Medicine1995;152(2):473-9. [DOI: 10.1164/ajrccm.152.2.7633695]">Naughton 1995b</a>; <a href="./references#CD012889-bbs2-0012" title="PhilippeC , Stoica-HermanM , DrouotX , RaffestinB , EscourrouP , HittingerL , et al. Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart2006;92(3):337-42. [DOI: 10.1136/hrt.2005.060038]">Philippe 2006</a>; <a href="./references#CD012889-bbs2-0013" title="CowieM , WoehrleH , WegscheiderK , AngermannC , D'OrthoMP , ErdmannE , et al. Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results. European Respiratory Journal2015;46:OA3475. [DOI: 10.1183/13993003.congress-2015.OA3475]CowieMR , WoehrleH , WegscheiderK , AngermannC , D'Ortho M-P, ErdmannE , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. New England Journal of Medicine2015;373(12):1095-105. [DOI: 10.1056/NEJMoa1506459]CowieMR , WoehrleH , WegscheiderK , VettorazziE , LeziusS , KoenigW , et al. Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF. European Journal of Heart Failure2018;20:536-44. [DOI: 10.1002/ejhf.1048]EulenburgC , WegscheiderK , WoehrleH , AngermannC , D'Ortho M-P, ErdmannE , et al. Understanding SERVE-HF: a multistate analysis to explain mechanisms underlying increased mortality risk in patients randomised to adaptive servo-ventilation (ASV). European Respiratory Journal2016;48:OA1985. [DOI: 10.1183/13993003.congress-2016.OA1985]TamisierR , PepinJL , CowieM , WegscheiderK , VettorazziE , SulingA , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure: PSG data from the SERVE-HF major substudy. American Journal of Respiratory and Critical Care Medicine2017;195:A4513. [DOI: 10.1164/ajrccm-conference.2017.B80-G]TamisierR , Pepin J-L, SalvatM , WoehrleH , Barone-RochetteG , RoccaC , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure does not improve muscle sympathetic nerve activity: a SERVE-HF substudy. European Respiratory Journal2016;48:PA2083. [DOI: 10.1183/13993003.congress-2016.PA2083]">SERVE HF 2015</a>); we assessed these studies as at high risk of performance bias. We assessed the remaining studies as at low risk of performance bias. </p> <p>For detection bias, we judged subjective or self‐reported outcomes separately from other outcomes. Only nine trials evaluated subjective outcomes (<a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a>; <a href="./references#CD012889-bbs2-0002" title="D'eliaE , FerreroP , VittoriC , BaioP , DuinoV , GrosuA , et al. Enhanced adaptive servo-ventilation improves echocardiographic parameters of diastolic and right ventricle function in patients with sleep apnea and heart failure with preserved ejection fraction. European Journal of Heart Failure2016;18:474. D’EliaE , FerreroP , VittoriC , IacovoniA , GrosuA , GoriM , et al. Beneficial effects of adaptive servo-ventilation on natriuretic peptides and diastolic function in acute heart failure patients with preserved ejection fraction and sleep-disordered breathing. Sleep and Breathing2019;23:287-91. [DOI: 10.1007/s11325-018-1681-z]">D'Elia 2019</a>; <a href="./references#CD012889-bbs2-0006" title="HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three months treatment with adaptive servo-ventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration in a prospective randomized controlled trial. Circulation2011;124(21 Suppl):A11007. [DOI: 10.1161/circ.124.suppl_21.A11007]HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three-month treatment with adaptive servoventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration: a prospective randomized controlled trial. Cardiology2013;126(C(2)):81-90. [DOI: 10.1159/000350826]OlsengMW , OlsenBF , HetlandA , FagermoenS , JacobsenM . Quality of life improves in patients with chronic heart failure and Cheyne-Stokes respiration treated with adaptive servo-ventilation in a nurse-led heart failure clinic. Journal of Clinical Nursing2017;26(9-10):1226-33. [DOI: 10.1111/jocn.13416]">Hetland 2013</a>; <a href="./references#CD012889-bbs2-0007" title="KasaiT , KasagiS , Maeno K-I, DohiT , KawanaF , KatoM , et al. Adaptive servo-ventilation in cardiac function and neurohormonal status in patients with heart failure and central sleep apnea nonresponsive to continuous positive airway pressure. JACC: Heart Failure2013;1(1):58-63. [DOI: 10.1016/j.jchf.2012.11.002]">Kasai 2013</a>; <a href="./references#CD012889-bbs2-0008" title="MorgenthalerTI , KuzniarTJ , WolfeLF , WillesL , McLainWC , GoldbergR . The Complex Sleep Apnea Resolution Study: a prospective randomized controlled trial of continuous positive airway pressure versus adaptive servoventilation therapy. Sleep2014;37(5):927-34. [DOI: 10.5665/sleep.3662]">Morgenthaler 2014</a>; <a href="./references#CD012889-bbs2-0009" title="NaughtonMT , LiuPP , BernardDC , GoldsteinRS , BradleyTD . Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. American Journal of Respiratory and Critical Care Medicine1995;151(1):92-7. [DOI: 10.1164/ajrccm.151.1.7812579]NaughtonMT , LuiPP , BenardDC , GoldsteinRS , BradleyTD . A randomized controlled clinical trial of CPAP in patients with heart failure and Cheyne-Stokes respiration. American Review of Respiratory Disease1993;147(7):A687. ">Naughton 1995a</a>; <a href="./references#CD012889-bbs2-0011" title="PepperellJCT , MaskellNA , JonesDR , Langford-WileyBA , CrosthwaiteN , StradlingJR , et al. A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. American Journal of Respiratory and Critical Care Medicine2003;168(9):1109-14. [DOI: 10.1164/rccm.200212-1476OC]">Pepperell 2003</a>; <a href="./references#CD012889-bbs2-0012" title="PhilippeC , Stoica-HermanM , DrouotX , RaffestinB , EscourrouP , HittingerL , et al. Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart2006;92(3):337-42. [DOI: 10.1136/hrt.2005.060038]">Philippe 2006</a>; <a href="./references#CD012889-bbs2-0013" title="CowieM , WoehrleH , WegscheiderK , AngermannC , D'OrthoMP , ErdmannE , et al. Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results. European Respiratory Journal2015;46:OA3475. [DOI: 10.1183/13993003.congress-2015.OA3475]CowieMR , WoehrleH , WegscheiderK , AngermannC , D'Ortho M-P, ErdmannE , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. New England Journal of Medicine2015;373(12):1095-105. [DOI: 10.1056/NEJMoa1506459]CowieMR , WoehrleH , WegscheiderK , VettorazziE , LeziusS , KoenigW , et al. Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF. European Journal of Heart Failure2018;20:536-44. [DOI: 10.1002/ejhf.1048]EulenburgC , WegscheiderK , WoehrleH , AngermannC , D'Ortho M-P, ErdmannE , et al. Understanding SERVE-HF: a multistate analysis to explain mechanisms underlying increased mortality risk in patients randomised to adaptive servo-ventilation (ASV). European Respiratory Journal2016;48:OA1985. [DOI: 10.1183/13993003.congress-2016.OA1985]TamisierR , PepinJL , CowieM , WegscheiderK , VettorazziE , SulingA , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure: PSG data from the SERVE-HF major substudy. American Journal of Respiratory and Critical Care Medicine2017;195:A4513. [DOI: 10.1164/ajrccm-conference.2017.B80-G]TamisierR , Pepin J-L, SalvatM , WoehrleH , Barone-RochetteG , RoccaC , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure does not improve muscle sympathetic nerve activity: a SERVE-HF substudy. European Respiratory Journal2016;48:PA2083. [DOI: 10.1183/13993003.congress-2016.PA2083]">SERVE HF 2015</a>); we assessed all of these trials as having a high risk of bias because blinding was not performed, and the lack of blinding was likely to influence the outcome results. </p> <p>Regarding other outcomes, one study did not have blind outcome assessors, and we considered the lack of blinding likely to influence the results (<a href="./references#CD012889-bbs2-0003" title="DellwegD , KerlJ , HoehnE , WenzelM , KoehlerD . Randomized controlled trial of noninvasive positive pressure ventilation (NPPV) versus servoventilation in patients with CPAP-induced central sleep apnea (complex sleep apnea). Sleep2013;36(8):1163-71. [DOI: 10.5665/sleep.2878]">Dellweg 2013</a>). Four trials provided insufficient information to permit a judgement of whether outcome assessors were blind; we therefore assessed these studies as at unclear risk of detection bias (<a href="./references#CD012889-bbs2-0004" title="FietzeI , BlauA , GlosM , TheresH , BaumannG , PenzelT . Bi-level positive pressure ventilation and adaptive servo ventilation in patients with heart failure and Cheyne-Stokes respiration. Sleep Medicine2008;9:652-9. [DOI: 10.1016/j.sleep.2007.09.008]">Fietze 2008</a>; <a href="./references#CD012889-bbs2-0005" title="GrantonJT , NaughtonMT , BenardDC , LiuPP , GoldsteinRS , BradleyTD . CPAP improves inspiratory muscle strength in patients with heart failure and central sleep apnea. American Journal of Respiratory and Critical Care Medicine1996;153(1):277-82. [DOI: 10.1164/ajrccm.153.1.8542129]">Granton 1996</a>; <a href="./references#CD012889-bbs2-0008" title="MorgenthalerTI , KuzniarTJ , WolfeLF , WillesL , McLainWC , GoldbergR . The Complex Sleep Apnea Resolution Study: a prospective randomized controlled trial of continuous positive airway pressure versus adaptive servoventilation therapy. Sleep2014;37(5):927-34. [DOI: 10.5665/sleep.3662]">Morgenthaler 2014</a>; <a href="./references#CD012889-bbs2-0015" title="ToyamaT , HoshizakiH , KasamaS , MiyaishiY , KanH , YamashitaE , et al. Adaptive servo-ventilation therapy improves cardiac sympathetic nerve activity, cardiac function, exercise capacity, and symptom in patients with chronic heart failure and Cheyne-Stokes respiration. Journal of Nuclear Cardiology2016;24(6):1-12. [DOI: 10.1007/s12350-016-0529-9]">Toyama 2016</a>). In all other trials, the outcome assessors were blind, and the trials were judged as having a low risk of bias. </p> </section> <section id="CD012889-sec-0054"> <h4 class="title">Incomplete outcome data</h4> <p>In six trials (<a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a>; <a href="./references#CD012889-bbs2-0003" title="DellwegD , KerlJ , HoehnE , WenzelM , KoehlerD . Randomized controlled trial of noninvasive positive pressure ventilation (NPPV) versus servoventilation in patients with CPAP-induced central sleep apnea (complex sleep apnea). Sleep2013;36(8):1163-71. [DOI: 10.5665/sleep.2878]">Dellweg 2013</a>; <a href="./references#CD012889-bbs2-0006" title="HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three months treatment with adaptive servo-ventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration in a prospective randomized controlled trial. Circulation2011;124(21 Suppl):A11007. [DOI: 10.1161/circ.124.suppl_21.A11007]HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three-month treatment with adaptive servoventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration: a prospective randomized controlled trial. Cardiology2013;126(C(2)):81-90. [DOI: 10.1159/000350826]OlsengMW , OlsenBF , HetlandA , FagermoenS , JacobsenM . Quality of life improves in patients with chronic heart failure and Cheyne-Stokes respiration treated with adaptive servo-ventilation in a nurse-led heart failure clinic. Journal of Clinical Nursing2017;26(9-10):1226-33. [DOI: 10.1111/jocn.13416]">Hetland 2013</a>; <a href="./references#CD012889-bbs2-0009" title="NaughtonMT , LiuPP , BernardDC , GoldsteinRS , BradleyTD . Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. American Journal of Respiratory and Critical Care Medicine1995;151(1):92-7. [DOI: 10.1164/ajrccm.151.1.7812579]NaughtonMT , LuiPP , BenardDC , GoldsteinRS , BradleyTD . A randomized controlled clinical trial of CPAP in patients with heart failure and Cheyne-Stokes respiration. American Review of Respiratory Disease1993;147(7):A687. ">Naughton 1995a</a>; <a href="./references#CD012889-bbs2-0012" title="PhilippeC , Stoica-HermanM , DrouotX , RaffestinB , EscourrouP , HittingerL , et al. Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart2006;92(3):337-42. [DOI: 10.1136/hrt.2005.060038]">Philippe 2006</a>; <a href="./references#CD012889-bbs2-0013" title="CowieM , WoehrleH , WegscheiderK , AngermannC , D'OrthoMP , ErdmannE , et al. Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results. European Respiratory Journal2015;46:OA3475. [DOI: 10.1183/13993003.congress-2015.OA3475]CowieMR , WoehrleH , WegscheiderK , AngermannC , D'Ortho M-P, ErdmannE , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. New England Journal of Medicine2015;373(12):1095-105. [DOI: 10.1056/NEJMoa1506459]CowieMR , WoehrleH , WegscheiderK , VettorazziE , LeziusS , KoenigW , et al. Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF. European Journal of Heart Failure2018;20:536-44. [DOI: 10.1002/ejhf.1048]EulenburgC , WegscheiderK , WoehrleH , AngermannC , D'Ortho M-P, ErdmannE , et al. Understanding SERVE-HF: a multistate analysis to explain mechanisms underlying increased mortality risk in patients randomised to adaptive servo-ventilation (ASV). European Respiratory Journal2016;48:OA1985. [DOI: 10.1183/13993003.congress-2016.OA1985]TamisierR , PepinJL , CowieM , WegscheiderK , VettorazziE , SulingA , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure: PSG data from the SERVE-HF major substudy. American Journal of Respiratory and Critical Care Medicine2017;195:A4513. [DOI: 10.1164/ajrccm-conference.2017.B80-G]TamisierR , Pepin J-L, SalvatM , WoehrleH , Barone-RochetteG , RoccaC , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure does not improve muscle sympathetic nerve activity: a SERVE-HF substudy. European Respiratory Journal2016;48:PA2083. [DOI: 10.1183/13993003.congress-2016.PA2083]">SERVE HF 2015</a>), there were important losses of participants during follow‐up; we assessed these trials as at high risk of attrition bias. Three studies provided insufficient information to permit a judgement of whether there were important losses, so these studies were classified as having an unclear risk of bias (<a href="./references#CD012889-bbs2-0002" title="D'eliaE , FerreroP , VittoriC , BaioP , DuinoV , GrosuA , et al. Enhanced adaptive servo-ventilation improves echocardiographic parameters of diastolic and right ventricle function in patients with sleep apnea and heart failure with preserved ejection fraction. European Journal of Heart Failure2016;18:474. D’EliaE , FerreroP , VittoriC , IacovoniA , GrosuA , GoriM , et al. Beneficial effects of adaptive servo-ventilation on natriuretic peptides and diastolic function in acute heart failure patients with preserved ejection fraction and sleep-disordered breathing. Sleep and Breathing2019;23:287-91. [DOI: 10.1007/s11325-018-1681-z]">D'Elia 2019</a>; <a href="./references#CD012889-bbs2-0004" title="FietzeI , BlauA , GlosM , TheresH , BaumannG , PenzelT . Bi-level positive pressure ventilation and adaptive servo ventilation in patients with heart failure and Cheyne-Stokes respiration. Sleep Medicine2008;9:652-9. [DOI: 10.1016/j.sleep.2007.09.008]">Fietze 2008</a>; <a href="./references#CD012889-bbs2-0005" title="GrantonJT , NaughtonMT , BenardDC , LiuPP , GoldsteinRS , BradleyTD . CPAP improves inspiratory muscle strength in patients with heart failure and central sleep apnea. American Journal of Respiratory and Critical Care Medicine1996;153(1):277-82. [DOI: 10.1164/ajrccm.153.1.8542129]">Granton 1996</a>). In the remaining trials, there were no large numbers of losses, and when there were losses, dropouts were reported, along with the reasons for the dropouts. We therefore assessed these trials as at low risk of bias. </p> </section> <section id="CD012889-sec-0055"> <h4 class="title">Selective reporting</h4> <p>One trial registered the protocol retrospectively (<a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a>), and one trial did not describe the results for all outcomes planned in the protocol (<a href="./references#CD012889-bbs2-0006" title="HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three months treatment with adaptive servo-ventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration in a prospective randomized controlled trial. Circulation2011;124(21 Suppl):A11007. [DOI: 10.1161/circ.124.suppl_21.A11007]HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three-month treatment with adaptive servoventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration: a prospective randomized controlled trial. Cardiology2013;126(C(2)):81-90. [DOI: 10.1159/000350826]OlsengMW , OlsenBF , HetlandA , FagermoenS , JacobsenM . Quality of life improves in patients with chronic heart failure and Cheyne-Stokes respiration treated with adaptive servo-ventilation in a nurse-led heart failure clinic. Journal of Clinical Nursing2017;26(9-10):1226-33. [DOI: 10.1111/jocn.13416]">Hetland 2013</a>); we assessed these trials as at high risk of reporting bias. Three trials reported all prespecified outcomes and were therefore assessed as at low risk of reporting bias (<a href="./references#CD012889-bbs2-0003" title="DellwegD , KerlJ , HoehnE , WenzelM , KoehlerD . Randomized controlled trial of noninvasive positive pressure ventilation (NPPV) versus servoventilation in patients with CPAP-induced central sleep apnea (complex sleep apnea). Sleep2013;36(8):1163-71. [DOI: 10.5665/sleep.2878]">Dellweg 2013</a>; <a href="./references#CD012889-bbs2-0008" title="MorgenthalerTI , KuzniarTJ , WolfeLF , WillesL , McLainWC , GoldbergR . The Complex Sleep Apnea Resolution Study: a prospective randomized controlled trial of continuous positive airway pressure versus adaptive servoventilation therapy. Sleep2014;37(5):927-34. [DOI: 10.5665/sleep.3662]">Morgenthaler 2014</a>; <a href="./references#CD012889-bbs2-0013" title="CowieM , WoehrleH , WegscheiderK , AngermannC , D'OrthoMP , ErdmannE , et al. Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results. European Respiratory Journal2015;46:OA3475. [DOI: 10.1183/13993003.congress-2015.OA3475]CowieMR , WoehrleH , WegscheiderK , AngermannC , D'Ortho M-P, ErdmannE , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. New England Journal of Medicine2015;373(12):1095-105. [DOI: 10.1056/NEJMoa1506459]CowieMR , WoehrleH , WegscheiderK , VettorazziE , LeziusS , KoenigW , et al. Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF. European Journal of Heart Failure2018;20:536-44. [DOI: 10.1002/ejhf.1048]EulenburgC , WegscheiderK , WoehrleH , AngermannC , D'Ortho M-P, ErdmannE , et al. Understanding SERVE-HF: a multistate analysis to explain mechanisms underlying increased mortality risk in patients randomised to adaptive servo-ventilation (ASV). European Respiratory Journal2016;48:OA1985. [DOI: 10.1183/13993003.congress-2016.OA1985]TamisierR , PepinJL , CowieM , WegscheiderK , VettorazziE , SulingA , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure: PSG data from the SERVE-HF major substudy. American Journal of Respiratory and Critical Care Medicine2017;195:A4513. [DOI: 10.1164/ajrccm-conference.2017.B80-G]TamisierR , Pepin J-L, SalvatM , WoehrleH , Barone-RochetteG , RoccaC , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure does not improve muscle sympathetic nerve activity: a SERVE-HF substudy. European Respiratory Journal2016;48:PA2083. [DOI: 10.1183/13993003.congress-2016.PA2083]">SERVE HF 2015</a>). The protocols were not available for the remaining 10 trials, therefore we assessed these studies as at unclear risk of bias. </p> </section> <section id="CD012889-sec-0056"> <h4 class="title">Other potential sources of bias</h4> <p>We noted no other potential sources of bias in any of the included studies, therefore we rated all studies as at low risk of other bias. </p> </section> </section> <section id="CD012889-sec-0057"> <h3 class="title" id="CD012889-sec-0057">Effects of interventions</h3> <p>See: <a href="./full#CD012889-tbl-0001"><b>Summary of findings 1</b> Continuous positive airway pressure (CPAP) plus best supportive care versus best supportive care for central sleep apnoea associated with chronic heart failure</a>; <a href="./full#CD012889-tbl-0002"><b>Summary of findings 2</b> Adaptive servo ventilation (ASV) versus continuous positive airway pressure (CPAP) for central sleep apnoea associated with chronic heart failure</a>; <a href="./full#CD012889-tbl-0003"><b>Summary of findings 3</b> Adaptive servo ventilation (ASV) versus bilevel ventilation for central sleep apnoea associated with chronic heart failure</a>; <a href="./full#CD012889-tbl-0004"><b>Summary of findings 4</b> Adaptive servo ventilation (ASV) versus continuous positive airway pressure (CPAP) for CPAP‐induced central sleep apnoea</a>; <a href="./full#CD012889-tbl-0005"><b>Summary of findings 5</b> Adaptive servo ventilation (ASV) versus bilevel ventilation for CPAP‐induced central sleep apnoea</a>; <a href="./full#CD012889-tbl-0006"><b>Summary of findings 6</b> Adaptive servo ventilation (ASV) plus best supportive care versus best supportive care alone or inactive control for central sleep apnoea associated with chronic heart failure</a> </p> <p>The results for the outcomes of interest for this review are reported below. We planned to perform subgroup analyses considering the severity of CSA, severity of chronic heart failure, and cause of CSA, using AHI and cardiovascular mortality outcomes. However, as few studies were meta‐analysed for these outcomes, and the studies were homogeneous regarding these characteristics, it was not possible to perform any of the planned subgroup analyses. </p> <section id="CD012889-sec-0058"> <h4 class="title">Continuous positive airway pressure versus inactive control (subtherapeutic positive pressure, no treatment, or usual care) </h4> <section id="CD012889-sec-0059"> <h5 class="title">CPAP plus best supportive care versus best supportive care alone (or inactive control) in CSA associated with chronic heart failure </h5> <section id="CD012889-sec-0060"> <h6 class="title">Primary outcomes</h6> <section id="CD012889-sec-0061"> <p><b>Central apnoea hypopnoea index ‐ Short term</b></p> <p>CPAP plus best supportive care may reduce cAHI (mean difference (MD) −14.60, 95% confidence interval (CI) −20.11 to −9.09; 1 study; 205 participants) (<a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a>). The certainty of evidence was low due to serious risk of bias and imprecision (<a href="./full#CD012889-tbl-0001">summary of findings Table 1</a>). </p> </section> <section id="CD012889-sec-0062"> <p><b>Cardiovascular mortality ‐ Long term</b></p> <p>In the long term, CPAP plus best supportive care may result in little to no difference in cardiovascular mortality compared to best supportive care alone (risk ratio (RR) 1.17, 95% CI 0.68 to 2.02; 1 study; 258 participants; low‐certainty evidence due to serious risk of bias and imprecision) (<a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a>). </p> </section> <section id="CD012889-sec-0063"> <p><b>Serious adverse events ‐ Short term</b></p> <p>The authors of <a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a> state in their trial that no serious adverse effects occurred in participants randomised to CPAP within one month of its initiation; however, results for the best supportive care study arm are not reported. </p> </section> </section> <section id="CD012889-sec-0064"> <h6 class="title">Secondary outcomes</h6> <section id="CD012889-sec-0065"> <p><b>Quality of sleep</b></p> <p>This outcome was not reported.</p> </section> <section id="CD012889-sec-0066"> <p><b>Quality of life</b></p> <p>This outcome was not reported.</p> </section> <section id="CD012889-sec-0067"> <p><b>Apnoea hypopnoea index ‐ Short term</b></p> <p>CPAP plus best supportive care may reduce AHI (MD −15.27, 95% CI −22.44 to −8.11; 4 studies; 264 participants; I<sup>2</sup> = 24%, favouring CPAP plus best supportive care; <a href="./references#CD012889-fig-0003" title="">Analysis 1.1</a>). As planned, we performed a sensitivity analysis to compare the results derived from a fixed‐effect model versus those obtained from a random‐effects model, and the results remained similar (MD −17.23, 95% CI −22.25 to −12.22; 4 studies; 264 participants; I<sup>2</sup> = 24%). We also performed a sensitivity analysis to compare the results derived from industry‐sponsored trials. We found different results between industry‐sponsored (MD −18.86, 95% CI −24.25 to −13.48; 2 studies; 229 participants; I<sup>2</sup> = 0%) and non‐industry‐sponsored trials (MD −6.56, 95% CI −20.34 to 7.22; 2 studies; 35 participants; I<sup>2</sup> =0%; <a href="./references#CD012889-fig-0003" title="">Analysis 1.1</a>). Whilst the results of industry‐sponsored trials show that CPAP plus best supportive care may reduce AHI, the results of non‐industry‐sponsored trials show that CPAP plus best supportive care may result in little to no difference in AHI in participants with CSA associated with chronic heart failure. </p> </section> <section id="CD012889-sec-0068"> <p><b>Apnoea hypopnoea index ‐ Long term</b></p> <p>In the long term, we found low‐certainty evidence (due to serious risk of bias and imprecision) that CPAP plus best supportive care may reduce AHI compared to best supportive care alone (MD −15.99, 95% CI −23.06 to −8.92; 1 study; 258 participants) (<a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a>). </p> </section> <section id="CD012889-sec-0069"> <p><b>All‐cause mortality ‐ Long term</b></p> <p>The evidence is very uncertain (due to serious risk of bias and very serious imprecision) about the effect of CPAP plus best supportive care on all‐cause mortality in the long term (RR 1.14, 95% CI 0.83 to 1.56; 2 studies; 287 participants; <a href="./references#CD012889-fig-0004" title="">Analysis 1.2</a>). </p> </section> <section id="CD012889-sec-0070"> <p><b>Time to life‐saving cardiovascular intervention</b></p> <p>In <a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a>, after six months there was an early divergence in the event rates that favoured the control group (hazard ratio (HR) for transplantation‐free survival, 1.5; P = 0.02) that was altered after 18 months to favour the CPAP group (HR for transplantation‐free survival, 0.66; P = 0.06). Due to the early divergence in the event rates, enrolment at only 50% of the predicted rate, and a falling rate of death and heart transplantation that precluded the ability to detect a difference in the primary outcome between the two groups, the data and safety monitoring committee recommended termination of the study. The executive committee therefore stopped the trial on 21 May 2004. </p> </section> <section id="CD012889-sec-0071"> <p><b>Adverse events/side effects</b></p> <p>Only one trial mentioned that no immediate or long‐term adverse effects of nasal CPAP were observed (<a href="./references#CD012889-bbs2-0009" title="NaughtonMT , LiuPP , BernardDC , GoldsteinRS , BradleyTD . Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. American Journal of Respiratory and Critical Care Medicine1995;151(1):92-7. [DOI: 10.1164/ajrccm.151.1.7812579]NaughtonMT , LuiPP , BenardDC , GoldsteinRS , BradleyTD . A randomized controlled clinical trial of CPAP in patients with heart failure and Cheyne-Stokes respiration. American Review of Respiratory Disease1993;147(7):A687. ">Naughton 1995a</a>); however, results for the best supportive care study arm are not reported. </p> </section> </section> </section> </section> <section id="CD012889-sec-0072"> <h4 class="title">Adaptive servo ventilation versus another type of non‐invasive positive pressure</h4> <section id="CD012889-sec-0073"> <h5 class="title">ASV versus CPAP in CSA associated with chronic heart failure</h5> <section id="CD012889-sec-0074"> <h6 class="title">Primary outcomes</h6> <section id="CD012889-sec-0075"> <p><b>Central apnoea hypopnoea index ‐ Short term</b></p> <p>This outcome was not reported.</p> </section> <section id="CD012889-sec-0076"> <p><b>Cardiovascular mortality</b></p> <p>This outcome was not reported.</p> </section> <section id="CD012889-sec-0077"> <p><b>Serious adverse events</b></p> <p>This outcome was not reported, and it is not clear whether these data were sought but not found. </p> </section> </section> <section id="CD012889-sec-0078"> <h6 class="title">Secondary outcomes</h6> <section id="CD012889-sec-0079"> <p><b>Quality of sleep</b></p> <p>This outcome was not reported.</p> </section> <section id="CD012889-sec-0080"> <p><b>Quality of life</b></p> <p>This outcome was not reported.</p> </section> <section id="CD012889-sec-0081"> <p><b>Quality of life ‐ Short and medium term</b></p> <p>The evidence is very uncertain (due to serious risk of bias and very serious imprecision) (<a href="./full#CD012889-tbl-0002">summary of findings Table 2</a>) about the effect of ASV versus CPAP on quality of life evaluated in the short term (MD 1.20, 95% CI −11.47 to 13.87; 1 study; 20 participants) and medium term (MD −8.64, 95% CI −25.56 to 8.28; 1 study; 17 participants) (<a href="./references#CD012889-bbs2-0012" title="PhilippeC , Stoica-HermanM , DrouotX , RaffestinB , EscourrouP , HittingerL , et al. Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart2006;92(3):337-42. [DOI: 10.1136/hrt.2005.060038]">Philippe 2006</a>). </p> </section> <section id="CD012889-sec-0082"> <p><b>Apnoea hypopnoea index ‐ Short term</b></p> <p>In the short term, ASV may reduce AHI compared to CPAP ventilation (MD −20.37, 95% CI −25.32 to −15.41; <a href="./references#CD012889-fig-0005" title="">Analysis 2.1</a>). </p> </section> <section id="CD012889-sec-0083"> <p><b>Apnoea hypopnoea index ‐ Medium term</b></p> <p>Only one study evaluated AHI in the medium term (<a href="./references#CD012889-bbs2-0012" title="PhilippeC , Stoica-HermanM , DrouotX , RaffestinB , EscourrouP , HittingerL , et al. Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart2006;92(3):337-42. [DOI: 10.1136/hrt.2005.060038]">Philippe 2006</a>). We found low‐certainty evidence (due to serious risk of bias and imprecision) that ASV may reduce AHI compared to CPAP (MD −28.67, 95% CI −48.28 to −9.06; 1 study; 17 participants) (<a href="./references#CD012889-bbs2-0012" title="PhilippeC , Stoica-HermanM , DrouotX , RaffestinB , EscourrouP , HittingerL , et al. Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart2006;92(3):337-42. [DOI: 10.1136/hrt.2005.060038]">Philippe 2006</a>). </p> </section> <section id="CD012889-sec-0084"> <p><b>All‐cause mortality</b></p> <p>This outcome was not reported.</p> </section> <section id="CD012889-sec-0085"> <p><b>Time to life‐saving intervention</b></p> <p>This outcome was not reported.</p> </section> <section id="CD012889-sec-0086"> <p><b>Adverse events/side effects</b></p> <p>This outcome was not reported, and it is not clear whether these data were sought but not found. </p> </section> </section> </section> <section id="CD012889-sec-0087"> <h5 class="title">ASV versus bilevel ventilation in CSA associated with chronic heart failure</h5> <section id="CD012889-sec-0088"> <h6 class="title">Primary outcomes</h6> <section id="CD012889-sec-0089"> <p><b>Central apnoea hypopnoea index ‐ Short term</b></p> <p>We found low‐certainty evidence (due to serious risk of bias and imprecision) (<a href="./full#CD012889-tbl-0003">summary of findings Table 3</a>) of no difference between ASV and bilevel ventilation in cAHI in the short term (MD 0.90, 95% CI −2.40 to 4.20; 1 study; 30 participants) (<a href="./references#CD012889-bbs2-0004" title="FietzeI , BlauA , GlosM , TheresH , BaumannG , PenzelT . Bi-level positive pressure ventilation and adaptive servo ventilation in patients with heart failure and Cheyne-Stokes respiration. Sleep Medicine2008;9:652-9. [DOI: 10.1016/j.sleep.2007.09.008]">Fietze 2008</a>). </p> </section> <section id="CD012889-sec-0090"> <p><b>Cardiovascular mortality</b></p> <p>This outcome was not reported.</p> </section> <section id="CD012889-sec-0091"> <p><b>Serious adverse events</b></p> <p>The authors of one study reported that they did not detect any adverse events of treatment, but did not provide data for the control group (<a href="./references#CD012889-bbs2-0004" title="FietzeI , BlauA , GlosM , TheresH , BaumannG , PenzelT . Bi-level positive pressure ventilation and adaptive servo ventilation in patients with heart failure and Cheyne-Stokes respiration. Sleep Medicine2008;9:652-9. [DOI: 10.1016/j.sleep.2007.09.008]">Fietze 2008</a>). </p> </section> </section> <section id="CD012889-sec-0092"> <h6 class="title">Secondary outcomes</h6> <section id="CD012889-sec-0093"> <p><b>Quality of sleep</b></p> <p>This outcome was not reported.</p> </section> <section id="CD012889-sec-0094"> <p><b>Quality of life</b></p> <p>This outcome was not reported.</p> </section> <section id="CD012889-sec-0095"> <p><b>Apnoea hypopnoea index ‐ Short term</b></p> <p>In the short term, the evidence is very uncertain (due to serious risk of bias and very serious imprecision) about the effect of ASV on total AHI (MD −5.20, 95% CI −14.63 to 4.23; 1 study; 30 participants) (<a href="./references#CD012889-bbs2-0004" title="FietzeI , BlauA , GlosM , TheresH , BaumannG , PenzelT . Bi-level positive pressure ventilation and adaptive servo ventilation in patients with heart failure and Cheyne-Stokes respiration. Sleep Medicine2008;9:652-9. [DOI: 10.1016/j.sleep.2007.09.008]">Fietze 2008</a>). </p> </section> <section id="CD012889-sec-0096"> <p><b>All‐cause mortality</b></p> <p>This outcome was not reported.</p> </section> <section id="CD012889-sec-0097"> <p><b>Time to life‐saving intervention</b></p> <p>This outcome was not reported.</p> </section> <section id="CD012889-sec-0098"> <p><b>Adverse events/side effects</b></p> <p>The authors of one study reported that they did not detect any adverse events of treatment, but did not provide data for the control group (<a href="./references#CD012889-bbs2-0004" title="FietzeI , BlauA , GlosM , TheresH , BaumannG , PenzelT . Bi-level positive pressure ventilation and adaptive servo ventilation in patients with heart failure and Cheyne-Stokes respiration. Sleep Medicine2008;9:652-9. [DOI: 10.1016/j.sleep.2007.09.008]">Fietze 2008</a>). </p> </section> </section> </section> <section id="CD012889-sec-0099"> <h5 class="title">ASV versus CPAP maintenance in CPAP‐induced CSA</h5> <section id="CD012889-sec-0100"> <h6 class="title">Primary outcomes</h6> <section id="CD012889-sec-0101"> <p><b>Central apnoea hypopnoea index ‐ Short term</b></p> <p>We found low‐certainty evidence (due to serious risk of bias and imprecision) (<a href="./full#CD012889-tbl-0004">summary of findings Table 4</a>) that ASV may slightly reduce cAHI compared to CPAP ventilation in the short term (MD −4.10, 95% CI −6.67 to −1.53; 1 study; 60 participants) (<a href="./references#CD012889-bbs2-0008" title="MorgenthalerTI , KuzniarTJ , WolfeLF , WillesL , McLainWC , GoldbergR . The Complex Sleep Apnea Resolution Study: a prospective randomized controlled trial of continuous positive airway pressure versus adaptive servoventilation therapy. Sleep2014;37(5):927-34. [DOI: 10.5665/sleep.3662]">Morgenthaler 2014</a>). </p> </section> <section id="CD012889-sec-0102"> <p><b>Cardiovascular mortality</b></p> <p>This outcome was not reported.</p> </section> <section id="CD012889-sec-0103"> <p><b>Serious adverse events</b></p> <p>This outcome was not reported, and it is not clear whether these data were sought but not found. </p> </section> </section> <section id="CD012889-sec-0104"> <h6 class="title">Secondary outcomes</h6> <section id="CD012889-sec-0105"> <p><b>Quality of sleep</b></p> <p>This outcome was not reported.</p> </section> <section id="CD012889-sec-0106"> <p><b>Quality of life ‐ Short term</b></p> <p>In the short term, ASV may result in little to no difference in quality of life (MD 0.00, 95% CI −0.46 to 0.46; 1 study; 61 participants; low‐certainty evidence due to serious risk of bias and imprecision) (<a href="./references#CD012889-bbs2-0008" title="MorgenthalerTI , KuzniarTJ , WolfeLF , WillesL , McLainWC , GoldbergR . The Complex Sleep Apnea Resolution Study: a prospective randomized controlled trial of continuous positive airway pressure versus adaptive servoventilation therapy. Sleep2014;37(5):927-34. [DOI: 10.5665/sleep.3662]">Morgenthaler 2014</a>). </p> </section> <section id="CD012889-sec-0107"> <p><b>Apnoea hypopnoea index ‐ Short term</b></p> <p>We found low‐certainty evidence (due to serious risk of bias and imprecision) that ASV may slightly reduce AHI in the short term (MD −5.50, 95% CI −10.74 to −0.26; 1 study; 60 participants) (<a href="./references#CD012889-bbs2-0008" title="MorgenthalerTI , KuzniarTJ , WolfeLF , WillesL , McLainWC , GoldbergR . The Complex Sleep Apnea Resolution Study: a prospective randomized controlled trial of continuous positive airway pressure versus adaptive servoventilation therapy. Sleep2014;37(5):927-34. [DOI: 10.5665/sleep.3662]">Morgenthaler 2014</a>). </p> </section> <section id="CD012889-sec-0108"> <p><b>All‐cause mortality</b></p> <p>This outcome was not reported.</p> </section> <section id="CD012889-sec-0109"> <p><b>Time to life‐saving intervention</b></p> <p>This outcome was not reported.</p> </section> <section id="CD012889-sec-0110"> <p><b>Adverse events/side effects</b></p> <p>This outcome was not reported, and it is not clear whether these data were sought but not found. </p> </section> </section> </section> <section id="CD012889-sec-0111"> <h5 class="title">ASV versus bilevel ventilation in CPAP‐induced CSA</h5> <section id="CD012889-sec-0112"> <h6 class="title">Primary outcomes</h6> <section id="CD012889-sec-0113"> <p><b>Central apnoea hypopnoea index ‐ Short term</b></p> <p>We found low‐certainty evidence (due to serious risk of bias and imprecision) (<a href="./full#CD012889-tbl-0005">summary of findings Table 5</a>) that ASV may slightly reduce cAHI compared to bilevel ventilation in the short term (MD −8.70, 95% CI −11.42 to −5.98; 1 study; 30 participants) (<a href="./references#CD012889-bbs2-0003" title="DellwegD , KerlJ , HoehnE , WenzelM , KoehlerD . Randomized controlled trial of noninvasive positive pressure ventilation (NPPV) versus servoventilation in patients with CPAP-induced central sleep apnea (complex sleep apnea). Sleep2013;36(8):1163-71. [DOI: 10.5665/sleep.2878]">Dellweg 2013</a>). </p> </section> <section id="CD012889-sec-0114"> <p><b>Cardiovascular mortality</b></p> <p>This outcome was not reported.</p> </section> <section id="CD012889-sec-0115"> <p><b>Serious adverse events</b></p> <p>This outcome was not reported, and it is not clear whether these data were sought but not found. </p> </section> </section> <section id="CD012889-sec-0116"> <h6 class="title">Secondary outcomes</h6> <section id="CD012889-sec-0117"> <p><b>Quality of sleep</b></p> <p>This outcome was not reported.</p> </section> <section id="CD012889-sec-0118"> <p><b>Quality of life</b></p> <p>This outcome was not reported.</p> </section> <section id="CD012889-sec-0119"> <p><b>Apnoea hypopnoea index ‐ Short term</b></p> <p>We found low‐certainty evidence (due to serious risk of bias and imprecision) that ASV may slightly reduce AHI compared to bilevel ventilation in the short term (MD −9.10, 95% CI −13.67 to −4.53; 1 study; 30 participants) (<a href="./references#CD012889-bbs2-0003" title="DellwegD , KerlJ , HoehnE , WenzelM , KoehlerD . Randomized controlled trial of noninvasive positive pressure ventilation (NPPV) versus servoventilation in patients with CPAP-induced central sleep apnea (complex sleep apnea). Sleep2013;36(8):1163-71. [DOI: 10.5665/sleep.2878]">Dellweg 2013</a>). </p> </section> <section id="CD012889-sec-0120"> <p><b>All‐cause mortality</b></p> <p>This outcome was not reported.</p> </section> <section id="CD012889-sec-0121"> <p><b>Time to life‐saving intervention</b></p> <p>This outcome was not reported.</p> </section> <section id="CD012889-sec-0122"> <p><b>Adverse events/side effects</b></p> <p>This outcome was not reported, and it is not clear whether these data were sought but not found. </p> </section> </section> </section> </section> <section id="CD012889-sec-0123"> <h4 class="title">Adaptive servo‐ventilation versus inactive control (subtherapeutic positive pressure, no treatment, or usual care) </h4> <section id="CD012889-sec-0124"> <h5 class="title">ASV plus best supportive care versus best supportive care alone (or inactive control) in CSA associated with chronic heart failure </h5> <section id="CD012889-sec-0125"> <h6 class="title">Primary outcomes</h6> <section id="CD012889-sec-0126"> <p><b>Central apnoea hypopnoea index</b></p> <p>This outcome was not reported.</p> </section> <section id="CD012889-sec-0127"> <p><b>Cardiovascular mortality ‐ Long term</b></p> <p>We found moderate‐certainty evidence (due to serious risk of bias) (<a href="./full#CD012889-tbl-0006">summary of findings Table 6</a>) that ASV plus best supportive care likely increases cardiovascular mortality compared to best supportive care in the long term (RR 1.25, 95% CI 1.04 to 1.49; 1 study; 1325 participants) (<a href="./references#CD012889-bbs2-0013" title="CowieM , WoehrleH , WegscheiderK , AngermannC , D'OrthoMP , ErdmannE , et al. Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results. European Respiratory Journal2015;46:OA3475. [DOI: 10.1183/13993003.congress-2015.OA3475]CowieMR , WoehrleH , WegscheiderK , AngermannC , D'Ortho M-P, ErdmannE , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. New England Journal of Medicine2015;373(12):1095-105. [DOI: 10.1056/NEJMoa1506459]CowieMR , WoehrleH , WegscheiderK , VettorazziE , LeziusS , KoenigW , et al. Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF. European Journal of Heart Failure2018;20:536-44. [DOI: 10.1002/ejhf.1048]EulenburgC , WegscheiderK , WoehrleH , AngermannC , D'Ortho M-P, ErdmannE , et al. Understanding SERVE-HF: a multistate analysis to explain mechanisms underlying increased mortality risk in patients randomised to adaptive servo-ventilation (ASV). European Respiratory Journal2016;48:OA1985. [DOI: 10.1183/13993003.congress-2016.OA1985]TamisierR , PepinJL , CowieM , WegscheiderK , VettorazziE , SulingA , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure: PSG data from the SERVE-HF major substudy. American Journal of Respiratory and Critical Care Medicine2017;195:A4513. [DOI: 10.1164/ajrccm-conference.2017.B80-G]TamisierR , Pepin J-L, SalvatM , WoehrleH , Barone-RochetteG , RoccaC , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure does not improve muscle sympathetic nerve activity: a SERVE-HF substudy. European Respiratory Journal2016;48:PA2083. [DOI: 10.1183/13993003.congress-2016.PA2083]">SERVE HF 2015</a>). </p> </section> <section id="CD012889-sec-0128"> <p><b>Serious adverse events</b></p> <p>This outcome was evaluated but not reported.</p> </section> </section> <section id="CD012889-sec-0129"> <h6 class="title">Secondary outcomes</h6> <section id="CD012889-sec-0130"> <p><b>Quality of sleep</b></p> <p>This outcome was not reported.</p> </section> <section id="CD012889-sec-0131"> <p><b>Quality of life ‐ Short, medium, and long term</b></p> <p>ASV plus best supportive care may result in little to no difference in quality of life in the short term (MD −0.04, 95% CI −2.31 to 2.23; 2 studies; 1355 participants; <a href="./references#CD012889-fig-0006" title="">Analysis 3.1</a>; <a href="./references#CD012889-bbs2-0006" title="HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three months treatment with adaptive servo-ventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration in a prospective randomized controlled trial. Circulation2011;124(21 Suppl):A11007. [DOI: 10.1161/circ.124.suppl_21.A11007]HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three-month treatment with adaptive servoventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration: a prospective randomized controlled trial. Cardiology2013;126(C(2)):81-90. [DOI: 10.1159/000350826]OlsengMW , OlsenBF , HetlandA , FagermoenS , JacobsenM . Quality of life improves in patients with chronic heart failure and Cheyne-Stokes respiration treated with adaptive servo-ventilation in a nurse-led heart failure clinic. Journal of Clinical Nursing2017;26(9-10):1226-33. [DOI: 10.1111/jocn.13416]">Hetland 2013</a>; <a href="./references#CD012889-bbs2-0013" title="CowieM , WoehrleH , WegscheiderK , AngermannC , D'OrthoMP , ErdmannE , et al. Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results. European Respiratory Journal2015;46:OA3475. [DOI: 10.1183/13993003.congress-2015.OA3475]CowieMR , WoehrleH , WegscheiderK , AngermannC , D'Ortho M-P, ErdmannE , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. New England Journal of Medicine2015;373(12):1095-105. [DOI: 10.1056/NEJMoa1506459]CowieMR , WoehrleH , WegscheiderK , VettorazziE , LeziusS , KoenigW , et al. Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF. European Journal of Heart Failure2018;20:536-44. [DOI: 10.1002/ejhf.1048]EulenburgC , WegscheiderK , WoehrleH , AngermannC , D'Ortho M-P, ErdmannE , et al. Understanding SERVE-HF: a multistate analysis to explain mechanisms underlying increased mortality risk in patients randomised to adaptive servo-ventilation (ASV). European Respiratory Journal2016;48:OA1985. [DOI: 10.1183/13993003.congress-2016.OA1985]TamisierR , PepinJL , CowieM , WegscheiderK , VettorazziE , SulingA , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure: PSG data from the SERVE-HF major substudy. American Journal of Respiratory and Critical Care Medicine2017;195:A4513. [DOI: 10.1164/ajrccm-conference.2017.B80-G]TamisierR , Pepin J-L, SalvatM , WoehrleH , Barone-RochetteG , RoccaC , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure does not improve muscle sympathetic nerve activity: a SERVE-HF substudy. European Respiratory Journal2016;48:PA2083. [DOI: 10.1183/13993003.congress-2016.PA2083]">SERVE HF 2015</a>) and medium term (MD 0.34, 95% CI −2.11 to 2.79; 1 study; 1325 participants; <a href="./references#CD012889-bbs2-0013" title="CowieM , WoehrleH , WegscheiderK , AngermannC , D'OrthoMP , ErdmannE , et al. Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results. European Respiratory Journal2015;46:OA3475. [DOI: 10.1183/13993003.congress-2015.OA3475]CowieMR , WoehrleH , WegscheiderK , AngermannC , D'Ortho M-P, ErdmannE , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. New England Journal of Medicine2015;373(12):1095-105. [DOI: 10.1056/NEJMoa1506459]CowieMR , WoehrleH , WegscheiderK , VettorazziE , LeziusS , KoenigW , et al. Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF. European Journal of Heart Failure2018;20:536-44. [DOI: 10.1002/ejhf.1048]EulenburgC , WegscheiderK , WoehrleH , AngermannC , D'Ortho M-P, ErdmannE , et al. Understanding SERVE-HF: a multistate analysis to explain mechanisms underlying increased mortality risk in patients randomised to adaptive servo-ventilation (ASV). European Respiratory Journal2016;48:OA1985. [DOI: 10.1183/13993003.congress-2016.OA1985]TamisierR , PepinJL , CowieM , WegscheiderK , VettorazziE , SulingA , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure: PSG data from the SERVE-HF major substudy. American Journal of Respiratory and Critical Care Medicine2017;195:A4513. [DOI: 10.1164/ajrccm-conference.2017.B80-G]TamisierR , Pepin J-L, SalvatM , WoehrleH , Barone-RochetteG , RoccaC , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure does not improve muscle sympathetic nerve activity: a SERVE-HF substudy. European Respiratory Journal2016;48:PA2083. [DOI: 10.1183/13993003.congress-2016.PA2083]">SERVE HF 2015</a>). ASV plus best supportive care may also result in little to no difference in quality of life in the long term (MD 0.83, 95% CI −1.81 to 3.47; 1 study; 1325 participants; low‐certainty evidence; <a href="./references#CD012889-bbs2-0013" title="CowieM , WoehrleH , WegscheiderK , AngermannC , D'OrthoMP , ErdmannE , et al. Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results. European Respiratory Journal2015;46:OA3475. [DOI: 10.1183/13993003.congress-2015.OA3475]CowieMR , WoehrleH , WegscheiderK , AngermannC , D'Ortho M-P, ErdmannE , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. New England Journal of Medicine2015;373(12):1095-105. [DOI: 10.1056/NEJMoa1506459]CowieMR , WoehrleH , WegscheiderK , VettorazziE , LeziusS , KoenigW , et al. Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF. European Journal of Heart Failure2018;20:536-44. [DOI: 10.1002/ejhf.1048]EulenburgC , WegscheiderK , WoehrleH , AngermannC , D'Ortho M-P, ErdmannE , et al. Understanding SERVE-HF: a multistate analysis to explain mechanisms underlying increased mortality risk in patients randomised to adaptive servo-ventilation (ASV). European Respiratory Journal2016;48:OA1985. [DOI: 10.1183/13993003.congress-2016.OA1985]TamisierR , PepinJL , CowieM , WegscheiderK , VettorazziE , SulingA , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure: PSG data from the SERVE-HF major substudy. American Journal of Respiratory and Critical Care Medicine2017;195:A4513. [DOI: 10.1164/ajrccm-conference.2017.B80-G]TamisierR , Pepin J-L, SalvatM , WoehrleH , Barone-RochetteG , RoccaC , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure does not improve muscle sympathetic nerve activity: a SERVE-HF substudy. European Respiratory Journal2016;48:PA2083. [DOI: 10.1183/13993003.congress-2016.PA2083]">SERVE HF 2015</a>). </p> </section> <section id="CD012889-sec-0132"> <p><b>Apnoea hypopnoea index ‐ Short term</b></p> <p>We found low‐certainty evidence (due to serious risk of bias and imprecision) that ASV plus best supportive care may reduce AHI compared to best supportive care alone in the short term (MD −9.30, 95% CI −16.50 to −2.10; 1 study; 30 participants; <a href="./references#CD012889-bbs2-0011" title="PepperellJCT , MaskellNA , JonesDR , Langford-WileyBA , CrosthwaiteN , StradlingJR , et al. A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. American Journal of Respiratory and Critical Care Medicine2003;168(9):1109-14. [DOI: 10.1164/rccm.200212-1476OC]">Pepperell 2003</a>). </p> </section> <section id="CD012889-sec-0133"> <p><b>Apnoea hypopnoea index ‐ Medium term</b></p> <p>We found low‐certainty evidence (due to serious risk of bias and imprecision) that ASV plus best supportive care may reduce AHI compared to best supportive care alone in the medium term (MD −20.30, 95% CI −28.75 to −11.85; 1 study; 30 participants; <a href="./references#CD012889-bbs2-0015" title="ToyamaT , HoshizakiH , KasamaS , MiyaishiY , KanH , YamashitaE , et al. Adaptive servo-ventilation therapy improves cardiac sympathetic nerve activity, cardiac function, exercise capacity, and symptom in patients with chronic heart failure and Cheyne-Stokes respiration. Journal of Nuclear Cardiology2016;24(6):1-12. [DOI: 10.1007/s12350-016-0529-9]">Toyama 2016</a>). </p> </section> <section id="CD012889-sec-0134"> <p><b>All‐cause mortality ‐ Medium term</b></p> <p>In the medium term, ASV plus best supportive care may result in little to no difference in all‐cause mortality (RR 0.33, 95% CI 0.01 to 7.58; 1 study; 30 participants; <a href="./references#CD012889-bbs2-0006" title="HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three months treatment with adaptive servo-ventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration in a prospective randomized controlled trial. Circulation2011;124(21 Suppl):A11007. [DOI: 10.1161/circ.124.suppl_21.A11007]HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three-month treatment with adaptive servoventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration: a prospective randomized controlled trial. Cardiology2013;126(C(2)):81-90. [DOI: 10.1159/000350826]OlsengMW , OlsenBF , HetlandA , FagermoenS , JacobsenM . Quality of life improves in patients with chronic heart failure and Cheyne-Stokes respiration treated with adaptive servo-ventilation in a nurse-led heart failure clinic. Journal of Clinical Nursing2017;26(9-10):1226-33. [DOI: 10.1111/jocn.13416]">Hetland 2013</a>). </p> </section> <section id="CD012889-sec-0135"> <p><b>All‐cause mortality ‐ Long term</b></p> <p>In the long term, ASV plus best supportive care may result in little to no difference in all‐cause mortality (RR 0.56, 95% CI 0.06 to 4.93; 2 studies; 1355 participants; low‐certainty evidence (due to serious risk of bias and imprecision); <a href="./references#CD012889-fig-0007" title="">Analysis 3.2</a>) (<a href="./references#CD012889-bbs2-0006" title="HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three months treatment with adaptive servo-ventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration in a prospective randomized controlled trial. Circulation2011;124(21 Suppl):A11007. [DOI: 10.1161/circ.124.suppl_21.A11007]HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three-month treatment with adaptive servoventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration: a prospective randomized controlled trial. Cardiology2013;126(C(2)):81-90. [DOI: 10.1159/000350826]OlsengMW , OlsenBF , HetlandA , FagermoenS , JacobsenM . Quality of life improves in patients with chronic heart failure and Cheyne-Stokes respiration treated with adaptive servo-ventilation in a nurse-led heart failure clinic. Journal of Clinical Nursing2017;26(9-10):1226-33. [DOI: 10.1111/jocn.13416]">Hetland 2013</a>; <a href="./references#CD012889-bbs2-0013" title="CowieM , WoehrleH , WegscheiderK , AngermannC , D'OrthoMP , ErdmannE , et al. Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results. European Respiratory Journal2015;46:OA3475. [DOI: 10.1183/13993003.congress-2015.OA3475]CowieMR , WoehrleH , WegscheiderK , AngermannC , D'Ortho M-P, ErdmannE , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. New England Journal of Medicine2015;373(12):1095-105. [DOI: 10.1056/NEJMoa1506459]CowieMR , WoehrleH , WegscheiderK , VettorazziE , LeziusS , KoenigW , et al. Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF. European Journal of Heart Failure2018;20:536-44. [DOI: 10.1002/ejhf.1048]EulenburgC , WegscheiderK , WoehrleH , AngermannC , D'Ortho M-P, ErdmannE , et al. Understanding SERVE-HF: a multistate analysis to explain mechanisms underlying increased mortality risk in patients randomised to adaptive servo-ventilation (ASV). European Respiratory Journal2016;48:OA1985. [DOI: 10.1183/13993003.congress-2016.OA1985]TamisierR , PepinJL , CowieM , WegscheiderK , VettorazziE , SulingA , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure: PSG data from the SERVE-HF major substudy. American Journal of Respiratory and Critical Care Medicine2017;195:A4513. [DOI: 10.1164/ajrccm-conference.2017.B80-G]TamisierR , Pepin J-L, SalvatM , WoehrleH , Barone-RochetteG , RoccaC , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure does not improve muscle sympathetic nerve activity: a SERVE-HF substudy. European Respiratory Journal2016;48:PA2083. [DOI: 10.1183/13993003.congress-2016.PA2083]">SERVE HF 2015</a>). Of note, I<sup>2</sup> for this analysis was 63%. As only two studies evaluated this outcome, no subgroup analysis could be performed to investigate causes of heterogeneity. </p> </section> <section id="CD012889-sec-0136"> <p><b>Time to life‐saving cardiovascular intervention</b></p> <p>The results of time to life‐saving cardiovascular intervention were not reported separately.</p> </section> <section id="CD012889-sec-0137"> <p><b>Adverse events/side effects</b></p> <p>This outcome was evaluated but not reported.</p> </section> </section> </section> <section id="CD012889-sec-0138"> <h5 class="title">ASV plus best supportive care versus best supportive care alone (or inactive control) in CSA with acute heart failure with preserved ejection fraction </h5> <section id="CD012889-sec-0139"> <h6 class="title">Primary outcomes</h6> <section id="CD012889-sec-0140"> <p><b>Central apnoea hypopnoea index</b></p> <p>This outcome was not reported.</p> </section> <section id="CD012889-sec-0141"> <p><b>Cardiovascular mortality</b></p> <p>This outcome was not reported.</p> </section> <section id="CD012889-sec-0142"> <p><b>Serious adverse events</b></p> <p>The authors of one study reported that no adverse events were recorded in either group (<a href="./references#CD012889-bbs2-0002" title="D'eliaE , FerreroP , VittoriC , BaioP , DuinoV , GrosuA , et al. Enhanced adaptive servo-ventilation improves echocardiographic parameters of diastolic and right ventricle function in patients with sleep apnea and heart failure with preserved ejection fraction. European Journal of Heart Failure2016;18:474. D’EliaE , FerreroP , VittoriC , IacovoniA , GrosuA , GoriM , et al. Beneficial effects of adaptive servo-ventilation on natriuretic peptides and diastolic function in acute heart failure patients with preserved ejection fraction and sleep-disordered breathing. Sleep and Breathing2019;23:287-91. [DOI: 10.1007/s11325-018-1681-z]">D'Elia 2019</a>). </p> </section> </section> <section id="CD012889-sec-0143"> <h6 class="title">Secondary outcomes</h6> <section id="CD012889-sec-0144"> <p><b>Quality of sleep</b></p> <p>This outcome was not reported.</p> </section> <section id="CD012889-sec-0145"> <p><b>Quality of life</b></p> <p>This outcome was not reported.</p> </section> <section id="CD012889-sec-0146"> <p><b>Apnoea hypopnoea index</b></p> <p>This outcome was not reported.</p> </section> <section id="CD012889-sec-0147"> <p><b>All‐cause mortality</b></p> <p>This outcome was not reported.</p> </section> <section id="CD012889-sec-0148"> <p><b>Time to life‐saving intervention</b></p> <p>This outcome was not reported.</p> </section> <section id="CD012889-sec-0149"> <p><b>Adverse events/side effects</b></p> <p>The authors of one study reported that no adverse events were recorded in either group (<a href="./references#CD012889-bbs2-0002" title="D'eliaE , FerreroP , VittoriC , BaioP , DuinoV , GrosuA , et al. Enhanced adaptive servo-ventilation improves echocardiographic parameters of diastolic and right ventricle function in patients with sleep apnea and heart failure with preserved ejection fraction. European Journal of Heart Failure2016;18:474. D’EliaE , FerreroP , VittoriC , IacovoniA , GrosuA , GoriM , et al. Beneficial effects of adaptive servo-ventilation on natriuretic peptides and diastolic function in acute heart failure patients with preserved ejection fraction and sleep-disordered breathing. Sleep and Breathing2019;23:287-91. [DOI: 10.1007/s11325-018-1681-z]">D'Elia 2019</a>). </p> </section> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012889-sec-0150" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012889-sec-0150"></div> <section id="CD012889-sec-0151"> <h3 class="title" id="CD012889-sec-0151">Summary of main results</h3> <p>In this systematic review, we summarised the available evidence on the effects of non‐invasive positive pressure ventilation in people with CSA. We found 15 RCTs, including a wide range of treatment techniques using non‐invasive ventilation, with several configurations of parameters, and few data that could be pooled. Most participants were men and had CSA associated with chronic heart failure. </p> <p>When comparing CPAP plus best supportive care versus best supportive care (or inactive control), we found that CPAP plus best supportive care may reduce cAHI in the short term, and may reduce AHI in the short and long term. However, CPAP plus best supportive care may result in little to no difference in cardiovascular mortality, and the evidence is very uncertain about its effects on all‐cause mortality in the long term. One trial mentioned that no immediate or long‐term adverse effects of nasal CPAP were observed (<a href="./references#CD012889-bbs2-0009" title="NaughtonMT , LiuPP , BernardDC , GoldsteinRS , BradleyTD . Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. American Journal of Respiratory and Critical Care Medicine1995;151(1):92-7. [DOI: 10.1164/ajrccm.151.1.7812579]NaughtonMT , LuiPP , BenardDC , GoldsteinRS , BradleyTD . A randomized controlled clinical trial of CPAP in patients with heart failure and Cheyne-Stokes respiration. American Review of Respiratory Disease1993;147(7):A687. ">Naughton 1995a</a>); however, no results for the best supportive care study arm were reported. Of note, whilst the results of industry‐sponsored trials showed that CPAP plus best supportive care may reduce AHI, the results of non‐industry‐sponsored trials showed that CPAP plus best supportive care may result in little to no difference in AHI in participants with CSA associated with chronic heart failure. As few studies were included in this analysis, there may be important imprecision in the effect estimates. The inclusion of further trials in future updates of this review may therefore clarify whether industry sponsorship can influence the results. </p> <p>In people with CSA associated with chronic heart failure, ASV may result in little to no difference in cAHI compared to bilevel ventilation. We are uncertain about the effect of ASV on total AHI when compared to bilevel ventilation. However, in people with CPAP‐induced CSA, ASV may slightly reduce cAHI and AHI in the short term compared to bilevel ventilation. Adverse events were also not reported in these participants. No trials compared the effect of ASV on cardiovascular mortality versus bilevel ventilation. </p> <p>Compared to CPAP, ASV may reduce AHI in the short and medium term in people with CSA associated with chronic heart failure. However, the evidence is uncertain about the effect of ASV versus CPAP on quality of life in the short and medium term. Of note, the reduction in AHI for ASV is probably a consequence of the back‐up functionality inherent to this mode, which aims to assure a target minute ventilation. This finding should therefore be interpreted with caution, as it may not reflect a long‐lasting physiological effect. In CPAP‐induced CSA, we found that ASV may slightly reduce cAHI and AHI, but may result in little to no difference in quality of life in the short term. CPAP‐induced CSA may be caused by unstable ventilatory control with a change of ventilatory drive (<a href="./references#CD012889-bbs2-0082" title="MouraSMT , BittencourtLR , BagnatoMC , LucasSR , TufikS , NeryLE , et al. Acute effect of nasal continuous positive air pressure on the ventilatory control of patients with obstructive sleep apnea. Respiration2001;68(3):243-9. [DOI: 10.1159/000050505]">Moura 2001</a>). This condition appears to resolve spontaneously over time in some but not all patients during continued CPAP therapy (<a href="./references#CD012889-bbs2-0074" title="JavaheriS , SmithJ , ChungE . The prevalence and natural history of complex sleep apnea. Journal of Clinical Sleep Medicine2009;5:205-11.">Javaheri 2009</a>; <a href="./references#CD012889-bbs2-0077" title="KuzniarTJ , PusalavidyasagarS , GayPC , MorgenthalerTI . Natural course of complex sleep apnea - a retrospective study. Sleep and Breathing2008;12:135-9. [DOI: 10.1007/s11325-007-0140-z]">Kuźniar 2008a</a>) </p> <p>Interestingly, although we found that ASV plus best supportive care may reduce AHI in the short and medium term compared to best supportive care alone, we found moderate‐certainty evidence indicating that ASV likely increases cardiovascular mortality compared to best supportive care alone in people with CSA associated with chronic heart failure. Additionally, ASV plus best supportive care may result in little to no difference in quality of life in the short, medium, and long term, and in all‐cause mortality in the medium and long term. It should be mentioned that the finding regarding cardiovascular mortality was derived from a single study, although with a large sample size, and that all other outcomes for the comparison ASV plus best supportive care versus best supportive care alone were also largely influenced by this trial (<a href="./references#CD012889-bbs2-0013" title="CowieM , WoehrleH , WegscheiderK , AngermannC , D'OrthoMP , ErdmannE , et al. Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results. European Respiratory Journal2015;46:OA3475. [DOI: 10.1183/13993003.congress-2015.OA3475]CowieMR , WoehrleH , WegscheiderK , AngermannC , D'Ortho M-P, ErdmannE , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. New England Journal of Medicine2015;373(12):1095-105. [DOI: 10.1056/NEJMoa1506459]CowieMR , WoehrleH , WegscheiderK , VettorazziE , LeziusS , KoenigW , et al. Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF. European Journal of Heart Failure2018;20:536-44. [DOI: 10.1002/ejhf.1048]EulenburgC , WegscheiderK , WoehrleH , AngermannC , D'Ortho M-P, ErdmannE , et al. Understanding SERVE-HF: a multistate analysis to explain mechanisms underlying increased mortality risk in patients randomised to adaptive servo-ventilation (ASV). European Respiratory Journal2016;48:OA1985. [DOI: 10.1183/13993003.congress-2016.OA1985]TamisierR , PepinJL , CowieM , WegscheiderK , VettorazziE , SulingA , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure: PSG data from the SERVE-HF major substudy. American Journal of Respiratory and Critical Care Medicine2017;195:A4513. [DOI: 10.1164/ajrccm-conference.2017.B80-G]TamisierR , Pepin J-L, SalvatM , WoehrleH , Barone-RochetteG , RoccaC , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure does not improve muscle sympathetic nerve activity: a SERVE-HF substudy. European Respiratory Journal2016;48:PA2083. [DOI: 10.1183/13993003.congress-2016.PA2083]">SERVE HF 2015</a>). Also, only people with low ejection fraction were included in the one study that assessed cardiovascular mortality (<a href="./references#CD012889-bbs2-0013" title="CowieM , WoehrleH , WegscheiderK , AngermannC , D'OrthoMP , ErdmannE , et al. Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results. European Respiratory Journal2015;46:OA3475. [DOI: 10.1183/13993003.congress-2015.OA3475]CowieMR , WoehrleH , WegscheiderK , AngermannC , D'Ortho M-P, ErdmannE , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. New England Journal of Medicine2015;373(12):1095-105. [DOI: 10.1056/NEJMoa1506459]CowieMR , WoehrleH , WegscheiderK , VettorazziE , LeziusS , KoenigW , et al. Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF. European Journal of Heart Failure2018;20:536-44. [DOI: 10.1002/ejhf.1048]EulenburgC , WegscheiderK , WoehrleH , AngermannC , D'Ortho M-P, ErdmannE , et al. Understanding SERVE-HF: a multistate analysis to explain mechanisms underlying increased mortality risk in patients randomised to adaptive servo-ventilation (ASV). European Respiratory Journal2016;48:OA1985. [DOI: 10.1183/13993003.congress-2016.OA1985]TamisierR , PepinJL , CowieM , WegscheiderK , VettorazziE , SulingA , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure: PSG data from the SERVE-HF major substudy. American Journal of Respiratory and Critical Care Medicine2017;195:A4513. [DOI: 10.1164/ajrccm-conference.2017.B80-G]TamisierR , Pepin J-L, SalvatM , WoehrleH , Barone-RochetteG , RoccaC , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure does not improve muscle sympathetic nerve activity: a SERVE-HF substudy. European Respiratory Journal2016;48:PA2083. [DOI: 10.1183/13993003.congress-2016.PA2083]">SERVE HF 2015</a>), and some methodological limitations related to this study reduced our certainty in the evidence. Nevertheless, <a href="./references#CD012889-bbs2-0013" title="CowieM , WoehrleH , WegscheiderK , AngermannC , D'OrthoMP , ErdmannE , et al. Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results. European Respiratory Journal2015;46:OA3475. [DOI: 10.1183/13993003.congress-2015.OA3475]CowieMR , WoehrleH , WegscheiderK , AngermannC , D'Ortho M-P, ErdmannE , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. New England Journal of Medicine2015;373(12):1095-105. [DOI: 10.1056/NEJMoa1506459]CowieMR , WoehrleH , WegscheiderK , VettorazziE , LeziusS , KoenigW , et al. Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF. European Journal of Heart Failure2018;20:536-44. [DOI: 10.1002/ejhf.1048]EulenburgC , WegscheiderK , WoehrleH , AngermannC , D'Ortho M-P, ErdmannE , et al. Understanding SERVE-HF: a multistate analysis to explain mechanisms underlying increased mortality risk in patients randomised to adaptive servo-ventilation (ASV). European Respiratory Journal2016;48:OA1985. [DOI: 10.1183/13993003.congress-2016.OA1985]TamisierR , PepinJL , CowieM , WegscheiderK , VettorazziE , SulingA , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure: PSG data from the SERVE-HF major substudy. American Journal of Respiratory and Critical Care Medicine2017;195:A4513. [DOI: 10.1164/ajrccm-conference.2017.B80-G]TamisierR , Pepin J-L, SalvatM , WoehrleH , Barone-RochetteG , RoccaC , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure does not improve muscle sympathetic nerve activity: a SERVE-HF substudy. European Respiratory Journal2016;48:PA2083. [DOI: 10.1183/13993003.congress-2016.PA2083]">SERVE HF 2015</a> was a multicentre RCT with a long‐term follow‐up, and probably provides precise effects estimates for the outcomes assessed in this subgroup of patients. </p> <p>Of note, the differences favouring NIPV are related to potential improvements in surrogate markers only, such as laboratory measurements, but not to patient‐centred outcomes, such as quality of sleep, quality of life, or longer‐term survival. For example, a mean difference of 15 hypoventilation episodes per hour between CPAP plus best supportive care and best supportive care in people with CSA and chronic heart failure, that is one event every four minutes, as found in this review, could be interpreted by some clinicians as a dramatic clinical improvement. However, there are currently no data to define minimal clinically important differences for AHI in CSA patients. In the absence of data showing a favourable impact on meaningful patient‐centred outcomes, these findings need to be interpreted with caution. </p> </section> <section id="CD012889-sec-0152"> <h3 class="title" id="CD012889-sec-0152">Overall completeness and applicability of evidence</h3> <p>As most of the studies included in this systematic review included men and people with CSA associated with chronic heart failure, the generalisability of our results is mostly limited to individuals with these characteristics. Although we found some evidence on people with CSA associated with other conditions, such as CPAP‐induced CSA, further trials are needed including these individuals. </p> <p>In this review, we were cautious about analysing data and did not pool results of studies comparing different modes of NIPV and including participants with CSA with different causes. Despite this, we believe not only the mode, but also the parameters of NIPV and the interface used to perform the NIPV therapy may also influence the effect estimates of the interventions. Due to several methodological limitations in the included studies, a number of questions still persist, and the evidence found in this review is therefore of moderate to very low certainty. </p> </section> <section id="CD012889-sec-0153"> <h3 class="title" id="CD012889-sec-0153">Quality of the evidence</h3> <p>We included 15 RCTs with a total of 1936 participants in this review. The evidence found in the review was of moderate to very low certainty, therefore results should be interpreted in light of the confidence in the effects estimated for each outcome. For example, we found moderate‐certainty evidence suggesting that ASV plus best supportive care likely increases cardiovascular mortality in people with CSA associated with chronic heart failure. For this result, the true effect is likely to be close to the effect we estimated, but there is a possibility that it is substantially different. For evidence of low certainty, our confidence in the effect estimate is limited, and the true effect may be substantially different from the effect we estimated. For evidence of very low certainty, we have very little confidence in the effect estimate, and the true effect is likely to be substantially different from the estimate of effect. </p> <p>We downgraded the certainty of evidence due to methodological limitations and imprecision in the effects estimated. As most of the included studies were assessed as unclear and high risk of bias for several domains, we downgraded the certainty of evidence due to methodological limitations in the included studies for all outcomes. Finally, clinical heterogeneity precluded a large meta‐analysis, and where the effects estimated were derived from small sample sizes or had large confidence intervals, we also downgraded the certainty of evidence for imprecision. Nevertheless, we believe this scientifically rigorous systematic review provides critical data to support further trials as well as to expose literature gaps. </p> </section> <section id="CD012889-sec-0154"> <h3 class="title" id="CD012889-sec-0154">Potential biases in the review process</h3> <p>We conducted this review according to our prespecified protocol (<a href="./references#CD012889-bbs2-0092" title="PachitoDV , MartimbiancoALC , LatorracaCOC , PachecoRL , DragerLF , Lorenzi‐FilhoG , et al. Non‐invasive positive pressure ventilation for central sleep apnoea in adults. Cochrane Database of Systematic Reviews2017, Issue 11. Art. No: CD012889. [DOI: 10.1002/14651858.CD012889]">Pachito 2017</a>), and following the recommendations in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012889-bbs2-0072" title="HigginsJPT , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>). We performed sensitive searches in the most important databases and clinical trial registers and manual searches to identify and collect all relevant RCTs. Although we identified several trials, including conference abstracts, some studies lacked sufficient data to permit inclusion or exclusion; we assessed these trials as awaiting classification. The body of the available evidence may therefore be larger than the evidence presented in our systematic review. We also could not design a funnel plot to assess publication bias due to an insufficient number of RCTs included in the meta‐analyses. Many data were only available in incomplete formats in graphs, and our attempts to contact several authors did not receive a response in most cases. </p> </section> <section id="CD012889-sec-0155"> <h3 class="title" id="CD012889-sec-0155">Agreements and disagreements with other studies or reviews</h3> <p>We found a previous systematic review that evaluated the effects of NIPV in people with CSA and heart failure (<a href="./references#CD012889-bbs2-0084" title="NakamuraS , AsaiK , KubotaY , MuraiK , TakanoH , TsukadaYT , et al. Impact of sleep-disordered breathing and efficacy of positive airway pressure on mortality in patients with chronic heart failure and sleep-disordered breathing: a meta-analysis. Clinical Research in Cardiology2015;104(3):208-16. [DOI: 10.1007/s00392-014-0774-3]">Nakamura 2015</a>). Besides not including participants without heart failure, which we did, Nakamura’s review also included studies with both OSA and CSA patients, which we did not include in our review. <a href="./references#CD012889-bbs2-0084" title="NakamuraS , AsaiK , KubotaY , MuraiK , TakanoH , TsukadaYT , et al. Impact of sleep-disordered breathing and efficacy of positive airway pressure on mortality in patients with chronic heart failure and sleep-disordered breathing: a meta-analysis. Clinical Research in Cardiology2015;104(3):208-16. [DOI: 10.1007/s00392-014-0774-3]">Nakamura 2015</a> suggested that NIPV therapy significantly reduced mortality compared to control. In our systematic review, the certainty of evidence prevented any conclusions as to whether any type of NIPV leads to clinically important benefits in people with CSA. Conversely, we found that the addition of ASV to best supportive care may lead to greater harm than benefit. Besides being more up‐to‐date, our searches were broader, included more databases, and included studies published irrespective of language or publication status. The <a href="./references#CD012889-bbs2-0084" title="NakamuraS , AsaiK , KubotaY , MuraiK , TakanoH , TsukadaYT , et al. Impact of sleep-disordered breathing and efficacy of positive airway pressure on mortality in patients with chronic heart failure and sleep-disordered breathing: a meta-analysis. Clinical Research in Cardiology2015;104(3):208-16. [DOI: 10.1007/s00392-014-0774-3]">Nakamura 2015</a> authors only included trials published in English. We therefore provide a more comprehensive, rigorously conducted, up‐to‐date review on the effects of NIPV in people with CSA with or without heart failure, which could justify the differences between our results and those reported by Nakamura. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012889-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/urn:x-wiley:14651858:media:CD012889:CD012889-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD012889-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/image_n/nCD012889-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/image_t/tCD012889-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/full#CD012889-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/image_n/nCD012889-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012889-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/urn:x-wiley:14651858:media:CD012889:CD012889-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012889-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/image_n/nCD012889-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/image_t/tCD012889-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/full#CD012889-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/image_n/nCD012889-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012889-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/urn:x-wiley:14651858:media:CD012889:CD012889-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CPAP plus best supportive care versus best supportive care (or inactive control) in CSA associated with chronic heart failure, Outcome 1: AHI ‐ short term" data-id="CD012889-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/image_n/nCD012889-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/image_t/tCD012889-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: CPAP plus best supportive care versus best supportive care (or inactive control) in CSA associated with chronic heart failure, Outcome 1: AHI ‐ short term </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/references#CD012889-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/image_n/nCD012889-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012889-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/urn:x-wiley:14651858:media:CD012889:CD012889-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CPAP plus best supportive care versus best supportive care (or inactive control) in CSA associated with chronic heart failure, Outcome 2: All‐cause mortality ‐ long term" data-id="CD012889-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/image_n/nCD012889-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/image_t/tCD012889-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: CPAP plus best supportive care versus best supportive care (or inactive control) in CSA associated with chronic heart failure, Outcome 2: All‐cause mortality ‐ long term </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/references#CD012889-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/image_n/nCD012889-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012889-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/urn:x-wiley:14651858:media:CD012889:CD012889-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: ASV versus CPAP in CSA associated with chronic heart failure, Outcome 1: AHI ‐ short term" data-id="CD012889-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/image_n/nCD012889-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/image_t/tCD012889-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: ASV versus CPAP in CSA associated with chronic heart failure, Outcome 1: AHI ‐ short term </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/references#CD012889-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/image_n/nCD012889-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012889-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/urn:x-wiley:14651858:media:CD012889:CD012889-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: ASV plus best supportive care versus best supportive care alone (or inactive control) in CSA associated with chronic heart failure, Outcome 1: Quality of life ‐ short term" data-id="CD012889-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/image_n/nCD012889-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/image_t/tCD012889-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: ASV plus best supportive care versus best supportive care alone (or inactive control) in CSA associated with chronic heart failure, Outcome 1: Quality of life ‐ short term </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/references#CD012889-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/image_n/nCD012889-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012889-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/urn:x-wiley:14651858:media:CD012889:CD012889-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: ASV plus best supportive care versus best supportive care alone (or inactive control) in CSA associated with chronic heart failure, Outcome 2: All‐cause mortality ‐ long term" data-id="CD012889-fig-0007" src="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/image_n/nCD012889-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/image_t/tCD012889-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: ASV plus best supportive care versus best supportive care alone (or inactive control) in CSA associated with chronic heart failure, Outcome 2: All‐cause mortality ‐ long term </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/references#CD012889-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/media/CDSR/CD012889/image_n/nCD012889-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD012889-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Continuous positive airway pressure (CPAP) plus best supportive care versus best supportive care for central sleep apnoea associated with chronic heart failure</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>CPAP plus best supportive care versus best supportive care for CSA associated with chronic heart failure</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Participants:</b> people with CSA associated with chronic heart failure </p> <p><b>Setting:</b> outpatient </p> <p><b>Intervention:</b> CPAP plus best supportive care </p> <p><b>Comparison:</b> best supportive care </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>What happens</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With best supportive care</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With CPAP plus best supportive care</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Difference</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Central AHI ‐ after 3 months</p> <p>Number of participants: 205<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean central AHI with best supportive care was 30.70.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean central AHI with CPAP was 16.10 (12.81 to 19.39).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 14.60 lower</p> <p>(20.11 lower to 9.09 lower)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝</p> <p>Low<sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CPAP plus best supportive care may reduce central AHI in the short term.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cardiovascular mortality ‐ after 24 months</p> <p>Number of participants: 258<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>RR 1.17<br/>(0.68 to 2.02) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean death rate from cardiovascular events with best supportive care was 15.40%.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean death rate from cardiovascular events with CPAP was 18.0%<br/>(10.50 to 31.10). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.60% more deaths from cardiovascular events in the treatment group<br/>(4.90 fewer to 15.70 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CPAP plus best supportive care may result in little to no difference in cardiovascular mortality in the long term. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of sleep</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>AHI ‐ after up to 3 months</p> <p>Number of participants: 264<br/>(4 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean AHI with best supportive care ranged across control groups from 19.00 to 37.60. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean AHI with CPAP ranged across intervention groups from 14.7 to 18.5.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 15.27 lower<br/>(22.44 lower to 8.11 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CPAP plus best supportive care may reduce AHI in the short term.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All‐cause mortality ‐ after 24 months</p> <p>Number of participants: 287<br/>(2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>RR 1.14<br/>(0.83 to 1.56) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean death rate with best supportive care was 26.20%.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean death rate with CPAP was 29.90%<br/>(21.80 to 40.90). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.70% more deaths in the treatment group <br/>(4.50 fewer to 14.70 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low <sup>5 6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of CPAP plus best supportive care on all‐cause mortality in the long term. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to life‐saving cardiovascular intervention (assessed with: transplant‐free survival rate) ‐ after 18 months </p> <p>Number of participants: 258<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>1 study reported an HR for transplantation‐free survival of 0.66; P = 0.06 (<a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a>). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CPAP plus best supportive care may slightly increase time to life‐saving intervention in the long term. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>AHI:</b> apnoea hypopnoea index;<b>CI:</b> confidence interval; <b>CPAP:</b> continuous positive airway pressure; <b>CSA:</b> central sleep apnoea; <b>HR:</b> hazard ratio; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>We downgraded one level due to methodological limitations (one study with high risk of bias for blinding of participants and personnel, incomplete outcome data, and selective reporting).<br/><sup>2</sup>We downgraded one level due to small sample size.<br/><sup>3</sup>We downgraded one level due to methodological limitations (one study with high risk of bias for incomplete outcome data and selective reporting).<br/><sup>4</sup>We downgraded one level due to the presence of few events.<br/><sup>5</sup>We downgraded one level due to methodological limitations (one study with high risk bias for incomplete outcome data and selective reporting and one study with unclear risk of bias for random sequence generation, allocation concealment, and selective reporting).<br/><sup>6</sup>We downgraded two levels due to the presence of few events and large CI (CI includes both important benefit and important harm). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Continuous positive airway pressure (CPAP) plus best supportive care versus best supportive care for central sleep apnoea associated with chronic heart failure</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/full#CD012889-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012889-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Adaptive servo ventilation (ASV) versus continuous positive airway pressure (CPAP) for central sleep apnoea associated with chronic heart failure</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>ASV versus CPAP for CSA associated with chronic heart failure</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Participants:</b> people with CSA associated with chronic heart failure </p> <p><b>Setting:</b> outpatient </p> <p><b>Intervention:</b> ASV </p> <p><b>Comparison:</b> CPAP </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>What happens</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With CPAP</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With ASV</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Difference</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Central AHI</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cardiovascular mortality</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of sleep</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life measured with MLHFQ ‐ after 6 months</p> <p>Number of participants: 17<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean difference in quality of life with CPAP was −12.52.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean difference in quality of life with ASV was −21.16 (−33.14 to −9.18).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 8.64 lower<br/>(25.56 lower to 8.28 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of ASV on quality of life in the medium term. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>AHI ‐ after 6 months</p> <p>Number of participants: 17<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean difference in AHI with CPAP was −17.80.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean difference in AHI with ASV was −46.47 (−60.91 to −32.03).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 28.67 lower<br/>(48.28 lower to 9.06 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV may reduce AHI in the medium term.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All‐cause mortality</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to life‐saving cardiovascular intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>AHI:</b> apnoea hypopnoea index;<b>ASV:</b> adaptive servo ventilation;<b>CI:</b> confidence interval; <b>CPAP:</b> continuous positive airway pressure; <b>CSA:</b> central sleep apnoea; <b>MD:</b> mean difference; <b>MLHFQ:</b> Minnesota Living with Heart Failure Questionnaire; <b>RCT:</b> randomised controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>We downgraded one level due to important methodological limitations (one study with high risk of bias for blinding of participants and personnel, blinding of outcome assessors, and incomplete outcome data and unclear risk of bias for random sequence generation, allocation concealment, and selective reporting).<br/><sup>2</sup>We downgraded two levels due to small sample size and large CI (CI includes both important benefit and important harm).<br/><sup>3</sup>We downgraded one level due to important methodological limitations (one study with high risk of bias for blinding of participants and personnel and incomplete outcome data and unclear risk of bias for random sequence generation, allocation concealment, and selective reporting).<br/><sup>4</sup>We downgraded one level due to small sample size. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Adaptive servo ventilation (ASV) versus continuous positive airway pressure (CPAP) for central sleep apnoea associated with chronic heart failure</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/full#CD012889-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012889-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Adaptive servo ventilation (ASV) versus bilevel ventilation for central sleep apnoea associated with chronic heart failure</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>ASV versus bilevel ventilation for CSA associated with chronic heart failure</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Participants:</b> people with CSA associated with chronic heart failure </p> <p><b>Setting:</b> outpatient </p> <p><b>Intervention:</b> ASV </p> <p><b>Comparison:</b> bilevel ventilation </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>What happens</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With bilevel ventilation</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With ASV</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Difference</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Central AHI ‐ after 6 weeks</p> <p>Number of participants: 30<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean central AHI with bilevel ventilation was 1.60.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean central AHI with ASV was 2.50 (0.06 to 4.94).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.90 higher <br/>(2.40 lower to 4.20 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝</p> <p>Low<sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV may result in little to no difference in central AHI in the short term.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cardiovascular mortality</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of sleep</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>AHI ‐ after 6 weeks</p> <p>Number of participants: 30<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean AHI with bilevel ventilation was 16.40.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean AHI with ASV was 11.20 (5.99 to 16.41).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 5.20 lower<br/>(14.63 lower to 4.23 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of ASV on AHI in the short term.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All‐cause mortality</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to life‐saving cardiovascular intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>AHI:</b> apnoea hypopnoea index;<b>ASV:</b> adaptive servo ventilation;<b>CI:</b> confidence interval; <b>CSA:</b> central sleep apnoea; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>We downgraded one level due to methodological limitations (all domains at unclear risk of bias except other potential sources of bias).<br/><sup>2</sup>We downgraded one level due to small sample size.<br/><sup>3</sup>We downgraded two levels due to small sample size and large CI (CI includes both important benefit and important harm). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Adaptive servo ventilation (ASV) versus bilevel ventilation for central sleep apnoea associated with chronic heart failure</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/full#CD012889-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012889-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Adaptive servo ventilation (ASV) versus continuous positive airway pressure (CPAP) for CPAP‐induced central sleep apnoea</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>ASV versus CPAP for CPAP‐induced CSA</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Participants:</b> people with CPAP‐induced CSA </p> <p><b>Setting:</b> outpatient </p> <p><b>Intervention:</b> ASV </p> <p><b>Comparison:</b> CPAP </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>What happens</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With CPAP</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With ASV</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Difference</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Central AHI ‐ after 3 months</p> <p>Number of participants: 60<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean central AHI with CPAP was 4.80.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean central AHI with ASV was 0.70 (−0.59 to 1.99)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 4.10 lower<br/>(6.67 lower to 1.53 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝</p> <p>Low<sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV may slightly reduce central AHI in the short term.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cardiovascular mortality</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of sleep</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life ‐ after 3 months</p> <p>Number of participants: 61<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean difference in quality of life with CPAP was 0.10.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean difference in quality of life with ASV was 0.10 (−0.27 to 0.47).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.00<br/>(0.46 lower to 0.46 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV may result in little to no difference in quality of life in the short term.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>AHI ‐ after 3 months</p> <p>Number of participants: 60<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean AHI with CPAP was 9.90.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean AHI with ASV was 4.40 (0.75 to 8.05).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 5.50 lower <br/>(10.74 lower to 0.26 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV may slightly reduce AHI in the short term.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All‐cause mortality</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to life‐saving cardiovascular intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>AHI:</b> apnoea hypopnoea index; <b>ASV:</b> adaptive servo ventilation;<b>CI:</b> confidence interval; <b>CPAP:</b> continuous positive airway pressure; <b>CSA:</b> central sleep apnoea; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>We downgraded one level due to important methodological limitations (one study with high risk of bias for blinding of participants and personnel and incomplete outcome data and unclear risk of bias for random sequence generation, allocation concealment, and blinding of outcome assessors).<br/><sup>2</sup>We downgraded one level due to small sample size.<br/><sup>3</sup>We downgraded one level due to important methodological limitations (one study with high risk of bias for blinding of participants and personnel, blinding of outcome assessors, and incomplete outcome data and unclear risk of bias for random sequence generation and allocation concealment). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Adaptive servo ventilation (ASV) versus continuous positive airway pressure (CPAP) for CPAP‐induced central sleep apnoea</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/full#CD012889-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012889-tbl-0005"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Adaptive servo ventilation (ASV) versus bilevel ventilation for CPAP‐induced central sleep apnoea</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>ASV versus bilevel ventilation for CPAP‐induced CSA</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Participants:</b> people with CPAP‐induced CSA </p> <p><b>Setting:</b> outpatient </p> <p><b>Intervention:</b> ASV </p> <p><b>Comparison:</b> bilevel ventilation </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>What happens</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With bilevel ventilation</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With ASV</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Difference</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Central AHI ‐ after 6 weeks</p> <p>Number of participants: 30<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean central AHI with bilevel ventilation was 10.20.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean central AHI with ASV was 1.50 (0.56 to 2.44).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 8.70 lower<br/>(11.42 lower to 5.98 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV may slightly reduce central AHI in the short term.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cardiovascular mortality</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of sleep</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>AHI ‐ after 6 weeks</p> <p>Number of participants: 30<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean AHI with bilevel ventilation was 16.50.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean AHI with bilevel ventilation was 7.40 (5.07 to 9.73).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 9.10 lower<br/>(13.67 lower to 4.53 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV may slightly reduce AHI in the short term.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All‐cause mortality</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to life‐saving cardiovascular intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>AHI:</b> apnoea hypopnoea index;<b>ASV:</b> adaptive servo ventilation;<b>CI:</b> confidence interval; <b>CPAP:</b> continuous positive airway pressure; <b>CSA:</b> central sleep apnoea; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>We downgraded one level due to methodological limitations (one study with high risk of bias due to lack of blinding of outcome assessment and incomplete outcome data and unclear risk of bias for random sequence generation and allocation concealment).<br/><sup>2</sup>We downgraded one level due to small sample size. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Adaptive servo ventilation (ASV) versus bilevel ventilation for CPAP‐induced central sleep apnoea</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/full#CD012889-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012889-tbl-0006"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Adaptive servo ventilation (ASV) plus best supportive care versus best supportive care alone or inactive control for central sleep apnoea associated with chronic heart failure</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>ASV plus best supportive care versus best supportive care alone or inactive control for CSA associated with chronic heart failure</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Participants:</b> people with CSA associated with chronic heart failure </p> <p><b>Setting:</b> outpatient </p> <p><b>Intervention:</b> ASV plus best supportive care </p> <p><b>Comparison:</b> best supportive care alone or inactive control </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>What happens</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With best supportive care</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With ASV plus best supportive care</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Difference</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Central AHI</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cardiovascular mortality ‐ up to 80 months</p> <p>Number of participants: 1325<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>RR 1.25<br/>(1.04 to 1.49) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24.00%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30.00%<br/>(24.90 to 35.70) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.00% more<br/>(1.00 more to 11.70 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV plus best supportive care likely increases cardiovascular mortality in the long term. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of sleep</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life ‐ after 48 months</p> <p>Number of participants: 1325<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life with best supportive care was 32.03.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life with ASV plus best supportive care was 32.86 (30.99 to 34.73).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.83 higher<br/>(1.81 lower to 3.47 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV plus best supportive care may result in little to no difference in quality of life in the long term. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>AHI ‐ after 6 months</p> <p>Number of participants: 30<br/>(1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean difference in AHI with best supportive care was −0.50.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean difference in AHI with ASV plus best supportive care was 20.80 (−28.80 to −12.71). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 20.30 lower<br/>(28.75 lower to 11.85 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV plus best supportive care may reduce AHI in the medium term.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All‐cause mortality ‐ up to 80 months</p> <p>Number of participants: 1355<br/>(2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>RR 0.56<br/>(0.06 to 4.93) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>29.20%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16.40%<br/>(1.80 to 100.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12.90% fewer<br/>(27.50 fewer to 114.90 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low <sup>3 6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV plus best supportive care may result in little to no difference in all‐cause mortality in the long term. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Time to life‐saving cardiovascular intervention</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>AHI:</b> apnoea hypopnoea index;<b>ASV:</b> adaptive servo ventilation;<b>CI:</b> confidence interval; <b>CSA:</b> central sleep apnoea; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>We downgraded one level due to important methodological limitations (one study with high risk of bias for incomplete outcome data and unclear risk of bias for allocation concealment).<br/><sup>2</sup>We downgraded one level due to important methodological limitations (one study with high risk of bias for blinding of participants and personnel, blinding of outcome assessors, and incomplete outcome data and unclear risk of bias for allocation concealment).<br/><sup>3</sup>We downgraded one level due to large CI (CI includes both important benefit and important harm).<br/><sup>4</sup>We downgraded one level due to important methodological limitations (one study with unclear risk of bias for random sequence generation, allocation concealment, blinding of outcome assessors, and selective reporting).<br/><sup>5</sup>We downgraded one level due to small sample size.<br/><sup>6</sup>We downgraded one level due to important methodological limitations (one study with high risk of bias for incomplete outcome data and unclear risk of bias for allocation concealment, and one study with high risk of bias for incomplete outcome data and selective reporting and unclear risk of bias for random sequence generation). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Adaptive servo ventilation (ASV) plus best supportive care versus best supportive care alone or inactive control for central sleep apnoea associated with chronic heart failure</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/full#CD012889-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012889-tbl-0007"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Study characteristics</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="center" class="headercell" colspan="7" rowspan="1" scope="col" valign="bottom"> <p><b>Participants</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comparator</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>N, condition</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>CSA or CSR criteria</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Age, mean (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>AHI, mean (SD) per hour/cAHI, mean % (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>BMI, mean (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>LVEF, mean % (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Men n (%)</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012889-bbs2-0001" title="ArztM , FlorasJS , LoganAG , KimoffRJ , SeriesF , MorrisonD , et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation2007;115 C(25):3173-80. [DOI: 10.1161/CIRCULATIONAHA.106.683482] [CRSREF: 19581355]ArztM , FlorasJS , LoganAG , RyanC , TomlinsonG , DouglasBT . The CANPAP trial: effects of CPAP on central sleep apnea, cardiovascular function and mortality in heart failure [Abstract]. Sleep Medicine2006;7 C:S19 [142]. [DOI: 10.1016/j.sleep.2006.07.046]ArztM , RyanC , LoganAG , FlorasJS , BradleyTD . Transplant free survival of heart failure patients according to effect of CPAP on central sleep apnea in the CANPAP trial [Abstract]. Proceedings of the American Thoracic Society2006;3:A516. BradleyTD , LoganAG , KimoffRJ , SeriesF , MorrisonD , FergusonK , et al. Continuous positive airway pressure for central sleep apnea and heart failure. New England Journal of Medicine2005;353(19):2025-33. [DOI: 10.1056/NEJMoa051001]RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea. Sleep2009;32 C(1):91-8. RuttanaumpawanP , LoganAG , FlorasJS , BradleyTD , CANPAP Investigators. Effect of continuous positive airways pressure on sleep structure in heart failure patients with central sleep apnea [Abstract]. In: American Thoracic Society International Conference; 2007 May 18-23; San Francisco. 2007. ">CANPAP 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>258 participants with CSA associated with chronic heart failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 or more episodes of apnoea and hypopnoea per hour of sleep, more than 50% of which were determined to be central </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 (16)/89<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29.05<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24.50 (7.70)<br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>248 (96.12)</p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CPAP plus best supportive care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Best supportive care</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012889-bbs2-0005" title="GrantonJT , NaughtonMT , BenardDC , LiuPP , GoldsteinRS , BradleyTD . CPAP improves inspiratory muscle strength in patients with heart failure and central sleep apnea. American Journal of Respiratory and Critical Care Medicine1996;153(1):277-82. [DOI: 10.1164/ajrccm.153.1.8542129]">Granton 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17 participants with CSA associated with chronic heart failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CSR‐CSA with a cAHI of at least 10/h of sleep, alternating with a crescendo‐decrescendo pattern of hyperpnoea; at least 85% of apnoeas and hypopnoeas had to be central </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58.15<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42<sup>a</sup>/NR </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27.15<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22.30<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17 (100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CPAP plus best supportive care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Best supportive care</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012889-bbs2-0009" title="NaughtonMT , LiuPP , BernardDC , GoldsteinRS , BradleyTD . Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. American Journal of Respiratory and Critical Care Medicine1995;151(1):92-7. [DOI: 10.1164/ajrccm.151.1.7812579]NaughtonMT , LuiPP , BenardDC , GoldsteinRS , BradleyTD . A randomized controlled clinical trial of CPAP in patients with heart failure and Cheyne-Stokes respiration. American Review of Respiratory Disease1993;147(7):A687. ">Naughton 1995a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29 participants with CSA associated with chronic heart failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CSR‐CSA, with a crescendo‐decrescendo pattern of hyperpnoea alternating with central apnoeas or hypopnoeas at a rate of &gt; 10/h of sleep </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58.80<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38.15<sup>a</sup>/NR<br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.55<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20.45<sup>a</sup><br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29 (100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CPAP plus best supportive care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Best supportive care</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012889-bbs2-0010" title="NaughtonMT , BenardDC , LiuPP , RutherfordR , RankinF , BradleyTD . Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. American Journal of Respiratory and Critical Care Medicine1995;152(2):473-9. [DOI: 10.1164/ajrccm.152.2.7633695]">Naughton 1995b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18 participants with CSA associated with chronic heart failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CSR‐CSA, with a crescendo‐decrescendo pattern of hyperpnoea alternating with central apnoeas or hypopnoeas at a rate of &gt; 10/h of sleep </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60.50 (1.40)<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42.70 (4.60)<sup>b</sup>/NR </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.80 (1.00)<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18.30 (2.00)<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18 (100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CPAP plus best supportive care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Best supportive care</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012889-bbs2-0014" title="SinDD , LoganAG , FitzgeraldFS , LiuPP , BradleyTD . Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation2000;102 C(1):61-6. [DOI: 10.1161/01.cir.102.1.61]">Sin 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29 participants with CSA associated with chronic heart failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CSR‐CSA, with a crescendo‐decrescendo pattern of hyperpnoea, alternating with central apnoeas or hypopnoeas at a rate ≥ 15 per hour of sleep of which &gt; 75% of events were central </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>57.90 (9.70)<br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39.20 (21.90)/NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20.20 (10.00)<br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29 (100)<br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CPAP plus best supportive care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Best supportive care</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012889-bbs2-0007" title="KasaiT , KasagiS , Maeno K-I, DohiT , KawanaF , KatoM , et al. Adaptive servo-ventilation in cardiac function and neurohormonal status in patients with heart failure and central sleep apnea nonresponsive to continuous positive airway pressure. JACC: Heart Failure2013;1(1):58-63. [DOI: 10.1016/j.jchf.2012.11.002]">Kasai 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23 participants with CSA associated with chronic heart failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>AHI 15 events per hour, of which ≥ 50% were central</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65.05<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47.85<sup>a</sup>/81.60<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.60<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32.45<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23 (100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CPAP</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012889-bbs2-0012" title="PhilippeC , Stoica-HermanM , DrouotX , RaffestinB , EscourrouP , HittingerL , et al. Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart2006;92(3):337-42. [DOI: 10.1136/hrt.2005.060038]">Philippe 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 participants with CSA associated with chronic heart failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CSR, with a crescendo–decrescendo periodic ventilation and CSA with an AHI of 15/h of which more than 80% were central </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62.25<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43.75<sup>a</sup>/NR </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29.50<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 (100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CPAP</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012889-bbs2-0004" title="FietzeI , BlauA , GlosM , TheresH , BaumannG , PenzelT . Bi-level positive pressure ventilation and adaptive servo ventilation in patients with heart failure and Cheyne-Stokes respiration. Sleep Medicine2008;9:652-9. [DOI: 10.1016/j.sleep.2007.09.008]">Fietze 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 participants with CSA associated with chronic heart failure</p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CSR with an RDI &gt; 15/h, with less than 20% obstructive respiratory events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58.90 (10.40)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33.30<sup>a,c</sup>/ 32.20<sup>a,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28 (3.90)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.05<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34 (91.89)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bilevel ventilation</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012889-bbs2-0008" title="MorgenthalerTI , KuzniarTJ , WolfeLF , WillesL , McLainWC , GoldbergR . The Complex Sleep Apnea Resolution Study: a prospective randomized controlled trial of continuous positive airway pressure versus adaptive servoventilation therapy. Sleep2014;37(5):927-34. [DOI: 10.5665/sleep.3662]">Morgenthaler 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>66 participants with CPAP‐induced CSA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CPAP titration eliminating events defining OSA, but had a residual CAI ≥ 10 events/hour or residual CSR pattern that was predominant and disruptive during PSG </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>59.20 (12.90)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34.45<sup>a</sup>/ 23.70<sup>a,e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35.00 (8.00)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>56 (84.84)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CPAP</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012889-bbs2-0003" title="DellwegD , KerlJ , HoehnE , WenzelM , KoehlerD . Randomized controlled trial of noninvasive positive pressure ventilation (NPPV) versus servoventilation in patients with CPAP-induced central sleep apnea (complex sleep apnea). Sleep2013;36(8):1163-71. [DOI: 10.5665/sleep.2878]">Dellweg 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 participants with CPAP‐induced CSA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>AHI ≥ 15 during the initial PSG with a predominance of obstructive events according to AASM criteria and AHI ≥ 15 on CPAP therapy after 6 weeks of CPAP treatment during a follow‐up PSG with a predominance of central events according to AASM criteria </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62.50<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28.15<sup>a</sup>/ 17.45<sup>a,e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21 (70)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bilevel ventilation</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012889-bbs2-0013" title="CowieM , WoehrleH , WegscheiderK , AngermannC , D'OrthoMP , ErdmannE , et al. Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results. European Respiratory Journal2015;46:OA3475. [DOI: 10.1183/13993003.congress-2015.OA3475]CowieMR , WoehrleH , WegscheiderK , AngermannC , D'Ortho M-P, ErdmannE , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. New England Journal of Medicine2015;373(12):1095-105. [DOI: 10.1056/NEJMoa1506459]CowieMR , WoehrleH , WegscheiderK , VettorazziE , LeziusS , KoenigW , et al. Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF. European Journal of Heart Failure2018;20:536-44. [DOI: 10.1002/ejhf.1048]EulenburgC , WegscheiderK , WoehrleH , AngermannC , D'Ortho M-P, ErdmannE , et al. Understanding SERVE-HF: a multistate analysis to explain mechanisms underlying increased mortality risk in patients randomised to adaptive servo-ventilation (ASV). European Respiratory Journal2016;48:OA1985. [DOI: 10.1183/13993003.congress-2016.OA1985]TamisierR , PepinJL , CowieM , WegscheiderK , VettorazziE , SulingA , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure: PSG data from the SERVE-HF major substudy. American Journal of Respiratory and Critical Care Medicine2017;195:A4513. [DOI: 10.1164/ajrccm-conference.2017.B80-G]TamisierR , Pepin J-L, SalvatM , WoehrleH , Barone-RochetteG , RoccaC , et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure does not improve muscle sympathetic nerve activity: a SERVE-HF substudy. European Respiratory Journal2016;48:PA2083. [DOI: 10.1183/13993003.congress-2016.PA2083]">SERVE HF 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1325 participants with CSA associated with chronic heart failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>cAHI of ≥ 10 events/hour and AHI of ≥ 15 events/hour, of which &gt; 50% were central</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69.45<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31.45<sup>a</sup>/ 81.30<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28.50<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32.35<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1198 (90.42)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV plus best supportive care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Best supportive care</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012889-bbs2-0006" title="HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three months treatment with adaptive servo-ventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration in a prospective randomized controlled trial. Circulation2011;124(21 Suppl):A11007. [DOI: 10.1161/circ.124.suppl_21.A11007]HetlandA , HaugaaKH , OlsengM , GjesdalO , RossS , SaberniakJ , et al. Three-month treatment with adaptive servoventilation improves cardiac function and physical activity in patients with chronic heart failure and Cheyne-Stokes respiration: a prospective randomized controlled trial. Cardiology2013;126(C(2)):81-90. [DOI: 10.1159/000350826]OlsengMW , OlsenBF , HetlandA , FagermoenS , JacobsenM . Quality of life improves in patients with chronic heart failure and Cheyne-Stokes respiration treated with adaptive servo-ventilation in a nurse-led heart failure clinic. Journal of Clinical Nursing2017;26(9-10):1226-33. [DOI: 10.1111/jocn.13416]">Hetland 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51 participants with CSA associated with chronic heart failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CSR of &gt; 25%; CSB with a minimum of 3 consecutive cycles of a crescendo‐decrescendo pattern in the breathing signal with periods of hyperventilation separated by central apnoeas or hypopnoeas </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70.50<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29.65<sup>a</sup>/65.50<sup>a,f</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27.15<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31.80<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47 (92.16)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV plus best supportive care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Best supportive care</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012889-bbs2-0011" title="PepperellJCT , MaskellNA , JonesDR , Langford-WileyBA , CrosthwaiteN , StradlingJR , et al. A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. American Journal of Respiratory and Critical Care Medicine2003;168(9):1109-14. [DOI: 10.1164/rccm.200212-1476OC]">Pepperell 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 participants with CSA associated with chronic heart failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 50% of apnoeas or hypopnoea events were central</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>71.15<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24<sup>a</sup>/NR </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.20<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34.75<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29 (96.67)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV plus best supportive care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Best supportive care</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012889-bbs2-0015" title="ToyamaT , HoshizakiH , KasamaS , MiyaishiY , KanH , YamashitaE , et al. Adaptive servo-ventilation therapy improves cardiac sympathetic nerve activity, cardiac function, exercise capacity, and symptom in patients with chronic heart failure and Cheyne-Stokes respiration. Journal of Nuclear Cardiology2016;24(6):1-12. [DOI: 10.1007/s12350-016-0529-9]">Toyama 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31 participants with CSA associated with chronic heart failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CSR‐CSA, with at least 3 consecutive cycles of a cyclic crescendo‐decrescendo change in breathing and an AHI ≥ 5/h, or persistence of a cyclic crescendo‐decrescendo breathing pattern for at least 10 consecutive minutes </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68 (9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25.25<sup>a</sup>/37.85<sup>a,g</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24.10<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.50<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28 (93.33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV plus best supportive care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Best supportive care</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012889-bbs2-0002" title="D'eliaE , FerreroP , VittoriC , BaioP , DuinoV , GrosuA , et al. Enhanced adaptive servo-ventilation improves echocardiographic parameters of diastolic and right ventricle function in patients with sleep apnea and heart failure with preserved ejection fraction. European Journal of Heart Failure2016;18:474. D’EliaE , FerreroP , VittoriC , IacovoniA , GrosuA , GoriM , et al. Beneficial effects of adaptive servo-ventilation on natriuretic peptides and diastolic function in acute heart failure patients with preserved ejection fraction and sleep-disordered breathing. Sleep and Breathing2019;23:287-91. [DOI: 10.1007/s11325-018-1681-z]">D'Elia 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 participants with CSA associated with acute heart failure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>AHI &gt; 15/h, of which &gt; 50% were central</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69.90<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36.90<sup>a</sup>/28<sup>a,e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.65<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50.80<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 (100)<br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASV plus best supportive care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Best supportive care</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="10"> <div class="table-footnote"> <p>Abbreviations: AASM: American Academy of Sleep Medicine; AHI: apnoea hypopnoea index; ASV: adaptive servo ventilation; BMI: body mass index; cAHI: central apnoea hypopnoea index; CAI: central apnoea index; CPAP: continuous positive airway pressure; CSA: central sleep apnoea; CSB: Cheyne‐Stokes breathing; CSR: Cheyne‐Stokes respiration; LVEF: left ventricular ejection fraction; NR: not reported; OSA: obstructive sleep apnoea; PSG: polysomnography; RDI: respiratory disturbance index; SD: standard deviation </p> <p><sup>a</sup>As the study did not provide total measures, we calculated an average between means of experimental and control groups.<br/><sup>b</sup>Data expressed in standard error.<br/><sup>c</sup>Respiratory disturbance index per hour calculated by the sum of Cheyne‐Stokes respiration index, obstructive apnoea index, and mixed apnoea index.<br/><sup>d</sup>Cheyne‐Stokes respiration index per hour.<br/><sup>e</sup>Central sleep apnoea index, events per hour.<br/><sup>f</sup>Cheyne‐Stokes respiration %.<br/><sup>g</sup>CSA %. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Study characteristics</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/full#CD012889-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012889-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">CPAP plus best supportive care versus best supportive care (or inactive control) in CSA associated with chronic heart failure</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 AHI ‐ short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>264</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐15.27 [‐22.44, ‐8.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 Industry sponsored</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>229</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐18.86 [‐24.25, ‐13.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 Not industry sponsored</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.56 [‐20.34, 7.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 All‐cause mortality ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.83, 1.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">CPAP plus best supportive care versus best supportive care (or inactive control) in CSA associated with chronic heart failure</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/references#CD012889-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012889-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">ASV versus CPAP in CSA associated with chronic heart failure</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 AHI ‐ short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐20.37 [‐25.32, ‐15.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">ASV versus CPAP in CSA associated with chronic heart failure</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/references#CD012889-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012889-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">ASV plus best supportive care versus best supportive care alone (or inactive control) in CSA associated with chronic heart failure</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Quality of life ‐ short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1355</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐2.31, 2.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 All‐cause mortality ‐ long term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1355</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.06, 4.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">ASV plus best supportive care versus best supportive care alone (or inactive control) in CSA associated with chronic heart failure</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012889.pub2/references#CD012889-tbl-0010">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012889.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD012889-note-0012">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD012889-note-0022">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012889-note-0020">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD012889-note-0021">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD012889-note-0019">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD012889-note-0016">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD012889-note-0018">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD012889-note-0015">Português</a> </li> <li class="section-language"> <a class="" href="th#CD012889-note-0017">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD012889-note-0013">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD012889-note-0014">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012889\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012889\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012889\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012889\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012889\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012889\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012889\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012889\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012889\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012889\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012889\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012889\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012889\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012889\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012889\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012889\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012889\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012889\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=kKvAiZoF&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012889.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012889.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012889.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012889.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012889.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740717639079"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012889.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740717639083"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012889.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dbcd439bd9371',t:'MTc0MDcxNzYzOS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 